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PREFACE 
In 1954, Duboulez and Dumas reported the occurrence of lipid perox-
ides in the hind 1 imb of a rat as a consequence of injury by heat, X- and 
ultraviolet radiation. They distinguished between two types of peroxide 
formation: one as a direct result of injury and the other as a result of 
the inflammatory process following injury. 
Seventeen years later it was discovered that aspirin-] ike anti-
inflammatory drugs inhibited the biosynthesis of prostaglandins, which are 
formed from essential fatty acids via .endoperoxide intermediates. Since this 
discovery, the interactions between prostaglandin biosynthesis, its inhibi-
tion and acute inflammation, have been widely studied, and it appeared that 
the inhibition of the biosynthesis of prostaglandins was an essential 
component in the mode of action of anti._inflammatory drugs. Subsequent 
studies showed that many anti-inflammatory drugs which were highly 
efficient against inflammation models, were only slightly effective 
against rheumatoid arthritis. This fact led to the initiation of new 
investigations with anti-rheumatic drugs, but now with the emphasis on 
alternative modes of action, i.e. not 1 imited to the inhibition of prosta-
glandin biosynthesis and not 1 imited to the site of inflammation alone. 
This thesis deals with the suspected involvement of free radicals 
and 1 ipid peroxidation in various types of chronic inflammation in the rat, 
which are relevant as models for rheumatoid arthritis in man. Apart from 
local interactions at the site of inflammation, systemic effects have also 
been studied. Attention has been focussed on the role of the liver during 
a remote extra-hepatic inflammation. The underlyin~ supposition is the 
possibility of a central role of the 1 iver in endogenous modulation of 
inflammation. 
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PART I. INTRODUCTION 
1. LIPID PEROXIDATION 
Lipid peroxidation is the oxidative deterioration of 1 ipids 
involving free radical mechanisms. Sometimes the term 1autoxidation 1 is 
used in the 1 iterature to describe the chain of reactions occurring during 
this deterioration, although, strictly speaking, it is incorrect: during 
1 ipid peroxidation, molecular oxygen acts as the oxidant and accepts 
electrons from the oxidizing 1 ipids to form peroxides with them. ln fact, 
when left by itself (i.e. when atmospheric oxygen is excluded) even a fatty 
acid with a high degree of unsaturation wil 1 be stable for many hours, days 
and perhaps even years. The term 'deterioration 1 is also inadequate, in view 
of the fact that enzyme-catalyzed 1 ipid peroxidation provides an organism 
with essential, locally acting hormones, the prostaglandins. Thus, conversion 
is a better term than deterioration. 
In this thesis, I shall distinguish between two different types of 
1 ipid peroxidation, varying according to the initiating process. The 
peroxidation of unsaturated fatty acids containing a cis~cis-1 ,4-pentadiene 
system, for example arachidonic acid (20:4~ w6) and dihomo-y-1 inolenic acid 
(20:3, w6) (see structures belOw), which is initiated by a fatty acid 
w-site 
20
Nv=v=v=v=v0COOH 
arachidonic acid dihomo-y-linolenic acid 
cycle-oxygenase (or prostaglandin synthetase) and a 1 ipoxygenase, will be 
referred to as 1 specific 1 lipid peroxidation. The term 1 specific 1 is used 
to cover the substrate and product specificity of the peroxidative 
coversion of the fatty acids involved. On the other hand, the free radical-
induced peroxidation of 1 ipids will be referred to as 1unspecific 1 1 ipid 
peroxidation, because almost any 1 ipid substrate is susceptible to free 
radical attack and numerous products wil 1 be formed, although the formation 
of many products is dependent on certain structural properties of the 
substrate involved. An example of this is the formation of malonaldehyde 
(or malon~aldehyde) from unsaturated fatty acid precursors. Significant 
formation of malonaldehyde during unspecific peroxidation only occurs if 
the substrate has more than two double bonds (in other words, if it is more 
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than twofold unsaturated). This will be discussed in the section on reaction 
mechanisms of 1 ipid peroxidation. 
This chapter wil 1 deal with mechanisms of 1 ipid peroxidation, the 
different ways in which it can be initiated, the different radicals involved 
and their eventual scavengers, the problems of the detection of 1 ipid 
peroxidation in biological systems (especially 1 iving organisms) and the 
consequences of lipid peroxidation for these systems or organisms. Although 
a wide variety of 1 ipids are susceptible to peroxidation under appropriate 
conditions (i.e. temperature, oxygen pressure, presence of catalysts), 
attention will be focussed on polyunsaturated fatty acids (PUFA). The reason 
for this is twofold: PUFA are of major importance as constituents of al 1 
structural membranes of mammals and secondly, PUFA are extremely prone to 
1 ipid peroxidation, even at body temperature, on the base of their 
structural and thermodynamic properties. 
1.1. Free radical chemistry of 1 ipid peroxidation 
This section is largely based on reviews by Swern (1961), Slater 
(1972), Pryor (1973), Mead (1976) and Mead and Fulco (1976). 
Studies on oxidizing monolayers of PUFA clearly demonstrate that 
1 ipid peroxidation consists of a chain of free radical processes. The chain 
starts with the 1 initiation 1 , i.e. the generation of free radicals from 
nonradical parent molecules (reaction 1). The initiator may be any source 
RH - R· + H· (I ) 
of sufficient energy, 1 ike heat, ultraviolet radiation, X-rays and in this 
case t"he rupture of the covalent C-H bond is called 1 homolysis 1 • When the 
dissociation of the C-H bond is caused by the action of other atoms or 
molecules, as for example in reactions 2 and 3, this is referred to as 
RH + 0
2 
_.. ROO· + H· 
Fe2++ ROOH - Fe3++ RO· + HO 
(2) 
(3) 
1 molecule-induced homolysis 1 • Reaction 2 may represent the direct attack of 
singlet oxygen ( 1 ~9 o 2 ; the ~ctivated state, which is 92 kJ above the ground 
state or triplet oxygen, 3rgo 2), while reaction 3 is of great importance in 
the propagation of NADPH-dependent 1 ipid peroxidation in 1 iver cells. 
1Propagation 1 is the sequence of free radical reactions following 
the initiation step. During propagation, the total number of radicals either 
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remains constant or increases and many intermediates will be produced and 
degraded. Examples of propagation are given in reactions 4 and 5. Also during 
R· + 02 - ROO-
ROO· + RH - ROOH + R· 
(4) 
(5) 
propagation, the chain of a molecule R may break down into several smaller 
fragments and these fission products may then be partly radical and partly 
nonradical in nature. 
When radicals combine to deliver nonradical species, as for 
example shown in reactions 6-8, this is called the 1 termination 1 phase. In 
2R· - RR 
ROO· + R· - ROOR 
2ROO • - 02 + ROOR 
(6) 
(7) 
(8) 
the case of adequately chosen compounds and reaction conditions, the end 
products obtained in the termination phase may be polymeric substances, such 
as polyethylene, polyvinylchloride or polyethylene terephthalate. The 
reaction chain may even be broken during the propagation phase, if relativ-
ely unreactive radicals are formed. Unreactive radicals are, for example, 
formed from antioxidants, to yield products with a long half-] ife. The same 
effect can be achieved by lowering the temperature during the propagation 
phase, thus reducing the chances of collision of the radical species. It 
will be obvious now, that the addition of antioxidants, e.g. tocopherols, 
propyl gallate and butylated cresols, prevent the propagation phase of lipid 
peroxidation and thereby the usual formation of stable end products. Slater 
defines antioxidants in the broadest sense as: 1 compounds, which inhibit 
the oxidative deterioration of other materials, for example 1 ipids 1 • Using 
this definition, the antioxidants comprise free radical scavengers, chain-
breaking compounds and even chelators of metal ion catalysts. Free radical 
scavengers react with radical species to form nonradical products. Lipid 
peroxidation is prevented by the addition of certain scavengers, because 
the initiating radicals are transformed into less reactive molecules. The 
boundaries between 1 real 1 antioxidants and 1 real 1 scavengers are not very 
sharp. Thus, scavengers are not necessarily antioxidants as some radicals 
may have reducing properties, rather than oxidizing ones. Analogously, an 
antioxidant is not necessarily a radical scavenger, for instance the metal 
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Figure 1. Mechanism of free radical-induced 1 ipid peroxidation. This scheme has 
been composed from data in the literature. See text for further details. 
chelator, EDTA. 
In summary, it is possible to fit the pieces of the puzzle of 1 ipid 
peroxidation into a scheme of reaction pathways. The scheme should explain 
the formation of the well-known stable end products of 1 ipid peroxidation 
and also the levels of interaction of free radical scavengers and anti-
oxidants. A generalized scheme of reactions has been composed from data 
in the 1 iterature and is presented in Figure 1. This figure shows that the 
initial step in the peroxidation of PUFA (e.g. arachidonic acid) is the 
abstraction of a hydrogen atom (H·) from preferred positions of the fatty 
acid. The positions, which are the most 1 iable to hydrogen abstractions are 
the methylene groups, interposed between the unsaturated bonds and these are 
localized at the carbon atoms 7, 10 and 13 of the arachidonate molecule. 
Potent molecular initiators of 1 ipid peroxidation are the radical species, 
superoxide radical (·a;, Kellogg and Fridovich, 1975) and the hydroxyl 
radical (HO·, Lai and Piette, 1978), and also the nonradical species, 
singlet oxygen ( 1 ~go2 or 1o2 , Baird et al, 1977) and ozone (03 , Goldstein 
et al, 1968). 
As the superoxide radical is considered to be relatively unreactive 
toward other molecules (Koppenol and Butler, 1977), it is conceivable that 
·a; has to be transformed into one of the other species mentioned, before it 
is able to attack 1 ipids. Singlet oxygen attacks double bonds directly and 
the intermediates formed may be either hydroperoxides or dioxethanes (see 
Rabek and Ranby, 1978) as shown in reaction 9. Room temperature is probably 
o-o 
v-v and/or 
dioxetane 
/OOH 
v,-v 
hydroperoxide 
(9) 
sufficient to_ cause the cleavage of these intermediates, resulting in free 
radicals and concomitant 1 ipid peroxidation. The exact mechanisms of ozone-
induced 1 ipid peroxidation are still obscure, but recent investigations 
(Pryor, 1978) suggest that the initiation of peroxidation may proceed via 
reactions 10-11. The decomposition of the trioxide intermediate into 
,o, 
0 0 
v=v=v + a -3 
v=J-~ 
0\ HOO 0· 
\ I \ I 
v=v-v - v=v-v and 
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(I 0) 
HOO 0· 
v-,J-~ (II ) 
radical fragments (11), which can act as initiators, explains the fact that 
conjugated dienes are observed during ozone-induced 1 ipid peroxidation. 
Besides leading to the formation of trioxides, ozonolysis of olefines also 
leads to the formation of a type of ozonides named after Criegee. A Criegee 
ozonide decomposes to aldehydes and acids, but not to radicals, as shown in 
reaction 12. 
PUFA + 03 
( 12) 
Criegee ozonide 
After the initial abstraction of hydrogen atoms from the positions 
7, 10 and 13 of the arachidonate molecule (Figure 1), the reaction sequence 
proceeds with a rearrangement of double bonds to conjugated diene fragments. 
It will be clear from the figure that there will b·e 6 possible tetraenes 
containing a conjugated diene fragment. The tetraenes have a radical site 
at the positions 5, 8, 9, 11, 12 and 15, respectively. The following step is 
the attachment of molecular oxygen to the radical site of the conjugated 
diene. If a hydrogen atom is picked up from another fatty acid molecule, the 
resulting molecule is a relatively stable hydroperoxide, characterized by 
its -OOH group. Cycl ization wil 1 occur when the peroxy-radical group (-00·) 
has an adjacent double bond in a S,y-position. The resulting cyclic 
peroxides may undergo further cycl ization to prostaglandin endoperoxide-
1 ike compounds. The latter may decompose, due to heat or H+, to several 
fragments, including malonaldehyde, a ,component which can be very sensitiv-
ely detected by its reaction with 2-thio-barbituric acid (see Chapter 1.4). 
The theoretical ratio of formation of hydroperoxides versus cyclic peroxides 
is 2:4. However, in the presenCe of metal catalysts (ferrous ions), the 
hydroperoxides decompose to several fragments and among these, alkanes 
(ethane in the case of w3-fatty acids and pentane in the case of w6-fatty 
acids) are present (Donovan and Menzel, 1978). The importance of alkanes 
for the detection of 1 ipid peroxidation in vivo, wil 1 be considered in 
Chapter 1 .4. The peroxidation of fats results in numerous stable end 
products, many·of which contribute to the observed 1 rancidity 1 , as they 
flavour the original fat by their presence. Among these end products are 
hydroperoxides, endoperoxides, alkanes, alkenes, aldehydes, alcohols 
and carbon dioxide (Loury, 1972). Even epoxides and carbon monoxide have 
been detected under certain circumstances in peroxidizing biological 
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Figure 2. ~1ultiple pathways of arachidonate metabolism (courtesy of M.J.·Parnham). See text for details. 
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systems (Sevdnian et al, 1979; Wolff and Bidlack, 1976). 
1.2. Enzyme-catalyzed 1 ipid peroxidation 
a. Biosynthesis of prostdglandins and reldted substances 
Virtually all mammal ian eel ls have the capacity to biosynthesize 
prostaglandins, the 1 ipid autacoids (local hormones), which were named by 
Von Euler in Sweden (1935). He believed that the substances causing vasa-
depression and contraction of the uterus origindted from the prostate gland. 
The effects on the uterus of substances in fresh human semen actually led 
to the discovery of prostaglandins (Kurzrok and Lieb, 1930). This chapter 
surveys the biosynthesis of prostaglandins and related 1 ipids and the 
interactions with 1 ipid peroxidation of different origin. For general aspects 
of the mechanisms of prostaglandin biosynthesis and (patho-)physiological 
effects, other than related to inflammation, the reader is referred to 
excellent reviews by Hinman (1972), Gibson (1977), Hemler and Lands (1977), 
Vapaatalo and Parantainen (1978) and Lands (1979). 
The chemical structure of the prostaglandins is derived from the 
hypothetical 1 prostanoic acid 1 , with 20 cdrbon atoms and a cyclopentane 
element as elements of the skeleton. The autacoids are synthesized de novo 
from specific fatty acid precursor.:s, namely, dihomo-y-1 inolenic acid (8,11, 
14-eicosatrienoic acid), arachidonic acid (5.8,11 ,14-eicosatetraenoic acid) 
and 5,8, 11, 14, 17-eicosapentaenoic acid, with the formation of prostaglandins 
(PG 1 s) of the 1, 2 and 3 series, respectively. The enzyme system responsible 
for the bis-dioxygenation of the free fatty acids is cycle-oxygenase (PG-
synthetase). Cycle-oxygenase is localized in the microsomal fraction of 
cells (100,000 g), consists of four subunits of 70,000 daltons and requires 
heme for maximal activity. The substrates are obligatory free fatty acids, 
which have to be de-esterified before they are converted to prostaglandins. 
Arachidonic acid, the most abundant precursor in mammals, is esterified 
mainly in the membrane phospho] ipids. Other, less important stores are the 
triglycerides (e.g. adipose tissue) and cholesterol esters (e.g. adrenal 
tissue). The distribution of arachidonate in the phospho] ipids of human 
platelets is: 47% in the phosphatidyl ethanolamine fraction, 28% in the 
phosphatidyl inositol fraction, and 13 and 12% in the phosphatidyl serine 
and choline (lecithin) fractions, respectively (Blackwell et al, 1977). 
As a result of the actions of acylhydrolases (e.g. phospholipase 
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A2 , which splits off the fatty acid from the 2 1 -acyl position in phospho-
1 ipids), the polyenoic fatty acids are 1 iberated from their stores and once 
in the free form, become substrates for cyclo-oxygenases and 1 ipoxygenases. 
The multiple pathways of the metabolism of arachidonate are given in Figure 
2 (courtesy of M.J. Parnham). Lipoxygenase inserts one oxygen molecule into 
the fatty acid, resulting in a hydroperoxy intermediate (HPETE). Depending 
on the type of 1 ipoxygenase, the hydroperoxy moiety may be localized on the 
5, 8, 12 and 15 position (see Tobias and Hamilton, 1979). The hydroperoxy 
fatty acid is converted to the corresponding hydroxy derivative by the 
action of a peroxidase, which may be part of the 1 ipoxygenase itself. 
The heme-requiring bis-dioxygenase, cycle-oxygenase, inserts two 
oxygen molecules into one substrate molecule, resulting in the formation 
of the prostaglandin endoperoxide, PGG 2 , which is converted to PGH 2 by a 
peroxidase with an affinity for the 15-hydroperoxy moiety of PGG 2. In 
aqueous solutions, PGH 2 has a half-1 ife of 4 to 5 min. at 37°C. In cells, 
further conversion of PGH 2 is assured by the presence of isomerases, reduct-
ases and synthetases, which, depending on the kind of tissue, catalyze the 
formation of the 1 classical 1 PG 1 s, PGE 2 , PGF2~ and PGD 2 , the thromboxanes, 
TXA2 (T~ = 30 s at 37°C) and its decomposition product, TXB2. Prostacycl in 
(PGI 2 , T~ = 10 min. at 20°C) and its stable metabolite, 6-ketoPGFla' are 
also formed. Presumably also as-a result of a thromboxane synthetase, the 
hydroxy-fatty acid, 12L-hydroxy-5,8, 10-heptadecatrienoic acid (HHT) and 
malonaldehyde are formed. Thus, malonaldehyde is not only formed as a result 
of the free radical-induced peroxidation of 1 ipids (see Chapter 1. 1), but 
also enzymatically during the biosynthesis of prostaglandins, via the 
endoperoxide intermediates, PGG 2 and PGH2 . 
Recently, it has been shown that the formation of 1 slow-reacting 
substance of anaphylaxis 1 (SRS-A), the 1 ipid autacoid released from lungs 
on treatment with cobra venom or on immunological challenge (Feldberg and 
Kel laway, 1938; Kel ]away and Trethewie, 1940), is dependent on a 1 ipoxy-
genase with a specificity for the 5-position of the arachidonate molecule 
(Murphy et al, 1979). The originally postulated structure of SRS, given in 
Figure 2, is a 5-hydroxy-fatty acid derived from arachidonic acid with 
cysteine substituted at the 6-position. However, the structure of the 
substituent, which is thioether-1 inked at this position, is subject to 
controversion. A recent paper (Morris et al, 1980) revealed the presence 
of a cysteinyl-glycine substituent, which might be the ultimate result of 
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proteolytic cleavage of a complete glutathione molecule linked to the 6-
position. lt is speculative to consider SRS 1 s as detoxified hydroperoxides, 
in analogy with hepatic glutathione conjugation. lt is conceivable that 
different SRS 1 s exist depending on the kind of synthesizing cells. Recently, 
the name 1 Leukotrienes 1 has been introduced for the class of derivatives 
from 7,9,11 ,14-eicosatetraenoic acid (Borgeat and Samuelsson, 1979). Besides 
the formation of 5-HPETE, the intermediate in the biosynthesis of 
leukotrienes (LT 1 s), hydroperoxy moieties are also found to be inserted at 
positions 8, 12 or 15 of the arachidonate molecule, resulting in 8-HPETE, 
12-HPETE and 15-HPETE, respectively (see Tobias and Hamilton, 1979). 
Figure 3 shows the products formed as a result of the 1 ipoxygenase activities 
in different cells. 
5,8,11,14-Eicosotetroenoic Acid 
(Arachidonic Acid) 
8,11,14-Eicosotrienoic Acid 
Dihomo-y-Linolenic Acid 
soybeon 
bovine platelet 
human platelet, 
skin, spleen ond lung 
Ro,bbit PMN's 
Rabbit PMN's 
"' H OOH 
COOH 
cH3 
15-L-Hydroperoxy -5,8,! 1,13-
Eicosotetroenoic Acid 
COOH 
cH3 
H OOH 
12-L-Hydroperaxy- 5,8,10,14-
E icosatetroenolc Acid 
5-t-Hydroperoxy- 6,8, 11,14-
Eicosatetroenolc Acid 
~g~, 
8-L- Hydroperoxy- 9,1 !, 14-
Eicosotrienoic Acid 
Figure 3. Formation of hydroperoxy intermediates from fatty acid precursors, 
depending on the type of cell involved (adapted from Tobias and 
Hami 1 ton, 1979). 
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b. Interactions between prostaglandin synthetase-dependent 
and -independent 1 ipid peroxidation 
The formation of prostaglandin endoperoxides is not merely 1 imited 
to the enzymatic actions of cycle-oxygenase in various tissues, since it has 
been shown that during the autoxidation of PUFA, prostaglandin endoperoxide-
1 ike compounds are formed (Pryor and Stanley, 1975; Pryor et al, 1976). 
Furthermore, the nonvolatile precursor of malonaldehyde formed from PUFA 
containing more than two double bonds, is an endoperoxide (Pryor et al, 
1976; see Figure 1). In view of the fact that, from a trienoic acid, 128 
stereo isomers of the endoperoxide could possibly be formed during 1 ipid 
peroxidation, it is extremely 1 ikely that at least a few of them bear a 
close resemblance to the prostaglandin endoperoxides, PGG and PGH (Pryor 
and Stanley, 1975). ln addition to the formation of prostaglandin endoper-
oxide-1 ike compounds during PUFA autoxidation, hydroperoxides are also 
formed. It has for example been shown that the precursor of SRS-A, namely 
5-hydroperoxy-6,8,11 ,14-eicosatetraenoic acid (5-HPETE) is formed when 
arachidonic acid is expOsed to atmospheric oxygen for 48 h (Porter et al, 
1979). This emphasizes the point of view acco~ding to which SRS 1 s are 
regarded to be detoxified products of hydroperoxides due to conjugation 
with glutathione or its fragments. 
Another interaction between cycle-oxygenase-dependent and 
-independent 1 ipid peroxidation is the fact that cycle-oxygenase requires a 
peroxide activator to induce its activity (Cook and Lands, 1976). Evidence 
for this was obtained by the observed inhibition of cycle-oxygenase activity 
on the addition of glutathione peroxidase. This enzyme, which requires 
reduced glutathione (GSH) as an electron donor, catalyzes the conversion of 
hydrogen peroxide (or organic hydroperoxides) to water (or the corresponding 
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hydroxy derivatives). A direct implication of the cycle-oxygenase requirement 
for a peroxide activator is the regulating role on the biosynthesis of 
prostaglandins of peroxides (hydroperoxides, hydrogen peroxide, superoxide 
anions) or factors control 1 ing the eel lular levels of 8eroxides (GSH + 
glutathione peroxidase, catalase, superoxide dismutase, vitamin E; see 
Chapter 1 .3). Very low levels of peroxide may be sufficient to trigger the 
biosynthesis of prostaglandins, and PGG2 , once formed, can take over the 
activation of cycle-oxygenase by hydroperoxides (Hemler et al, 1979). These 
possibilities have been summarized in Figure 4. \n view of the fact that 
peroxidases 
catalase 
lipids decomposition (T,) 
l i poxygenases L 2 
autoxidation ____ _,__ _ _.I LIPID PEROXIDESI---::....---!tt-removal 
oxidants 
* ACTIVATION* 
free polyenoic fatty acids 
OF l d. CYCLO-OXYGENASE r+ PGG -+ prostag an 1 ns 
' · 2 thromboxanes 
Figure 4. Requirement of cycle-oxygenase for a peroxide activator (adapted 
from Hemler et al, 1979). Lipid peroxides are formed as a result 
of fatty acid autoxidation or 1 ipoxygenation and destroyed by 
spontaneous or enzyme-catalyzed decomposition. The prostaglandin 
endoperoxide, PGG2 may replace 1 ipid peroxide as an activator. 
1 ipoxygenases and cycle-oxygenase are distributed throughout the tissues in 
close proximity the generation of peroxide activators for cycle-oxygenase 
may be one of the physiological roles of the lipoxygenases. In addition, 
the 1 ipoxygenase pathway may function as a kind of 1overflow 1 pathway for 
the metabolism of polyenoic fatty acids, since it has been reported 
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that platelet 1 ipoxygenase deficiency leads to a decreased treshold for 
aggregation induced by arachidonic acid (Okuma and Uchino, 1977). 
The enzyme catalyzing the formation of prostacycl in (PG1 2) from the 
prostaglandin endoperoxide PGH 2 , prostacycl in synthetase, is very sensitive 
to inhibition by peroxides. For instance, 15-hydroperoxy arachidonate (15-
HPETE) and 3-hydroperoxy-3-methyl-2-phenyl-3H-indole (HPI) are potent 
HOO ~,v=v=v=vvCOOH 
15-HPETE 
inhibitors of prostacyclin synthetase (Gryglewski et al, 1976; Terashita et 
al, 1979). The effects of peroxides as inhibitors of prostacycl in synthetase 
are not very specific, as 9-, 11- and 12-HPETE are all potent inhibitors 
(lc50 ranges from 3-10 ~M) of human platelet cycle-oxygenase (Siegel et al, 
1979a). This inhibition is most probably due to the peroxidase activity of 
cycle-oxygenase, which is also responsible for the 1 iberation of 1oxygen-
centered1 radicals as a result of catalyzing the conversion of PGG to PGH. 
During this conversion, cycle-oxygenase is inactivated (Egan et al, 1976). 
In contrast, the biosynthesis of prostaglandins iS increased in the presence 
of free radical scavengers such as 1 ipoic acid (Marnett and Wilcox, 1977; 
Egan et al, 1978), 2-aminomethyl-4-t-butyl-6-iodophenol (MK-447), phenol 
(Kuehl et al, 1977) and sodium iodide (Egan et al, 1978). In later chapters 
(2. 1 and 2.2) it will be discussed that some free radical scavengers have 
anti-inflammatory properties, despite the fact that they stimulate (or do 
not affect) the biosynthesis of prostaglandins and related substances. 
c. Inhibitors of the cycle-oxygenase and 1 ipoxygenase pathways 
of arachidonic acid metabolism 
Inhibitors of prostaglandin biosynthesis may act at a number of 
distinct levels. These levels of action of some frequently used inhibitors 
(Flower, 1974; Gibson, 1977; Needleman, 1978; Nickander et al, 1979; Higgs 
et al, 1979; Shen, 1979) are shown in Figure 5- The phospho] ipase A2-
cata1yzed de-esterification of arachidonic acid and dihomo-y-1 inolenic acid 
is inhibited by mepacrine, chloroquine and glucocorticoids, such as hydro-
cortisone and dexamethasone. These inhibitors interfere with the activation 
of phospholipase A2, rather than antagonizing its effects. It has been shown 
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that the inhibition of phospho] ipase activation by corticosteroids depends 
on the synthesis of an inhibitory orotein and this may be an explanation of 
the the slow onset of action of the inhibition by steroids (Danon and 
Assoul ine, 1978). Recently, it has been shown that indomethacin inhibits 
phospholipase A2 from rabbit polymorphonuclear leukocytes (noncompetitive, 
K; = 12 ~M) but not that from snake venom or that from pig pancreas {Kaplan 
et al, 1978). 
The conversion of free polyenoic fatty acids by cycle-oxygenase is 
inhibited by nonsteroidal anti-inflammatory drugs (NSAID), among which, 
aspirin and indomethacin. Another inhibitor of cycle-oxygenase is 2,7-
dihydoxynaphthalene. Besides inhibiting cyclo-oxygenase, 5,8,11, 14-eicosa-
tetraynoic acid (ETYA, an acetylenic analogue of arachidonic acid), 3-
amino-1{m-(trifluoromethyl)phenyl}2-pyrazo1 ine (BW755C) and 1-phenyl-3-
pyrazol idone (phenidone) are about equipotent in the inhibition of 1 ipoxy-
genase. So far, no specific inhibitor of mammal ian 1 ipoxygenases has been 
discovered, although a-tocopherol (vitamin E) is a specific inhibitor of 
soybean lipoxygenase in comparison to cycle-oxygenase from bovine seminal 
vesicles (Panganamala et al, 1977). Equally, no inhibitors are known which 
selectively act on the conversion of PGH 2 , via isomerases and a reductase, 
to PGE2 , PGD2 and PGF2a' respectively. 
Apart from the possibi.lities of pharmacologically influencing the 
activity of cycle-oxygenase and subsequent prostaglandin formation, there 
is some evidence that the biosynthesis of prostaglandins may be endogenously 
inhibited. A fraction of human, mare, dog, rabbit or rat serum, associated 
with haptoglobin, has been shown to inhibit the biosynthesis of prostagland-
ins by bovine seminal vesicle microsomes (Saeed et al, 1977). On intravenous 
administration, the serum fraction was a'lso active in vivo against arachi-
donate- and bradykinin-induced bronchoconstriction in the guinea pig. This 
bronchoconstriction is dependent on prostaglandin formation. 
The thromboxane synthetase, catalyzing the formation of TXA2 from 
the prostaglandin endoperoxide, PGH 2 , and (at least in platelets) also the 
formation of the c17-hydroxy fatty acid, HHT, in combination with malon-
aldehyde, is inhibited by imidazole, benzydamine, 1 1-(isopropyl-2-indolyl)-
3-pyridyl-3-ketone (L-8027) and sodium p-benzyl-4-{1-oxo-2-(4-chlorobenzyl)-
3-phenyl}propylphenyl phosphonate (N-0164). 
As a 1 ready discussed in Chapter 1 . 2. b., the synthetase cat a 1 yz i ng 
the for~ation of prostacycl in (PGI2) from PGH 2 , is inhibited by the per-
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oxides 15-HPETE and HPI. Another inhibitor is the monoamine oxidase inhibitor 
and antidepressant, tranylcypromine. 
Many of the inhibitors described are frequently used as tools to 
investigate the involvement of the different arachidonate metabolites in 
physiology and pathology, e.g. of inflammation. However, these investigations 
are often hampered by the unspecificity of the inhibitors used. For instance, 
the inhibitors of thromboxane synthetase are nearly always inhibitors of 
cycle-oxygenase. Indomethacin-effects are not 1 imited to an inhibition of 
merely cycle-oxygenase, as this drug may also inhibit phospho] ipase activ-
ation in certain eel ls (Kaplan et al, 19?8) and, in addition, the peroxidase 
which catalyzes the decomposition of the hydroperoxy fatty acid, HPETE, to 
the corresponding stable end product of the 1 ipoxygenase pathway, HETE 
(Siegel et al, 1979b). 
d. Hepatic 1 ipid peroxidation dependent on NADPH or reducing 
agents and iron 
The first report dealing with 1 ipid peroxidation during hepatic 
microsomal NADPH oxidation, dates from 1963 (Hochstein and Ernster, 1963). 
It was shown in vitro that the oxygen consumption by microsomes during 
NADPH oxidation, was paralel led by an increased malonaldehyde formation. The 
production of malonaldehyde (see Figure 1) suggested the involvement of 
microsomal lipids as substrates for the peroxidizing system. Indeed, it 
was shown in 1968 (May and McCay, 1968) that NADPH oxidation, catalyzed by 
rat liver microsomes, resulted in a loss of arachidon·ate from membrane 
phospho] ipids and that arachidonate was a main target of 1 ipid peroxidation. 
The role of NADPH-cytochrome P-450 reductase, a flavoprotein catalyzing the 
reduction of ferric cytochrome P-450 to its reduced congener, was clearly 
demonstrated by the inhibition of NADPH-dependent 1 ipid peroxidation in the 
presence of antibodies against the flavoprotein (Pederson et al, 1973). 
The microsomal cytochrome P-450-dependent hydroxylation of drugs 
is dependent on electrons donated by NADPH and possibly NADH. Initially, 
the drug substrate is attached to the ferric form of cytochrome P-450 
and an electron is accepted from NADPH via the NADPH-cytochrome P-450 
reductase. As a result, NADPH is oxidized to NADP+. The reduced (ferrous) 
form of cytochrome P-450 in a complex with the substrate, binds oxygen and 
subsequently, activation of oxygen occurs after the acceptance of a second 
electron either from NADPH, via the flavoprotein reductase or from NADH, via 
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cytochrome b5 . One oxygen atom dissociates from the complex and reacts with 
two protons resulting in the formation of water, whereas the other oxygen 
now binds to the substrate resulting in hydroxylation of the latter, which 
then dissociates from the cytochrome catalytic site. The whole sequence of 
electron transfers is given in Figure 6 (Coon, 1978). Interestingly, 
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Figure 6. Drug hydroxylation via the cytochrome P-450 catalytic chain 
(from Coon, 1978). The upper part of t.he figure shows the 
electron flows from NADPH to substrate (RH) and water. The lower 
part shows the detailed reaction sequence of cytochrome P-450. 
Note that the ferric cytochrome-substrate complex can directly 
give the hydroxylated substrate, without accepting electrons from 
NADPH or NADH, when cytochrome P-450 acts as a peroxidase with 
organic peroxides (XOOH). 
cytochrome P-450 can act as a peroxidase and during the catalysis of the 
reduction of an organic hydroperoxide (XOOH) to the corresponding alcohol 
30 
(XOH), drug hydroxylation takes place without an electron flow from NADPH 
or NADH via cytochrome P-450 reductase and cytochrome b5 , respectively 
(O'Brien, 1978). 
Besides depending on the flavoprotein NADPH-cytochrome P-450 
reductase, NADPH-induced microsomal 1 ipid peroxidation requires the presence 
of iron in combination with ADP or (pyro)phosphate. EDTA in low concentra-
tions inhibits 1 ipid peroxidation and this is the result of the chelation of 
iron (Wills, 1969a). As a result of 1 ipid peroxidation, the activity of 
microsomal enzymes such as glucose-6-phosphatase and cytochrome P-450 is 
strongly depressed (Wills, 1971; Levin et al, 1973). The heme moiety of 
cytochrome P-450 is especially 1 iable to degeneration during 1 ipid peroxid-
ation (Levin et al, 1973). The catabolism of heme in general, during 1 ipid 
peroxidation may be responsible for the observed formation of carbon monoxide 
in peroxidizing microsomal lipids (Wolff and Bidlack, 1976). Inactivation of 
cytochrome P-450 leads to decreased hepatic drug metabolism as has been 
reported to occur for the demethylation of aminopyrine and ethylmorphine 
in vitro (Kamataki and Kitagawa, 1973). In contrast, as a result of their 
biotransformation, aminopyrine and codeine inhibit 1 ipid peroxidation in 
microsomes (Wills, 1969b). 
Recently, a study on the mechanism of NADPH-dependent microsomal 
1 ipid peroxidation has been published which explains most of the observations 
described above (Svingen et al, 1979). The reactions, given in Figure 7, 
consist of an initiation step, followed by propagation. The initiation is 
the ADP-perferryl (ADP-Fe3+.a;) catalyzed formation of 1 ipid hydroperoxides 
(LOOH). Evidence for such a mechanism was obtained by the observations that 
the reactions were inhibited by the superoxide scavenger, superoxide 
dismutase (SOD) and the antioxidant, butylated hydroxytoluene (BHT). The 
subsequent propagation of 1 ipid peroxidation is dependent on the breakdown 
of lipid hydroperoxides preformed during initiation. This breakdown result-
ing in the formation of radical fragments and singlet oxygen C1o2), is 
catalyzed by cytochrome P-450 or by NADPH in combination with iron chelates 
of EDTA or DPTA. The reactive fragments react with 1 ioids (LH) of the 
microsomal membrane system to form stable end products of 1 ipid peroxidation 
{e.g. malonaldehyde) and again 1 ipid hydroperoxides. The latter are 
decomposed and a cyclic chain is completed. During the catalysis of hydro-
p·eroxid.e breakdown, cytochrome P-450 is degraded. Arachidonic acid, on 
addition to mouse 1 iver microsomes, inhibits the N-demethylation of ethyl-
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Figure 7. NADPH-dependent microsomal 1 ipid peroxidation as proposed by 
Svingen et al (1979). Initiation leads to the formation of 
1 ipid hydroperoxides (LOOH) which are subsequently metabolized 
during propagation. During propagation, malonaldehyde is formed. 
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morphine and the hydroxylation of hexobarbital, both dependent on cytochrome 
P-450. Repeated intraperitoneal administration of arachidonate evoked 
biochemical and histological symptoms of hepatotoxicity and this is 1 ikely 
to be due to reactive metabolites from arachidonate peroxidation in vivo 
(Pessayre et al, 1979). As no details about the purity of arachidonate were 
given, it is possible that preformed hydroperoxides and aldehydes have 
been injected. 
The inhibition of 1 ipid peroxidation by drugs which depend on 
cytochrome P-450 metabolism, is the result of the cytochrome acting in the 
peroxidase mode, during which the drug is hydroxylated via a short-circuited 
pathway with peroxides as 1 oxygen donors 1 and without the intervention of 
NADPH as an electron donor (see: Lu, 1976; Coon, 1978; 0 1 Brien, 1978 and 
Paine, 1978). The possibility that the inhibition of microsomal lipid 
peroxidation by drugs is due to antioxidant activities of these substances 
should also be taken into consideration (Miles et al, 1980), a possibility 
which is a hiatus in the paper of Svingen and coworkers. The experimental 
drug, 2-diethylaminoethyl-2,2-diphenylvalerate hydrochloride (SKF-525A), an 
inhibitor of cytochrome P-450-dependent electron flow, acts as an inhibitor 
of the propagation and subsequent malonaldehyde formation, whereas the fact 
that BHT inhibits malonaldehyde formation proves the free radical nature of 
product formation during propagation (see Figure ?) . It must be emphasized 
that the effects of SKF-525A on malonaldehyde formation are strongly 
dependent on the type of cells under investigation. Our own studies on 
human thrombocytes indicate that SKF-525A inhibits platelet aggregation 
due to inhibition of thromboxane (the pro-aggregatory principle from human 
platelets) formation, but stimulates malonaldehyde formation (Parnham, 
Bragt, Bast and Zijlstra, to be published). 
The involvement of singlet oxygen-mediated propagation is only of 
minor importance, as the sing 1 et oxygen s.cavenger, 2, 5-d i phenyl fu ran, 
inhibited the formation of malonaldehyde by less than 30 percent. The system 
of NADPH-induced lipid peroxidation is, as far as is known at present, only 
relevant for in vitro investigations with 1 iver homogenates, isolated 
hepatocytes and microsomal preparations, although the amount of NADPH in 
isolated hepatocytes (6.63 nmoles NADPH versus 0.13 nmoles NADP+ per 106 
cells) is high enough to sustain 1 ipid peroxidation induced by the 
addi-tion of ADP and Fe3+ (HOgberg et a 1 , 1975) . 
Besides NADPH-induced 1 ipid peroxidation in 1 iver microsomes, 
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lipid peroxidation is also very rapidly induced in the presence of the 
combination of iron ions with ascorbic acid (vitamin C), in microsomal 
preparations as well as in mitochondria and nuclei. Incubation with this 
combination of systems rich in membrane structures leads to 1 ipid peroxid-
ation, which increases in time until a plateau is reached. This kind of 
peroxidation is enhanced by vitamin E deficiency of the donor animal and 
inhibited in preparations from scorbutic (vitamin C deficient) animals 
(see Mead, 1976). Lipid peroxidation dependent on ascorbate is not 
inhibited on heat-induced protein denaturation nor by treatment with 
sulphydryl reactants, such as p-chloromercuribenzoate. Furthermore, it is 
pronounced at pH 6 and very moderate at pH 7.4 (Wills, 1966). Whereas 
NADPH-dependent 1 ipid peroxidation requires free iron in combination with 
ADP, ascorbate-dependent 1 ipid peroxidation does not require ADP and is even 
operational in the presence of ferritin-bound iron (Wills, 1966). The latter 
phenomenon is believed to be due to the ability of ascorbate to release 
iron from its storage sites on the ferritin molecule, after reduction 
(Mazur et al, 1955). 
The detailed mechanism of ascorbate-induced 1 ipid peroxidation is 
still obscure. Possibly, ascorbate acts as a ferri-reductant in analogy to 
the superoxide anion in the iron-catalyzed Haber-Weiss reaction (reaction 
13). The nett, uncatalyzed, reaction is too slow to play any significant 
Fe3+ - 2+ + ·0 2 - Fe + 02 
Fe2+ + H2o2 - Fe
3+ + HO· -+ HO (13) 
·02 + H202 02 + HO· + HO 
role with respect to 1 ipid peroxidation and the associated effects in 
biological systems, since k = 0.13 M-ls- 1 (Weinstein and Bielski, 1979). 
The relevance of the 1 ipid peroxidation system depending on ascorbate and 
iron is not 1 imited to in vitro systems in view of the results with the 
intraperitoneal injection 
combination, iron (28.2 mg 
obtained by Fujita (1977). 
into mice of the 1 ipid peroxidation inducing 
2+ -1 -1 Fe as chloride)-ascorbate (176 mg kg d ) , 
This joint administration resulted in enhanced 
thiobarbituric acid reactivity (indicative of malonaldehyde formation; 
see Chapter 1 .4) of 1 iver samples from mice 1 and 3 days after treatment. 
Vitamin E deficient diet fed for 3 weeks also resulted in enhanced thio-
34 
barbituric acid reactivity. Furthermore, the administration of the oxidant 
system resulted in enhanced levels of triglycerides in the plasma (Fujita, 
1977) and iil the liver (Placer et al, 1971; Fujita, 1977). Vitamin E 
deficiency also resulted in hepatic triglyceride accumulation (Fujita, 1977). 
The conclusion could be drawn from these observations that lipid accumulation 
in the 1 iver ( 1 fatty 1 iver 1 ) may be causally related to lipid peroxidation, 
since CCL4 , the hepatic metabolism of which also leads to enhanced 1 ipid 
peroxidation, also induces fatty liver (see Judah et al, 1970). As an 
alternative, both fatty 1 iver and 1 ipid peroxidation may be evoked by the 
same phenomenon, namely cellular damage. However, the connection between 
fatty liver development and hepatic necrosis is still obscure (Judah eta), 
1970). Recently, it has been reported (Gravel a et al, 1979) that inhibition 
of CCL4-induced malonaldehyde formation in isolated hepatocytes by SKF-525A 
and promethazine was not paralelled by protection against depressed lipo-
protein excretion. This implies that malonaldehyde is not the lipid peroxide 
product responsible for triglyceride accumulation in the 1 iver and also that 
1 ipid p~roxidation per se is not responsible for this phenomenon. 
Increased levels of malonaldehyde have been observed in women, 
during the second and third trimester of pregnancy and as a result of toxemia 
of pregnancy, which is characterized by some or al 1 of the symptoms of 
hypertension, albuminuria, edema, convulsions and coma (Ishihara, 1978). 
Patients with recent cerebral infarctions and hemorrhages also have increased 
malonaldehyde levels in their serum (Satoh, 1978). Sate and coworkers (1979) 
reported the occurrence of elevated malonaldehyde leVels in the plasma of 
diabetic patients. They also demonstrated that in diabetic patients with 
angiopathy the malonaldehyde levels were twice as high as in diabetics 
without angiopathy. The relationship between 1 ipid peroxidation and 
degenerative diseases is again demonstrated by the fact that, during acute, 
fulminant and chronic active hepatitis, respectively, as well as during 
1 iver cirrhosis and fatty 1 iver, serum 1 ipid peroxide levels (measured as 
malonaldehyde) are elevated (Suematsu et al, 1977). Serum malonaldehyde 
levels in women tend to be lower than in the corresponding age group of male 
subjects and Increase with increasing age, both in male and female subjects 
(Suematsu et al, 1977). 
In conclusion it can be stated that the origin of malonaldehyde 
in the blood is, thus far, by no means clear. Neither is it known whether 
malonaldehyde formation with its subsequent appearance in the blood is due 
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to activation of cyclo-oxygenase (or, more precisely, thromboxane synthetase) 
in the tissues prone to the disease. The fact, however, that raised plasma 
levels of malonaldehyde are often associated with the so-called 1acute phase 
reactant 1 proteins of hepatic origin, tempts to suggest that concomitant 
1 ipid peroxidation also occurs in the 1 iver. The role of acute phase 
proteins in inflammation wil 1 be dealt with in Chapter 2.4. 
1 .3. Free radical scavengers and antioxidants as inhibitors 
of 1 ipid peroxidation 
Lipid peroxidation can be inhibited at different levels (see 
Figure 1). Radical scavengers and quenchers of singlet oxygen prevent the 
attack by their reactive substrates on labile unsaturated compounds, e.g. 
polyenoic fatty acids. The antioxidants, butylated hydroxytoluene (BHT) and 
hydroxyanisole (BHA), react with preformed lipid peroxy-radicals whilst 
preventing propagation of 1 ipid peroxidation and the formation of stable 
end products, e.g. aldehydes and alkanes. 
Scavengers may be used by biochemists and pharmacologists to 
unravel the involvement of distinct radical species and processes in 
biological systems, although caution has to be exercised as many scavengers 
are not specific for one radical. Table 1 summarizes some scavengers and 
quenchers of reactive oxygen species with the corresponding reaction or 
quenching constants for a second order reaction. From this table it can be 
seen that many of the scavengers mentioned react at an almost diffusion-
con.trolled rate with their substrates, i.e. with a magnitude of about 
10 -1 .-1 10 M s . Dimethylsulphoxide (DMSO) and thiourea are extremely good 
hydroxyl radical scave~gers (highest k values), whereas superoxide dismutase 
(SOD) and cupric ions are equally effective in scavenging superoxide. 
Furthermore, carotene and bilirubin are the most effective singlet oxygen 
quenchers. The values of the reaction constant k show great variances with 
changes in pH and temperature and also with the solvent used. Therefore, 
they cannot be di·rectly compared with each other. 
It is a well-known fact that oxygen is toxic to many organisms and 
this is demonstrated by decreased viability at elevated oxygen pressures. 
That we are able to survive at a partial oxygen tension of 0.21 atmosphere, 
is due to our equipment with at least two defence 1 i nes against oxygen 
toxicity, which act at the cellular level. These defence mechanisms deal 
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Table 1. Bimolecular rate constant of scavengers and quenchers reacting with 
their reactive substrates 
Reactive species Scavenger/Quencher 
HO· thiourea 
benzoate 
butanol 
ethanol 
mannitol 
DMSO 
glutathione 
MK-447 
SOD 
Cu 2+ 
Cu(lysine) 2 
S-carotene 
a.-tocopherol 
DAB CD 
bilirubin 
ascorbic acid 
2,5-dimethylfuran 
LOO· a.-tocopherol 
k(M-Is- 1) 
5x109 
3.8x109 
2.2x109 
1x1 o9 
>1 o9 
7x1 o9 
8x1 o9 
n .d. 
2.4x109 
2.7x10 9 
6x10 8 
1.65x1o 10 
1.05x1o 8 
3. 11x1 o7 
2.5x10 9 
"-2.2x10 8 
1. 4x1 0 8 
5x10 8 § 
t 
t 
t 
Authors and year 
Anbar & Neta, 1967 
" 
" 
" 
" 
Lin & Armstrong, 1977 
Kuehl et al, 1977 
Fielden et al, 1974 
Brigel ius et al, 1974 
" 
Koka & Song, 1978 
Lightner & Park, 1978 
Bodaness & Chan, 1979 
Foote, 1971 
Packer et a 1 , 1979 
tCalculated rate constant. §Reaction constant for reaction with Cl 3c-O-O· n.d. not determined. 
primarily with the detqxification of reactive intermediates arising 
accidentally from the respiration chain, the microsomal drug metabol ising 
system and other oxidases (e.g. xanthine oxidase, aldehyde oxidase). 
The first 1 ine of defence consists of compounds and enzymes which 
directly react with preformed radicals, thus protecting labile sulphydry'l 
proteins from inactivation and preventing 1 ipid peroxidation (see Chapter 
1. 1). Scavengers which play a role in vivo and act against ·0 2 , HO· and 
1
o2 , 
ar~ ascorbic acid, reduced glutathio0e, methionine, 1 ipoic acid, carotenoid 
pigments and bilirubin. Furthermore, the cytoplasmatic enzyme, superoxide 
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dismutase (SOD, identical to hepato- and erythrocuprein), with a molecular 
weight of 34,000 daltons, catalyzes the dismutation of superoxide anions to 
hydrogen peroxide (see Fridovich, 1974). Mitochondria contain a SOD with 
manganese as the active centre instead of copper and zinc in the cytoplasmic 
SOD. Recently, it has been shown that the copper storage protein, cerulo-
plasmin, is a scavenger of superoxide (Goldstein et al, 1979), although it 
has been known for several years that ceruloplasmin is the major antioxidant 
in blood (Al-Timimi and Dormandy, 1977). The ceruloplasmin apoprotein, 
without copper which is normally present as 6-8 atoms per protein molecule, 
is ineffective as an antioxidant. 
The second 1 ine of defence against the potential damaging effects 
of the products from reactions of free radicals with 1 ipids or with each 
other, consist of antioxidants and enzymes catalyzing the breakdown of 
peroxides to less toxic species. Catalase, the peroxisomal heme protein 
with a molecular weight of 234,000 daltons, catalyzes the conversion of 
hydrogen peroxide to molecular oxygen and water. Glutathione peroxidase with 
a molecular weight of 76,000 daltons and containing 4 selenium atoms per 
protein molecule, catalyzes the conversion of hydrogen peroxide to water and 
of 1 ipid peroxides to the corresponding alcohols. This enzyme is dependent 
on the availability of glutathione in the reduced form (GSH), which is 
oxidized to its disulphide congener (GSSG) during the catalytic action of 
the peroxidase (Flohe, 1971). Table 2 summarizes some characteristics of the 
defence enzymes mentioned and data in brackets are representative for the 
Table 2. Some characteristics of protecting enzymes. 
Glutathione Superoxide Cerulo-
Catalase peroxidase dismutase plasmin 
Molecular weight 234, DO 0 76,000 32' 000 132' 000 
(80,000) 
Subunits 4 4 2 
(4) 
Active centre atom Fe Se Cu/Zn Cu 
(Mn) 
Number of active 4 4 2/2 6-8 
centre atoms (4) 
Localization peroxisomes cytosol cytosol 1 iver 
(mitochondria) blood 
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manganese-containing SOD. The antioxidant vitamin E inhibits the propagation 
of 1 ipid peroxidation and may also act in the first 1 ine of defence as a 
scavenger o.f singlet oxygen. The protective function of ceruloplasmin may 
be even more important than that simply mentioned above, if one considers 
its oxidase activity. By virtue of its capacity to act as a ferro-oxidase, 
thus oxidizing the ferrous to the ferric form, ceruloplasmin prevents 
eventual decompartmentation of iron and thereby the possible involvement 
of iron in 1 ipid peroxidation reactions. Ceruloplasmin may also be active 
against somatic effects of stress, since it may oxidize catecholamines 
and serotonin, in analogy with monoamine oxidase (see Gutteridge, 1978). 
1 .4. Detection of 1 ipid peroxidation 
To detect lipid peroxidation in deteriorating edible fats and oils, 
the sense of smell is often sufficient to determine whether one should or 
not consume the objects of investigation! However, with biological samples 
in studies concerning the role of 1 ipid peroxidation in pathology, more 
reliabl.e and reproducible methods are needed to detect and quantify lipid 
peroxidation. Many methods have been described and many well-known methods 
yearly undergo revisions to make them more reliable, reproducible, sensitive, 
...... etc. One method is to study the loss of fatty acids from a sample as a 
consequence of peroxidative deterioration and this can be performed in 
combination with an oxygen electrode to monitor oxygen utilization. Most of 
the methods commonly used, however, are based on the detection of inter-
mediates or stable end products of 1 ipid peroxidation (see Gray, 1978). The 
formation of conjugated dienes (see Fi9ure 1) can be detected by the increase 
in 234 nm UV absorption. The presence of hydroperoxides can be detected by 
iodometry, either from the formation of iodine with iodide solutions or, as 
an alternative, in combination with colorimetric analysis of the r;-starch 
complex. Other methods of detection are gas-1 iquid chromatography of 
hydrocarbons formed (see Figure 1), of fatty acid hydroperoxides and of 
volatile aldehydes. 
On historical grounds, i.e. based on earlier experiments, I chose 
the reaction ·of malon(di)aldehyde (MA or MDA) with 2-thiobarbituric acid, 
which yields a chromogen with a strong absorbance at 535 nm (molar extinct-
ion coefficient at 25°C, 1 .56x105 M- 1cm- 1). After extraction in butanol, the 
complex can be detected fluorimetrically, thereby enhancing the specificity 
of the assay. Because of its great reactivity, malonaldehyde can be detected 
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by more than ten different spectrophotometric and spectrofluorometric assay 
methods, although the thiobarbituric acid (TBA) method is one of the most 
sensitive methods and the malonaldehyde-TBA complex is reasonably stable 
(Sawicki et al, 1977). A problem arising from the detection of malonaldehyde 
is the fact that the compound is further metabolized by mitochondrial 
oxidases present in ample biological samples (Recknagel and Ghoshal • 1966). 
After intraperitoneal injection of malonaldehyde, serum levels of the 
compound decrease with time, without a simultaneous increase in urinary 
malonaldehyde (Placer et al, 1965). This implies that failure to detect 
malonaldehyde does not necessarily prove absence of its formation or of 
lipid peroxidation. tn addition, it is probably not malonaldehyde itself, 
which is detected by the TBA method, as it is volatile at low pH values. 
The principle TBA reactants are supposed to be endoperoxides with a 
structural resemblance to the prostaglandin endoperoxides (Pryor and 
Stanley, 1975). Another disadvantage of the determination of malonaldehyde 
.bY the TBA method is the lack of available radioactively label led malon-
aldehyde for the determination of recoveries. Fortunately, methods for 
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synthesis of C-malonaldehyde have been described very recently. One 
method is based on the hydrolysis of labelled precursor to malonaldehyde 
and ethanol (Marnett et al, 1979), while the second method is based on the 
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substrate unspecificity of alcohol dehydrogenase. In this case, C-labelled 
1 ,3-propanediol is oxidized to malonaldehyde in the presence of an NAD+ 
regenerating system for the acceptance of electrons from the dial (Summer-
field and Tappel, 1978). Although intensive effort was made to synthesize 
malonaldehyde according to the latter method, thereby optimal izing and 
checking the partial reactions carefully, we were unable to obtain more than 
a few percent of malonaldehyde. 
Despite many shortcomings, the TBA assay is the method most 
frequently used for the detection of 1 ipid peroxidation. Its major advantage 
as compared to alternative methods is the relative simplicity and the 
sensitivity of the assay, provided that adequate controls are used. Using 
the TBA assay, it is now possible to discriminate between preformed 
malonaldehyde and the presence of malonaldehyde precursors of peroxidic 
nature (Asakawa and Matsushita, 1979). The discrimination is performed by 
the addition oF an antioxidant with or without ferrous sulphate. In the 
presence of the antioxidant alone, only preformed malonaldehyde is determined 
as the antioxidant prevents 1 ipids from further peroxidation. The addition of 
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ferrous ions, however, catalyzes the breakdown of preformed peroxides to 
malonaldehyde and other products, whereas the antioxidant present inhibits 
iron-catalyzed peroxidation of the 1 ipids under investigation. An extensive 
review on 1 ipid peroxidation, dealing extensively with the benefits and 
pitfalls of the TBA method has been written by Barber and Bernheim (1967). 
Finally, another method has been introduced which is based on the 
detection of fluorescent products resulting from the reaction of malon-
dehyde with free amino groups of proteins and primary amino phospho] ipids. 
The N,N 1 -disubstituted 1-amino-3-iminoprene moiety, which is the result of 
the reaction mentioned, is highly fluorescent (Chic and Tappel, 1969; Bidlack 
and Tappel, 1973). Reactions 14 and 15 show the subsequent steps of the 
fluorophore formation. The detection is based on the fact that cross-linked 
,C=O ~NH2 + C 
'c=o 
,C=O 
enamine + C 
'C=O 
$ H H H H rN -c ~c -c =O +-H o 
en amine 2 
! H H H Hl )N=C -C =C -N -~ + H 0 
N .. ,N 1 •• -1-amino-3-i~inoprene 
( 14) 
( 15) 
polymers, after extraction into 1 ipid solvents, display characteristic 
emission spectra (maxima 420-490 nm) on excitation (maxima 340-375 nm). The 
pigment, 1 ipofuscin, which accumulates during aging in heart muscle, liver 
and brain, has an emission maximum at 4?0 nm on excitation at 365 nm and 
its formation may be the result of the interaction of malonaldehyde with 
proteins and phospho] ipids (Chic et al, 1969). This observation is an 
important principle in the 1 free radi,cal theory of ag·ing 1 (see Hocman, 
1979). It has to be stressed that the authors of the 1 iterature prior to 
1967 were ignorant of the enzymatic formation of malonaldehyde during the 
biosynthesis of prostaglandinS (Hamherg and Samuelsson, 1967). Therefore, 
no dissociation can be made between enzymatic and free radical-induced 
1 ipid peroxidation in the old 1 iterature. An additional feature is the 
possibility of artifactually provoked 1 ipid peroxidation (i.e. prostaglandin 
biosynthesis) in many experiments, which is nowadays prevented by the 
immediate addition of prostaglandin synthetase inhibitors, before manipula-
tion. Thus, if malonaldehyde is used as a monitor of 1 ipid peroxidation, it 
is necessary to investigate its actual origin, by treatment with aspirin-
] ike drugs or by measuring stable prostaglandins and thromboxane formed. 
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1.5. lmpl ications of 1 ipid peroxidation in biological systems 
At the biochemical level, it is well-known that 1 ipid peroxidation, 
via the generation of reactive products (free radicals, singlet oxygen, 
aldehydes), inhibits many enzymes and damages many compounds of biological 
importance. For instance, cytochrome c, cytochrome P-450 heme, cytochrome c 
reductase, glucose-6-phosphatase, glucose-6-phosphate dehydrogenase and 
ribonuclease A have been shown to be inactivated or destroyed during, and as 
a consequence of 1 ipid peroxidation. In addition, 1 ipid hydroperoxides react 
with cysteine, methionine, hystidine and lysine, whereas malonaldehyde cross-
] inks DNA, serum albumin and many substances with free amino residues (see 
also Chapter 1 .4). In contrast to these inhibitory effects of 1 ipid peroxid-
ation, unsaturated fatty acid peroxides as we] 1 as superoxide and hydroxyl 
radicals, stimulate guanylate cyclase from platelets and 1 iver cells 
(Hidaka and Asano, 1977; Mittal and Murad, 1977). At the subcellular level, 
1 ipid peroxidation leads to lysosome rupture with subsequent release of 
lysosomal enzymes and to swe1 1 ing and lysis of mitochondria resulting in 
an inhibition of the respiratory chain. In addi.tion as a result of membrane 
alterations, 1 ipid peroxidation interferes with cellular transport processes 
for instance of calcium. At the eel Jular level, 1 ipid peroxidation may cause 
lysis of erythrocytes, whereas peroxidized fatty acids, in the presence of 
calcium ions, evoke platelet aggregation which is inhibited by indomethacin 
bu.t not inhibited by substances elevating cyclic AMP. Lipid peroxides may 
also contract isolated tissues, e.g. the rat stomach fundus, aorta, uterus 
and coronary arteries of the cat (Roycroft et al, 1977; Trachte et al, 
1979). Furthermore, fatty acid ·hydroperoxides cause a sensation of pain 
on intradermal injection in man (Ferreira, 1972). Finally, lipid peroxida-
tion has been demonstrated to be involved in the toxic effects of chlorinated 
hydrocarbons, bleomycin, adriamycin, dapsone, ethanol and UV radiation of 
the skin, while 1 ipid peroxides are very toxic on oral intake (see Barber 
and Bernheim, 1967). 
1.6. Summary 
In Chapters 1. 1-1.5, the mechanisms of 1 ipid peroxidation have been 
outlined. Polyunsaturated fatty acids, e.g. arachidonic acid which is 
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ubiquitous in mammal ian membranes, are particularly susceptible to peroxid-
ative deterioration at the methylene moieties interrupting the double bonds. 
Free radical scavengers and antioxidants prevent the formation of stable 
end products as a consequence of 1 ipid peroxidation. Lipoxygenases and 
cycle-oxygenase are present in virtually al 1 mammal ian cells and these 
enzymes catalyze the formation of (endo)peroxides from specific polyenoic 
acids, which are further metabolized to biologically active compounds, namely 
prostaglandins, thromboxanes and slow-reacting substance of anaphylaxis. The 
formation of prostaglandins and thromboxanes is inhibited by aspirin-1 ike 
drugs, whereas arachidonate analogues also inhibit the formation of 
1 ipoxygenase-dependent products. 
Although the products of enzymatic 1 ipid peroxidation often play 
physiological roles (e.g. in platelet aggregation, in the cardiovascular 
system), free radical-induced 1 ipid perox-idation is not benificial for the 
organism. It may inhibit several enzymes and cause cellular and tissue 
damage. Furthermore, 1 ipid peroxidation interferes with the metabolism of 
drugs. To prevent deleterious effects of lipid peroxidation, eel ls are 
equipped with defence systems against free radicals and peroxides. Inadequate 
functioning of theses 1 ines of defence leads to oxidant stress, e.g. in 
deficiencies of glutathione and vitamin E. The 1 ikel ihood of the presence 
of an oxidant stress as a result of inflammation and the anti-inflammatory 
effects of different free radical scavengers and antioxidants, will be 
dealt with in the experimental section (Appendix) of this thesis. 
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2. INFLAMMATION 
Inflammation is the reaction of the body on tissue injury of any 
kind. At the inflamed site, macroscopical changes occur which include redness, 
oedema, heat, pain and, after a certain period of time, loss of function. 
These symptoms had already been described in the time of the ancient Greeks. 
The noxa may be of a chemical, physical or microbiological nature. The acute 
phase of an inflammatory process is characterized by vasodilatation and 
increased vascular permeability which are the result of the local release 
of inflammatory mediators, such as histamine, serotonin, kinins and prosta-
glandins and activation of the complement system. In carrageenin-induced 
rat paw oedema, an acute type of inflammation, three different phases can 
be distinguished. The first phase (0-0.5 h) is characterized by histamine 
and serotonin release and is followed by the kinin phase (1-3 h) and the 
phase of prostaglandins (3-6 h) acting as mediators. 
Granulocytes are recruited from the blood by chemotactic factors 
originating from the complement cascade or from the oxidative conversion 
of fatty acids. Having arrived at the inflamed site, the granulocytes start 
phagocytozing the materials recognized as 1 foreign 1 • During phagocytosis, 
which is primarily intended to make the ingested materials harmless to the 
host, the granulocyte may act as a secretory cell, releasing lysosomal 
enzymes, prostaglandins, superoxide radicals, hydrogen peroxide and other 
substances into the extracellular environment. This release amp1 ifies the 
inflammatory response due to protein breakdown and the generation of new 
chemotactic principles. Monocytes arrive from the blood, become activated 
and differentiate into macrophages with a _heavy load of lysosomal enzymes 
which are partially released during phagocytosis. During their stay at the 
inflamed site, macrophages mature and form a granuloma in which fibroblasts, 
lymphocytes and even neutrophils may participate. In other words, granuloma-
tous inflammation is a proliferative type of chronic inflammation and it 
is characterized by continuous infiltration of mononuclear leukocytes from 
the blood. In addition, macrophages, sometimes in the form of epitheloid 
eel ls or fused to form giant cells, constantly undergo divisions within the 
granuloma. In this respect, granuloma models are analogous to and 
representative of the cellular proliferation and connective tissue synthesis 
observed during rheumatoid arthritis in man. This disease is characterized 
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by lesions in the synovia. The lesions consist of two types, namely an 
inflammatory lesion with mononuclear cell infiltration below the 1 ining eel ls 
and the accumulation of exudate rich in polymorphonuclear leukocytes within 
the synovial cavity. The second type is the proliferative lesion, character-
ized by an enormous increase in the amount of connective tissue, in the 
number of small blood vessels and in the number of mesenchymal cells with 
phagocytic and synthetic functions. Furthermore, connective tissue activating 
peptides are released, including lymphokines, which stimulate fibroblast 
activation and the production of collagenase. This so-cal led 1 pannus 1 of 
granulation tissue may lead to joint destruction and fibrosis. 
The granuloma represents a dynamic state of eel 1 proliferation 
and breakdown. Macrophages die, but their enzymes may retain their activities 
over long periods. Necrosis of tissue may, but does not necessarily occur. 
At any stage of inflammation, the balance between" the various processes 
involved, may be influenced by the actions of inflammatory modulators 
(e.g. prostaglandins, anti-inflammatory proteins), resulting in a cessation 
of the inflammatory response. The inflammation may occasionally fail to 
achieve chronicity if the damaging agent is rendered harmless within a 
short period after the induction of inflammation (see Adams, 1976; Willoughby 
1978). 
The studies performed which have led to this thesis, have been 
carried out on models of granulomatous inflammation in the rat and some of 
the results obtained with them will be discussed in terms of their relevance 
to rheumatoid arthritis. 
2.1. Generation of free radicals and other oxidants at the 
site of inflammation 
After the recognition by phagocytes (granulocytes, monocytes) of 
opsonized 1 foreign 1 materials, a burst of oxygen consumption is observed and 
an activation of the hexose monophosphate shunt. The oxygen consumed is 
mainly converted to superoxide anions and hydrogen peroxide. The micro-
organism or particle becomes attached to the phagocyte membrane which 
subsequently invaginates the particle within the phagocyte. When the 
material is completely surrounded by the cell membrane cavity, the latter 
splits off to form a phagosome that migrates into the cytoplasm. Concomitant-
ly with the invagination, an NADPH oxidase is activated which univalently 
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reduces molecular oxygen to superoxide radicals. The flux of radicals is 
primarily directed against the invader within the membrane sink, but there 
is evidence that many radicals escape into the extracellular environment 
(Sal in and McCord, 1975; Baehner et al, 1977). Besides the release of the 
relatively unreactive superoxide radical, there is now considerable evidence 
that the highly reactive hydroxyl radical is also produced as a result of 
stimulation of both granulocytes and monocytes (Tauber and Babior, 1977; 
Green et al, 1979; Weiss et al, 1977). Therefore it is not surprising that 
phagocytozing eel ls rapidly loose their motility and phagocytic capacity 
in vitro (Baehner et al, 1977) and die a premature death (Sal in and McCord, 
1975), during which the lysosomal enzymes they contain leak into the 
environment. Premature death of granulocytes is prevented by the addition 
of either superoxide dismutase or catalase, or of the hydroxyl radical 
scavenger mannitol (see Chapter 1.3, Table 1) to the medium (Sal in and 
McCord, 1975). 
Internally, the phagocyte is well equipped with defence mechanisms 
against reactive intermediates. The sequence of reactions concerned with 
this defence are given in Figure 8 (from Roos, 1977). The superoxide radical, 
generated by a membrane-bound NADPH oxidase, is.scavenged by the cytoplasmic 
superoxide dismutase and converted to hydrogen peroxide. Hydrogen peroxide 
is utilized by myeloperoxidase to convert halides to hypohalides, which 
results in chlorination, decarboxylation and proteolysis of the invader 1 s 
proteins. Catalase deals with the ubiquitous hydrogen peroxide and catalyzes 
it~ decomposition to oxygen and water. Glutathione peroxidase also converts 
hydrogen·peroxide to water, but this conversion requires reduced glutathione 
(GSH) which is oxidized to its disulphide congener (GSSG). GSH is regenerated 
by glutathione reductase, with NAOPH from the heXose monophosphate shunt as 
an electron donor. The possible generation of si.nglet molecular oxygen has 
been offered as an explanation for the chemiluminescence of phagocytozing 
granulocytes, but this possibility has severely been questioned (see Roos, 
1977). 
Reduced availability of protecting enzymes and scavengers leads 
to alterations in the response of granulocytes to 1 foreign 1 materials. Thus, 
deficiency of glutathione synthetase makes the eel 1 membrane and the micro-
tubular system vulnerable to oxidative damage and the result is impaired 
phagocytic function in cOmbination with attenuated microbicidal properties 
(Spielberg et al, 1979). Vitamin E may restore some of the basic functions 
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Figure 8. Mechanisms of protection against potentially damaging molecules 
in phagocytozing cells (from Roes, 1977) 
of glutathione synthetase-deficient polymorphs during phagocytosis, such as 
reducing hydrogen peroxide release to normal values and increasing the 
bactericidal capacity (Boxer et al, 1979). Glutathione peroxidase deficiency 
leads to an attenuation of microbicidal capacity, increased H2o2 release 
and a decreased response to chemotactic stimuly in rat granulocytes 
(McCallister et al, 1980). Vitamin E deficiency leads to increased oxygen 
consumption, slightly i~creased H2o2 release and again decreased chemotactic 
activity (Boxer et al, 1979). Lack of ability to produce superoxide, as a 
result of NADPH oxidase deficiency or lack of activity, leads to chronic 
granulomatous disease (Curnutte et al, 1974). Patients suffering from the 
disease are highly susceptible to infections. In contrast, it has been shown 
that children with rhe.umatoid arthritis have low superoxide dismutase levels 
in their polymorphonuclear leukocytes (Rister et al, 1979). This reduced 
ava~labil ity of the protecting enzyme may lead to enhanced damage to 
phagocytozing granulocytes, release of lysosomal enzymes and amplification 
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Table 3. Inhibition by NSAID of the release and activities of 
oxygen derived free radicals 
Drug 
Indomethacin 
Mefenamic acid 
Phenylbutazone 
Oxyphenbutazone 
Paracetamol 
Acetylsalicylic acid 
Diclofenac 
Niflumic acid 
Flufenamic acid 
Scavenging of hypoxanthine-
xanthine oxidase-derived ·0; 
HX-XOD catalyzed Depolymeriza-
oxidation of tion of bovine 
NADH (lc 50 ) 
3 X 10 _,. M 
1 X 10- 3 
Inactive 
Inactive 
lnact ive 
Inactive 
3 X 10-lj 
synovia 1 f 1 u i d 
(%·inhibition 
at 8D pM drug) 
96% 
63 
62 
7!J 
Inactive 
9" 
NSAID: nonsteroidal anti-inflammatory drugs. 
HX-XOD: hypoxanthine-xanthine oxidase. 
IC 50 : concentration of drug halving effect. 
Generation of 
·o2 by guinea 
pig macro-
phages (I c50 ) 
X 10- 5 M 
7 X 10- 5 
7 X 10-5 
X 10-6 
1.5 x10 
_,. 
4x1o-7 • 
8 X 10-5 
Horse radish 
peroxidase-
H2o2 catalyzed 
oxidation of 
o-dianisidine 
(IC50) 
J.lj X 10-5 M 
8 X 10-lj 
9 x 1 o-" 
1, 8 X 10 
_,. 
1.9 X 10 
_,. 
Inactive 
0 
"' 
of superoxide, using another testsystem (Table 3). 
The potency of the NSAID in inhibiting superoxide production by 
maccrophages correlates positively with their potency in inhibiting sheep 
seminal vesicle (SSV) cycle-oxygenase (Oyanagui, 1976; (Ham et al, 1972) 
with an rs = 0.70 (n = 5, Spearman rank test). The ICso values for the 
inhibition of synovial fluid depolymerization (Puig-Parellada and Planas, 
1978) and the horse radish/H 2o2 system (Saeed and Warren, 1965) are also 
correlated with their 1c50 values for the inhibition of SSV cycle-oxygenase 
with an rs = 1.00 in both cases (n = 5 and 4 drugs, respectively). Thus, 
while these compounds are inhibitors of cycle-oxygenase and therefore of 
the biosynthesis of prostaglandins, this activity is closely related to 
their ability to inhibit the generation and/or activity of free radicals. 
\,Jhether these two actions are causally linked or not is, as yet, unclear, 
but both represent feasible mechanisms for their anti-inflammatory actions. 
In this context, MK-447 is an experimental anti-inflammatory drug, which 
may act as a hydroxyl radical scavenger. It prevents the pro-inflammatory 
actions of hydroxyl radicals themselves and shortens the half-] ife of 
the prostaglandin endoperoxide PGG2 , which is a potential inflammatory 
mediator (Kuehl et al, 1976). The effects of MK-447 on the qualitative 
formation of arachidonate-dependent products has been discussed elsewhere 
in the review (Bonta et al, 1980). Kuehl and coworkers (1976) have suggested 
that the free radical formed during the conversion of PGG2 to PGH2 and 
which is scavenged by MK-447, may be more important as an inflammatory 
mediator than the stable prostaglandins such as PGE2 . 
b. The steroidal anti-inflammatory drugs 
Prednisone, dexamethasone, triamcinolone and hydrocortisone, when 
added in a concentration of 80 vM, inhibit the depolymerization of bovine 
synovial fluid induced by hypoxanthine/xanthine oxidase. The degrees of 
inhibition are 74, 67, 59 and 39 percent, respectively (Puig-parellada and 
Planas, 1978). This action is probably not due to a direct inhibition of 
superoxide generating mechanisms, as dexamethasone was inactive against .a; 
production by macrophages and the hypoxanthine/xanthine oxidase system 
(Oyanagui, 1976). However, methylprednisolone (sodium succinate) inhibited 
the UV-induced peroxidation of 1 iposomes but not in a dose-dependent 
manner (Seligman et al, 1979). It is possible that membrane-stabilizing 
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properties are involved in the complex mechanisms of protection by methyl-
prednisolone. 
c. Phenothiazines 
The sedatives and histamine (H 1) antagonists such as chlorpromazine 
and promethazine, which have anti-inflammatory properties in several inflam-
mation models (Green et al, 1979), are used commercially in the oil industry 
as antioxidants. Their antioxidant properties may be due to the fact that 
the free radical forms of the phenothiazines are relatively stable (Piette 
et al, 1964) and inhibit the propagation of 1 ipid peroxidation (see 
Chapters 1.1 and 1 .3). Furthermore, chlorpromazine inhibits superoxide 
production by hypoxanthine/xanthine oxidase and by macrophages (Oyanagui, 
1976). 
d. Sulphydryl compounds 
This chapter emphasizes the radical scavenging and antioxidant 
properties of penicillamine and related compounds, such as cysteine, 
cysteamine (S-mercaptoethylamine) and glutathione (y-L-glutamyl-L-cyteinyl-
glycine). Like penicillamine on rheumatoid arthritis, cysteine and gluta-
thione have benificial effects on experimentally induced inflammation 
(Bailey and Sheffner, 1967; Thomas and West, 1973). The mechanisms of action 
of these compounds in protecting against ionizing radiation may be explained 
in two ways: firstly by their sulphydryl-saving properties and secondly, by 
their heavy metal chelating properties. As already mentioned, the sulphydryl 
compounds (RSH) are important 1 ines of defence against free radicals and 
1 ipid peroxidation, either by reacting directly with free radicals or 
indirectly, by saving cellular glutathione, which is the specific substrate 
for the peroxide metabolizing enzyme, glutathione peroxidase. 
e. Copper-containing scavengers: ceruloplasmin, superoxide dismutase 
The mechanisms by which the chelation of metals protects against 
radiation damage is still controversial (Thomson, 1962), but a point of 
unanimity is the crucial role of copper in the production of cellular 
damage. From the positive correlation between the copper content of certain 
eel ls or tissues and their sensitivity toward radiation damage (heart, 1 iver, 
brains > spleen, pancreas, leukocytes), it has been postulated that the 
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damage is due to the preferential oxidation by free radicals of copoer 
bound to endogenous 1 igands, for instance in cytochrome c oxidase. The 
oxidized copper is then immediately reduced by an electron from the protein 
1 igand which in return also becomes oxidized. This oxidized molecule, 
whether the 1 igand decomposes or not, is no longer able to exert its physio-
logical function. The merit of the chelating agents is thought 'to be the 
removal of copper from its storage site on the endogenous ligands and the 
preferential decomposition of the chelating agent. The copper is released 
on decomposition and rebound to the original endogenous 1 igand (Anbar, 1964). 
Interestingly, the main storage site of copper in mammals, namely 
ceruloplasmin, with a molecular weight of about 140,000 and containing 8 
copper atoms per molecule, has been shown to be a scavenger of .a; (Gold-
stein et al, 1979) and to have anti-inflammatory properties against urate-
induced rat paw edema (Denko, 1979). During rheumatoid arthritis, the 
enhanced hepatic synthesis of acute phase proteins leads to elevated levels 
of ceruloplasmin in the serum. Besides maintaining in this way the systemic 
antioxidant potential, ceruloplasmin possibly protects the inflamed site by 
virtue of its scavenging and anti-inflammatory properties. In this context 
it has been shown that ceruloplasmin may be synthesized locally at the 
site of inflammation (Gitlin et al, 1977). In addition, the protecting 
enzyme, superoxide dismutase, with a molecular weight of 34,000 daltons and 
containing 2 atoms of copper and 2 of zinc per molecule, has anti-inflamma-
tory properties in mammals (Huber et al, 1977). Whereas superoxide dismutase 
protects synovial membranes and fluid against superoxide-induced degradation 
(McCord, 1974), the levels of this enzyme in polymorhonuclear leukocytes of 
childre-n with rheumatoid arthritis are decreased (Rister et al, 1979). Based 
on the idea that the release of superoxide by granulocytes during inflamma-
tion may contribute to inflammatory reaction, superoxide dismutase was 
successfully used to combat osteoarthri_tis in horses (H_uber et al, 1977). 
However, the efficacy of superoxide dismutase as an anti-inflammatory agent 
is limited by its rapid degradation after systemic and local injection 
(McCord et al, 1979), whether enzymatically or by its own product, hydrogen 
peroxide, which is formed during the dismutation of superoxide. 
Ceruloplasmi-n, superoxide dismutase and the sulphydryl compounds 
have one profile in common, i.e. the ability to react directly with free 
radicals and to form strong complexes with copper. On this base, compounds 
such as cysteamine, cysteine and acetylcysteine might therefore be consider-
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ed as candidates for clinical trials against rheumatoid arthritis. Another 
mode of action of anti-inflammatory agents to be developed may be the 
stimulation of the synthesis of the acute phase pr~tein, ceruloplasmin, as 
this protein is an endogenous antioxidant in combination with an anti-
inflammatory agent. 
f. Other compounds combining anti-inflammatory activity with 
the scavenging of free radicals 
Imidazole has a complex spectrum of action against inflammation and 
some of.the underlying mechanisms are based on interactions with the 
prostaglandin cascade. !n addition, at a concentration of 80 f,tM, imidazole 
is as potent as mefenamic acid in inhibiting superoxide-induced degradation 
of bovine synovial fluid (Puig-parel lada and Planas, 1978; see Table 3). 
Antioxidant compounds, such as phenol. nordihydroguaiaretic acid 
(NDGA). N,N 1 -dipheny1-p-phenylenediamine (DPPD), propyl gal late and 
a-tocopherol (vitamin E), which are used as preservatives in rubber and 
food technology for example, have anti-inflammatory properties rn a wide 
range Of inflammation models in animals (Stuyvesant and Jolley, 1967; Egan 
et al, 1978; Sobariski et al, 1976; Levy and Kerley, 1974 and McDonald-
Gibson et al, 1976). Although some of these antioxidants are reasonably 
good inhibitors of cycle-oxygenase, vitamin E, for example, is not 
(Panganamala et al, 1977; confirmed by our own experiments)! This suggests 
that lipid peroxides which are formed independently of the prostaglandin 
pathway, may play roles as inflammatory mediators. 
Finally, there are some other unusual compounds, such as 1 ipoic acid, 
sodium iodide, zinc salts, adrenal in and dimethylsulphoxide, which have been 
reported to be anti-inflammatory in at least one type of (clinical or 
experimental) inflammation and which have free radical scavenging properties 
(Oyanagui, 1976; Egan et al, 1978; Dorfman and Adams, 1973 and Wilson, 1977). 
!n conclusion, the inhibition of the formation of free radicals or 
the scavenging of newly formed radicals during inflammation may represent 
a possible mechanism of action of many established anti-inflammatory 
compounds. Although many investigations have to be carried out in this area, 
it is possible that the scavenging of free radicals in some types of 
inflammation may be even more important than the inhibition of prostaglandin 
biosynthesis, in order to exert anti-inflammatory effects (Kuehl et al, 1976). 
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This may be so for two main reasons, namely on one hand, the intrinsic 
tissue damaging effects of free radicals and, on the other hand, the 
reported anti-inflammatory effects of some arachidonate-dependent products 
such as PGE 2 , in the chronic phase of inflammation. 
2.3. Systemic response to inflammation: role of the 1 iver 
Two characteristics of the systemic response to inflammation are 
usually obvious, namely increased body temperature and pain. Other features 
are not noticeable without the use of an invasive technique to obtain blood 
or a sample of inflamed tissue. These features of the systemic response 
comprise the activation of the pituitary-adrenal axis, elevated blood levels 
of the (positive) acute phase proteins in combination with decreased levels 
of albumin and reduction of the hepatic drug metabolizing capacity (see 
Whitehouse, 1977). The acute phase reactant proteins are synthesized in the 
1 iver (parenchymal cells) and contain carbohydrate moieties within the 
molecule. Hence, it is justifiable to define acute phase proteins as 1 trauma-
induced plasma proteins synthesized by the 1 iver 1 • An excellent review on the 
significance of the acute phase reactants has been written by Koj (1974). 
The acute phase response is unspecific since it is not 1 imited to 
a specific disease, e.g. rheumatoid arthritis. However, the response seems 
to be associated with any kind of tissue damage and with the inflammation 
parallel] ing trauma. Thus, increased blood levels of acute phase proteins 
are found after surgical trauma, in rheumatoid arthritis, in some types of 
cancer and after myocardial infarction. The acute phase response as a 
result of inflammation consists of an initial increase in the blood levels 
of C-reactive protein, which occur rapidly (4-8 h) ~fter the initiation of 
inflammation. Fibrinogen, haptoglobin, a 1-antitrypsin and ceruloplasmin are 
slowly (12 h) elevated. The maximum levels of the 1 fast 1 acute phase proteins 
are reached within 48-72 h, whereas the. 1 slow 1 ones reach their maxima 
within 72-96 h. Other acute phase reactants are transferrin, the iron trans-
port protein, and a2-fetoprotein. The latter and C-reactive protein are not 
detectable in blood of normal subjects. Albumin behaves 1 ike a 1 negative 1 
acute phase protein, since its levels decrease in parallel with a rise in 
the other reactants. The decrease in albumin represents an important loss 
of the (low affinity, high capacity) plasma drug-binding capacity, which may 
lead to significantly elevated conce·ntrations of the free drug in the blood. 
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The decrease in serum albumin during the acute phase response is also 
important for the maintenance of the osmotic pressure of the blood (Smith, 
1977). A perennial question associated with the acute phase response is the 
means by which it is induced. lt is generally believed that some humoral 
factor from the site of injury initiates the hepatic synthesis of the acute 
phase proteins or inhibits the gene repression. The differences in the time-
dependent maxima of different acute phase reactants do not necessarily 
require distinct 1 trigger signals 1 from the inflamed site, as the gene 
repression may be affected in different ways. The factor responsible for the 
initiation of the acute phase response is transferable from one animal 
(sterile exudate) to another and it is heat labile. Histamine, lysosomal 
proteases and factors obtained from leukocytes have been susoected 1 the 1 
triggers but experiments with the perfused isolated 1 iver did not confirm 
these hypotheses (see Koj, 1974). Recently, it has been reported that PGE 1 
induces an elevation in the serum levels of haptoglobin, on intravenous 
administration to rabbits (Shim, 1976). PGE 2 also induces the acute phase 
response, as elevated levels of fibrinogen are observed in rabbi_t plasma 
24 h after PGE2 infusion into the marginal ear veins. PGF2a and PGD2 were 
almost ineffective as initiators. The prostaglandin precursors, 1 inoleic 
acid, dihomo-y-1 inolenic acid and arachidonic acid are also initiators of 
the acute phase response measured as fibrinogen. The effect of arachidonate 
was not blocked by indomethacin. This, and the fact that oleic and palmitic 
acid also elicited the acute phase response, implies that prostaglandins 
are not necessarily involved the initiation by fatty acids (Carlson et al, 
1978). ln view of the observations that (15S)-15-methyl-prostaglandin E2 
(methyl ester), which is not metabolized by 15-hydroxydehydrogenase, is more 
potent than PGD 2 and PGFza but less potent than PGE2 , it is 1 ikely that 
there are several disti.nct triggering mechanisms. Fatty acids and irritants 
may initiate an 1 unspecific 1 response, whereas selected prostaglandins may 
initiate a 1 Specific 1 response. This has been confirmed by the observation 
of Shim (1976) that inhibitors of protein synthesis inhibit the acute phase 
response triggered by PGE 1, but not that by turpentine. ln rabbits bearing 
the VXz-carcinoma, enhanced levels of the acute phase proteins, ceruloplasmin 
and haptoglobin, occur in the blood in combination with the PGE2 metabolite, 
13,14-dihydro-15-keto-prostaglandin E2 , which follows the same time course. 
Indomethacin inhibited the increased levels of the PGE2 metabolite as well 
as those of ceruloplasmin, indicating that locally formed prostaglandins 
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may have initiated the acute phase reaction on transport to the liver (Voelkel 
et al, 1978). 
With regard to inflammation, it is interesting that the intraperito-
neal administration of the prostaglandin precursor, arachidonate, to mice 
inhibits the hepatic metabolism of type 1 substrates to cytochrome P-450 
and leads to a loss of cytochrome P-450 activity, after prolonged (5 days) 
administration (Pessayre et al, 1979). This might be a competitive inhibi-
tion but it is also conceivable that oxygenated arachidonate metabolites 
inhibit, and lead to destruction of, cytochrome P-450 (see Chapter 1 .2d). 
Inflammation leads to a hepatic syndrome, which is obvious from a 
number of independent observations from different laboratoria. Some of these 
data are given in Table 4. The enzymes, s-galactosidase and S-N-acetyl-
Table 4. Hepatic changes as a result of remote localized inflammation 
Hepatic parameter inhibited 
adaptive synthesis of 
fatty acid synthetase 
peroxisomal catalase 
synthesis 
levels of reduced 
glutathione 
glutathione-S-
transferase 
S-galactosidase and S-N-
acetylglucosaminidase 
ascorbic acid levels 
Type of injury Authors and year 
s.c. turpentine oi 1 Shutler et al, 
;n the rat 1977 
Canonico et a 1. 
1977 
unilateral hind 1 imb Marozzi & .~a 1 one, 
tourniquet ; n rat 1968 
subp 1 anta r oleyl a 1- Fujihara et al, 
cohol and s. c. M. 1979 
tuberculosis ; n ta i 1 
s.c. turpentine oil Kaplan & Jamieson, 
in the rat 1977 
subplantar oleyl al- Fujihara & White-
cohol and s.c. M. 
tuberculosis in tail 
house, 1977 
glucosaminidase, are involved in the catabolism of serum glycoproteins and 
their inhibition as a result of inflammation, may contribute to the 
57 
elevation of the serum acute phase glycoproteins. This is merely a contribu-
tion to and as such not the only reason for the elevated levels, as it has 
clearly been demonstrated (see Koj, 1974) that the enhanced levels are due 
mainly to the increase of de novo synthesis of acute phase proteins in the 
1 iver. 
Catalase and glutathione participate in the defence system against 
reactive states of oxygen (see Chapter 1.3). Decreased avai labi 1 ity of these 
substances may lead to oxidative damage to the 1 iver, as it has been shown 
that depletion of glutathione induces lipid peroxidation in the 1 ivers of 
rats and mice (Younes and Siegers, 1980). During carrageenin-induced 
paw edema in mice, increased 1 ipid peroxidation has been shown to occur when 
1 ivers are removed from the animals and subsequently incubated for 3 hours 
(Sharma et al, 1972). Although different inflammation models have been used, 
it is 1 ikely that a remote localized inflammation, by one way or another, 
decreases hepatic catalase and glutathione levels and increases 1 ipid 
peroxidation. The trigger signal may be the same as that responsible for 
the initiation of the acute phase response. 
The exact functions of the acute phase proteins have by no means 
been elucidated yet. Increased fibrinogen levels may protect against blood 
loss from damaged vessels at the inflamed site, while C-reactive protein 
reacts with the C-polysaccharide .from pneumococci occasionally infiltrated. 
a 1-Antitrypsin is an antiprotease, which protects against proteolytic 
enzymes released at the inflamed site. Haptoglobin combines with hemoglobin 
and the complex formed has essential peroxidase activity. That means that it 
oxidizes organic substrates in the presence of hydrogen peroxide as an 
electron acceptor. Ceruloplasmin is an oxidase, preferentially oxidizing 
ferrous iron and organic substrates, such-asp-phenylenediamine, catechols 
and hydroxy-indoles. This means that ceruloplasmin may act as a monoamine 
oxidase, thus terminating the actions of (nor)adrenalin and serotonin, which 
are released during stress and shock. By virtue of its ferro-oxidase 
activity, ceruloplasmin protects against iron decompartmental ization, since 
ferrous iron is not bound to the iron stores, ferritin and transferrin. 
Another aspect of the acute phase protein ceruloplasmin is that this 
protein is the main storage site for copper in the body. Enhanced levels of 
ceruloplasmin result in enhanced serum copper levels. Copper(ll) ions, as 
well as copper bound to amino acids, are scavengers of superoxide radicals 
(see Chapter 1.3), while copper in combination with zinc, is essential for 
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the activity of cytoplasmic superoxide dismutase. This enzyme protects 
against the depolymerization of synovial fluid and hyaluronate in vitro, 
induced by the xanthine/xanthine oxidase system (McCord, 1974) and has 
anti-inflammatory properties in many inflammation models (Huber et al, 
1977). Many copper chelates also have anti-inflammatory properties against 
adjuvant arthritis in the rat (Sorenson, 1976), while salicylat"es may exert 
anti-inflammatory activities by virtue of forming chelates with copper in 
vivo (Richardson, .1976). Totally in agreement with aforementioned anti-
inflammatory activities of numerous copper compounds, is the reported anti-
inflammatory activity of ceruloplasmin against urate-induced rat paw 
oedema (Denko, 1979). This may be at least one valid explanation for the 
remission of rheumatoid arthritis durinq preqnancy, as serum levels of 
ceruloplasmin gradually rise during this state. 
In the 1 ight of the subject of this thesis, it is of great 
importance that ceruloplasmin has the ability to scavenge superoxide 
radicals, albeit less effectively than superoxide dismutase (Goldstein et 
al, 1979). It has been known for a long time that ceruloplasmin is respons-
ible for the major part of serum antioxidant activity (see Cranfield et al, 
1979). Furthermore, a plasma fraction associated with haptoglobin, is an 
endogenous inhibitor of the prostaglandin-synthesizing enzyme, cycle-oxy-
genase (see Chapter 1 .2c). The haptoglobin-hemoglobin complex can deal with 
hydrogen peroxide released from granulocytes, by virtue of its peroxidase 
activity, while also the complex of C-reactive protein and hematin has 
peroxidase activity (see Koj, 1974). 
Injection of 2-amino-1 ,2,4-triazole into rabbits, leading to an 
inhibition of catalase activity, results in enhanced levels of serum C-
reactive protein and when the hepatic catalase levels had returned to normal, 
the levels of C-reactive protein were lowered in parallel. Furthermore, 
purified C-reactive pr.otein inhibited c~talase synthesi? on addition to 
1 iver slices in tissue culture (Hokama et al, 1969). From these observations 
it seems 1 ikely that C-reactive protein inversely reflects the hepatic 
catalase activity. This may be extrapolated to the elevated C-reactive 
protein levels in patients with rheumatoid arthritis and animal models of 
inflammation. In adjuvant arthritic rabbits it was possible to restore the 
decreased hepatic catalase activity to normal (and even supranormal) levels 
bY. the intravenous injection of hem~tin. The induction of catalase activity 
was marked as early as 3 h after treatment with hematin (0.5 mg/kg), both in 
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the 1 iver and in the kidneys. Furthermore, the induction of catalase activ-
ity was parallel led by a decrease in serum C-reactive protein levels 
(Hokama et al, 1970). The authors suggest a possib_le role of C-reactive 
protein as a dimeric precursor for the tetrameric catalase apoenzyme, which 
protects against hydrogen peroxide provided that heme is incorporated. 
Rat a.2-macroglobul in (foetoprotein), 1 ike ceruloplasmin. has al-so 
been shown to display anti-inflammatory properties against carrageenin-
induced rat paw oedema. Injury (laparotomy) prior to the administration of 
carrageenin, enhanced the levels of serum a.2-foetoprotein, and the maximum 
serum concentration was reached 24 h after laparotomy. Subsequently, maximal 
suppression of paw oedema was observed 24 h after laparotomy, suggesting that 
the inhibition of oedema formation was a consequence of enhanced levels of 
foetoprotein (van Gaol et al, 1974). Analogously, one of the modes of action 
of anti-inflammatory glucocorticoids may be their ability to enhance plasma 
levels of the antiprotease, a.,-antitrypsin and thus, indirectly, gluco-
corticoids inhibit eel lular and tissue damage at the site of inflammation 
(Pitt and Lewis, 1979), 
In addition to the anti-inflammatory proteins which can be recover-
ed from the blood of inflamed animals, a heterogenous group of anti-inflam-
matory proteins has been shown to occur at the site of inflammation (for a 
review, see Bonta, 1978). This g-roup may include several acute phase proteins 
as extra-hepatic synthesis of some acute phase reactants occurs, for 
instance, a.,-antitrypsin and a.2-macroglobul in synthesis have been observed 
in human tumours (see Cooper and Milford Ward, 1979). It is conceivable that 
the protease-antiprotease complexes are trapped from the circulation by 
macrophages from the tumour, thus providing an apparent extra-hepatic site 
of synthesis. However, Gitlin and coworkers (1977) reported the ability of 
human synovial eel ls to produce ceruloplasmin in vitro, emphasizing the 
possibility of a close relationship between local anti-inflammatory proteins 
at the inflamed site and acute phase proteins in the blood .. 
In view of the properties of the acute phase proteins mentioned in 
this chapter, it seems justifiable to characterize the acute phase response 
as being a homeostatic phenomenon. The activities of several proteases are 
antagonized, the levels of the fibrin precursor are enhanced, thus, protect-
ing against eventual blood loss, free hemoglobin is bound by haptoglobin 
and the complex displays peroxidase activity. Ceruloplasmin protects against 
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Fe(ll)-catalyzed 1 ipid peroxidation and is a superoxide scavenger. As an 
oxidase, it may 1 imit the actions of released catecholamines and hydroxy-
indoles. Like. o. 1-antitrypsin and rat o.2-macroglobulin, it has anti-inflamma-
tory properties. C-reactive protein is 1 ikely to provide precursor peptides 
for hepatic and renal catalase, the activities of ,which are diminished as 
a result of a remote localized injury. 
The acute phase response can be affected in several ways, but the 
individual acute phase reactants do not respond uniformly. Corticosteroid 
administration leads to enhanced levels of rat o.2-foetoprotein and hapto-
globin, but not of ceruloplasmin, while the administration of PGE 1 or PGE2 
results in increased levels of fibrinogen and haptoglobin. Injury and 
pregnancy inhibit inflammation, presumably as a result of an extra stimula-
tion of the acute phase response. Finally, haptoglobin-) ike proteins 
inhibit, in turn, the formation of prostaglandins,·which is indicative of 
the extremely fine-balanced automodulation mechanisms which are operative 
as a result of and directed against injury of many kinds. 
2.4. Summary 
Inflammation is characterized by local events, such as redness, 
oedema and pain, and humoral mediators of inflammation play an important 
role in the local response. In the sub-acute phase of inflammation, granulo-
cytes and monocytes invade the inflamed area to engulf the inflammagen. 
During phagocytosis, superoxide anions are generated at sites on the cell 
membrane of the phagocytes by an NADPH oxidase. Superoxide anions are 
dismutated to hydrogen peroxide by superoxide dismutase, which, in combina-
tion with catalase protects the cytoplasma and its organelles from 
damage. Nevertheless, superoxide radicals escape into the extracellular 
fluid and the potent oxidant, the hydroxyl radical, is also formed. This 
formation may lead to peroxidation of constitutional membrane 1 ipids. 
Apart from inhibiting the biosynthesis of prostaglandins, many anti-inflamma-
tory drugs act as free radical scavengers, as inhibitors of superoxide 
production by granulocytes and macrophages and as inhibitors of eel 1 migra-
tion to the inf·lamed site. Systemic effects of inflammation comprise 
activation of the pituitary-adrenal axis, increased body temperature and 
alterations in 1 iver function. The activity of many hepatic enzymes is 
decreased as is the drug handling capacity. In contrast, the 1 iver synthe-
sizes the, 1so-called 1 acute phase proteins at an enhanced rate. The role of 
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the acute phase proteins is likely to be a protective one, since distinct 
acute phase reactants inhibit the biosynthesis of prostaglandins, display 
peroxidase activity (i.e. they catalyze the breakdown of hydrogen peroxide), 
reflect hepatic catalase activity, scavenge superoxide radicals and have 
anti-inflammatory properties. The increased levels of acute phase proteins 
provides enhanced protection against oxidative events, by virtue of their 
peroxidase and superoxide-scavenging activities and this may be an 
indication of the occurrence of a systemic oxidant stress as a result of a 
remote localized inflammation. 
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PART I I. AIM OF THE STUDIES PERFORMED 
In 1954, Duboulez and Dumas showed that 1 ipid peroxidation is 
involved in acute inflammation. Many years later, it was recognized that 
after injury prostaglandins and related substances are formed by endo-
peroxidation of polyunsaturated fatty acids. Thus, dihomo-y-1 inolenic acid 
and arachidonic acid are converted to prostaglandin endoperoxides by 
cycle-oxygenase. These endoperoxides are then converted to the stable 
prostaglandins, thromboxane, prostacycl in, hydroxy-fatty acid and malon-
aldehyde. Thus, it is possible that the peroxides detected by Duboulez and 
Dumas were prostaglandin endoperoxides. 
The aim of our studies were to investigate whether 1 ipid peroxidation 
occurs at the site of inflammation independently of the biosynthesis of 
prostaglandins. This seemed likely, as fatty acid precursors are abundant 
at the inflamed site and since initiators of 1 ipid peroxidation, namely free 
radicals, are constantly generated and released by granulocytes and mono-
nuclear phagocytes, during phagocytosis. 
Malonaldehyde is a stable end product of the decomposition of 
endoperoxides formed during 1 ipid peroxidation, which has been used as a 
monitor of the extent of 1 ipid peroxidation in chemical and biological 
systems. As locally formed malonaldehyde may originate from the arachidonate 
cascade and, more specifically, from the thromboxane synthetase pathway, 
it was planned to investigate time-dependent changes in prostaglandin 
biosynthesis, for which purpose radioactively label led arachidonic acid 
was to be injected into the inflamed site. An inflammation model which allows 
the accurate injection of drugs and local hormone precursors into the 
inflamed site, namely the model of cannulated sponge implants in the rat, 
was in routine use within our laboratory. However, the sponges do not allow 
for the collection of inflammatory exudate from the granulomata around the 
sponges, without surgical intervention. Therefore, an analogous model was 
to be developed which permitted the collection by perfusion of inflammatory 
exudate containing the radioactively labelled metabolites of arachidonic 
acid. 
!n 1972, Sharma and coworkers showed that livers from mice with 
carrageenin-induced paw oedemata produced significantly more malonaldehyde 
than 1 ivers from control mice, indicating increased hepatic 1 ipid peroxid-
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at ion as a result of a remote localized inflammation. Another aim of the 
studies presented in this thesis was to extend the observations of Sharma 
and coworkers to (semi-)chronic inflammation models in the rat. It was 
the intention to demonstrate that increased hepatic 1 ipid peroxidation was not 
due to the resorption of carrageenin at the inflamed site. Therefore, the 
non-absorbable inflammagen kaolin was used. Furthermore, it was necessary 
to show eventual increases in the hepatic levels of malonaldehyde ex vivo, 
i.e. without incubation, as this seemed to be more indicative of in vivo 
alterations. 
Besides hepatic 1 ipid peroxidation as a result of an extra-hepatic 
inflammation, we were interested in hepatic changes which had been reported 
to occur in combination with 1 ipid peroxidation under conditions other than 
inflammation. Therefore, we were to investigate the levels of selected 
hepatic antioxidants at different stages of an extra-hepatic inflammation, 
as wel 1 as changes in the hepatic drug metabolizing capacity, measured using 
the model drug, aminopyrine. 
A final aim of the studies performed was to pharmacologically 
influence the inflammatory process by the local administration of antioxi-
dants and free radical scavengers, thereby attempting to dissociate between 
the distinct states of reduced oxygen which are involved in the inflammatory 
response. 
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PART Ill. GENERAL DISCUSS I ON AND CONCLUSIONS 
The problem of 1 ipid peroxidation in inflammation may be approached 
by studying either the local site of inflammation or changes which occur in 
the 1 iver. The majority of investigations in the field of inflammation have 
been concentrated on the inflamed site. Prostaglandin formation, its inter-
actions with the cyclic nucleotide system, the release and actions of brady-
kinin, serotonin and histamine, the aspects of chemotaxis and cellular 
infiltration, the release and actions of lysosomal enzymes, the occurrence 
of anti-inflammatory proteins at the site of inflammation and the local 
anti-inflammatory effects of corticosteroids and nonsteroidal anti-inflamma-
tory drugshave all been (and are still) widely investigated. 
Fewer investigators have worked on endogenou? modulation of inflam-
mation, attention then being focussed on the 1 iver as the site of production 
of anti-inflammatory proteins, which can be isolated from the blood and the 
site of inflammation. Very recently, a small number of investigators (Babior 
et al, 1973; McCord, 1974) started to study the role of free radicals and 
their products in humoral and cellular systems, which are relevant to 
inflammation, but their studies have been almost completely confined to 
in vitro experiments. 
The aim of our studies was to investigate the suggested role of 
1 ipid peroxidation in inflammation in vivo and its relation to hepatic 
changes occurring during extra-hepatic inflammation. We focussed our 
attention initially on the inflamed site, in view of the available know-how 
within the laboratory on inflammation models, the study of exudation, prosta-
glandin biosynthesis and granuloma formation. Models of granulomatous 
inflammation were chosen because of their similarity to the proliferative 
aspects of rheumatoid arthritis. The proliferative lesion is characterized 
by an enormous increase in the amount of collagen, which leads to destruct-
ion of cartilage and ultimately of the joint itself. The granuloma model and 
the proliferative lesion have in common the involvement of macrophages as 
the most importan_t cell type. The model is also representative fOr prosta-
glandin biosynthesis, superoxide formation, lysosomal enzyme release and 
col lag en formation and breakdown. 
In order to investigate the in vivo metabolism of the polyenoic 
fatty acid, arachidonic acid, the prostaglandin precursor which is highly 
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susceptible to peroxidation, we developed a new inflammation model, the 
model of teflon chamber implants in the rat (see Appendix, Chapter 1). This 
model shows similarities to other models of granulomatous inflammation, 
namely with respect to patterns of exudation, granuloma formation and the 
domination of polymorphonuclear leukocytes in the exudate. The fact that 
lymphocytes are the second most important cell type in the newly developed 
chamber model, whereas in the sponge model lymphocytes are hardly present, 
provides the former with a closer resemblance to rheumatoid arthritis than 
the model of implanted sponges. 
Another similarity of the chamber model with rheumatoid arthritis 
is the pattern of metabolism of arachidonate (see Appendix, Chapter 2). Thus, 
injected {1- 14c}arachidonate in our rat model was converted mainly to the 
hydroxy-fatty acids HHT and HETE, and to PGE 2 , whereas prostacycl in and 
thromboxane were formed only in very small amounts. In patients with 
rheumatoid arthritis, the synovial fluid contained mainly PGE 2 , whereas 
thromboxane was a minor arachidonate metabolite (Trang at al, 1977). Higgs 
and Salmon (1979) confirmed our results mare .recently, since they found 
similar patterns of endogenous arachidonate metabolites in the sponge model, 
using radioimmuno-assay for the detection of prostaglandins and related 
substances. Our results and the results of Higgs and Salmon with in vivo 
models are in marked contrast to the results of Chang et al (1978) in Japan, 
who found thromboxane and prostacycl in to be the main metabolites from 
arachidonate in vitro, using homogenate fractions of granulomata removed 
from rats on day 8 of inflammation. Thus, it is very 1 ikely that damage to 
platelets and vascular walls had interfered with their results and sub-
sequent interpretation. 
Another analogy to rheumatoid arthritis, which we observed with the 
newly developed chamber model, was the lack of improvement of the inflamma-
tory conditions on treatment with nonsteroidal anti-inflammatory drugs, 
such as indomethacin. Thus, indomethacin inhibited PGE2 for~ation but failed 
to inhibit granuloma formation (see Appendix, Chapter 3). As the inhibition 
by indomethacin of the different arachidonate metabolites did not occur 
uniformly, it is possible that different cyclo-oxygenases (or cycle-oxygen-
ase of different cells) are involved in prostaglandin formation at the 
inflamed site. This assumption is based on the observation that the cyclo-
oxygenase of arterial walls (main product prostacycl in) is less sensitive 
to inhi~ition by nonsteroidal anti-inflammatory drugs than platelet cyclo-
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oxygenase (main product thromboxane A2). Another possibility is that the 
prostaglandin endoperoxide-converting synthetases and isomerases are 
differently inhibited by aspirin-] ike drugs. 
A possible explanation for the observed lack of inhibition of 
granuloma formation by indomethacin, is that PGE2 , in the chronic phase of 
inflammation, may play an inhibitory role in granuloma formation, through the 
stimulation of the adenylate cyclase of macrophages (Bonta and Parnham, 
1978). The inhibition by injected PGE 2 of granuloma formation is potentiated 
by phosphodiesterase inhibitors and inhibited by the adenylate cyclase 
antagonist, SQ 22536. At the time of maximal macrophage infiltration in the 
granuloma, macrophages isolated from granulomata contain minimal amounts of 
cyclic AMP, which means that the eel ls are very sensitive to stimulation of 
their adenylate cyclase by PGE2. Administration of PGE 2 at this stage of 
granuloma formation leads to maximal inhibition of granuloma weight. 
Administration of inhibitors of prostaglandin formation during this ·stage, 
may have no benificial effects since they would eliminate the action of an 
anti-inflammatory endogenous modulator, namely PGE2 . 
The most interesting aspect of the actions of indomethacin in the 
chamber model was the (at that time) unexpected inhibition of HETE formation 
in the early phase of inflammation. It was then stil 1 believed that HETE 
formation from arachidonate, via the 1 ipoxygenase pathway (Part 1, Chapter 
1 .2c), was insensitive to inhibition by nonsteroidal anti-inflammatory 
drugs. The 1 ipoxygenase pathway leads to the formation of several hydro-
peroxy-fatty acid intermediates, from which HETE or the leukotrienes are 
subseq~ently formed. One of the leukotrienes is the local hormone, SRS-A, 
an important bronchoconstrictor in allergic condi~ions, while other 
leukotrienes, especially di- and trihydroxy-fatty acids, are chemotactic 
for granulocytes. Furthermore, our studies with indomethacin indicated that 
the formation of products from injected arachidonate could never be fully 
suppressed, which anticipated our later studies, by suggesting autoxidative 
formation of metabolites. 
The formation of malonaldehyde at the inflamed site, irrespective 
of the biosynthesis of prostaglandins, during granuloma formation, provides 
further evidence for the involvement of 1 ipid peroxidation in inflammation 
(see Appendix, Chapter 4). Our observation that local lipid peroxidation is 
correlated with the inflammatory strength, has also been observed in 
patients with different degrees of rheumatoid arthritis (Muus et al, 1979). 
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The studies on the in vivo metabolism of arachidonate indicated that a 
redirection of metabolism via the thromboxane pathway, leading to HHT, 
thromboxane and malonaldehyde formation at the expense of PGE2 , does not 
occur and is not responsible for the dissociation between locally formed 
malonaldehyde and PGE 2 . The increased levels of malonaldehyde in the 1 iver 
and plasma of rats with a remote localized inflammation, indicate that 
the 1 iver is involved in an extra-hepatic inflammation. That the malonalde-
hyde recovered from the 1 iver is really due to hepatic formation and not 
to trapping of the aldehyde from the circulation, is demonstrated by the 
enhanced formation of malonaldehyde on incubation of livers from inflamed 
rats, irrespective of the inflammagen used (Sharma et al, 1972; see also 
Appendix, Chapter 4). 
In many in vitro experiments, correlations have been demonstrated 
to exist between increased 1 ipid peroxidation and inhibition of oxidative 
drug metabolism and vice versa, using 1 iver homogenates and microsomal 
suspensions from various animal species. Possible underlying mechanisms 
have been discussed in Part I, Chapter 1 .Zd. We have shown that increased 
hepatic 1 ipid peroxidation and reduced aminopyrine metabolism occur 
simultaneously in vivo, during granulomatous inflammation in the rat (see 
Appendix, Chapters 5 and 6). The reduced aminopyrine metabolism, measured 
as an increased half-1 ife, was correlated with the inflammatory strenght. 
The nature of the inhibition of drug metabolism during inflammation has 
not yet been investigated, but one possibility is that the inhibition is due 
to destruction of cytochrome P-450 at the heme moiety or at the 1 ipid 
region. !n this respect, it has been reported that during adjuvant arthritis 
in the rat the amounts of cytochrome P-450 and also of NADPH-cytochrome c 
reductase were significantly reduced (Matthur et al, 1978). Unfortunately, 
no time-dependency of the changes have been investigated and thus, it is 
not possible to establish whether NADPH-cytochrome c reductase is respons-
ible for production of superoxide radicals, when cytochro~e P-450 has 
already been inactivated. 
The consequences of reduced drug metabolism may be of importance, if 
one extrapolates the data with rats to rheumatoid arthritis in man. A major 
implication of the experimental data would be that the 1 safety 1 of anti-
rheumatic drugs depending on hepatic metabolism, in patients with rheumatoid 
arthritis will be severely overestimated. Toxicity studies are based mainly 
on obse_rvations with healthy animals and volunteers, whereas data obtained 
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with patients can only be gathered after a long-term controlled study. !n 
other words, a patient suffering from rheumatoid arthritis will generally 
be more sensitive to toxic drug effects than a normal person, receiving the 
same dose. Time wil 1 show, however, whether it is justifiable to make such 
extrapolations, as investigations of hepatic drug metabolizing capacity have 
not yet been carried out on patients with rheumatoid arthritis·. 
Impairment of hepatic drug metabolizing capacity is not 1 imited to 
to experimental inflammation (nor possibly to rheumatoid arthritis), as it 
has also been reported to occur during pregnancy and hepatitis. During the 
latter conditions, increased serum levels of the acute phase proteins as well 
as of 1 ipid peroxides have been reported (see Part l, Chapter 1.2d). !t is, 
therefore, tempting to speculate that the same trigger mechanism may play a 
role in eliciting the acute phase response, hepatic 1 ipid peroxidation and 
decreased drug metabolism. 
During remote localized inflammation, changes occur in hepatic 
antioxidant levels. Catalase activity and the levels of reduced glutathione 
and ascorbic acid are markedly depressed, while 1 ipid peroxidation is 
strongly enhanced (see Appendix, Chapter 6). Possible consequences of lipid 
peroxidation in the 1 iver are stimulation of lysosomal enzyme release, 
membrane lysis and degranulation of rough and smooth endoplasmic reticulum 
with subsequent inhibition of protein synthesis and cellular excretory 
mechanisms. Decreased hepatic glutathione levels may lead to inhibition of 
phase ! 1 biotransformation of drugs which are normally conjugated to 
glutathione via hepatic glutathione-S-transferases, for instance, paracetamol 
(acetaminophen). Unconjugated reactive metabolites, formed during phase 
biotransformation (for instance by cytochrome P-450), attack sulphydryl 
moieties of hepatocytes, leading to hepatocellular dama_ge and ultimately, 
necrosis. 
Should our rat models also be representative of rheumatoid arthritis 
with respect to hepatic changes, then it is very 1 ikely that, during 
rheumatoid arthritis, some kind of hepatic oxidant stress exists. Indeed, it 
has been shown that plasma levels of malonaldehyde, the stable 1 ipid per-
oxidation product, are elevated during rheumatoid arthritis and correlate 
with disease activity (Muus et al, 1979). As in the rat models, this may 
indicate altered hepatic function. However, it is not clear whether the 
l_ipid peroxidation observed during. inflammation is due to the enhanced 
formation of 1 ipid peroxides or to decreased metabolizing capacity of the 
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liver with respect to lipid peroxides and xenobiotics. It is generally 
thought that low 1 steady-state 1 levels of several oxidants (superoxide 
anions, lipid peroxides, hydrogen peroxide) exist in the normal individual, 
but the body is able to detoxify them by means of ascorbic acid, vitamin E, 
glutathione and the enzymes, catalase, superoxide dismutase and glutathione 
peroxidase (see Chance et al, 1979). Disturbances in the capabi 1 ities of 
these detoxification mechanisms, whatever the underlying cause may be 
(genetically determined, drug-induced, inherent to states of disease or 
nutricional insufficiencies, etc.), may lead to increased 1 ipid peroxidation 
and its sequellae. 
It is of particular interest that several reports have described the 
presence of many biochemical and morphological aberrances in the 1 ivers of 
rheumatoid arthritis patients, varying from the well-known changes in 
plasma proteins to raised serum levels of alkaline phosphatase, 5 1 -
nucleotidase, bioptic findings of inflammatory cell infiltration and an 
increase of fibrous tissue around the portal triade (see Lefkovits and 
Farrow, 1955). Although some observations may be explained by i.atrogenic 
mechanisms, these findings suggest the existence of a reactive hepatitis 
during rheumatoid arthritis. This may represent one of the feed-back 
mechanisms involved in the self-curtailing processes of inflammation. Thus, 
it is a wel 1-known clinical experience that during hepatitis and jaundice, 
the activity of rheumatoid arthritis is decreased. Several explanations 
are feasible. One possible explanation maight be that, as a result of 1 iver 
dysfunction, the catabolism of adrenal corticosteroids by the 1 iver is also 
impaired, which would lead to an elevated serum level and a longer half-] ife 
of these hormones. However, in patients with 1 iver cirrhosis, a condition 
preceded by chronic hepatitis, plasma levels of 17a-hydroxy-corticosteroids 
(cortisone, hydrocortisone) are often not elevated, but administered 
corticosteroids are less rapidly cleared from the blood, when compared to 
healthy individuals (see Kornreich et al, 1971). This impl ~es that other 
mechanisms must be involved in the suppression of rheumatoid arthritis than 
merely the modulation by endogenous anti-inflammatory steroids. 
Another, almost similar, explanation is that bile salts and bil i-
rubin displace corticosteroids from their binding sites on plasma transport 
proteins, since bile duct 1 igation leads to an improvement of art paw 
oedema (see Bonta, 1978). A third explanation may be the enhanced synthesis 
of anti-inflammatory acute phase proteins as a result of hepatitis and other 
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forms of injury, for instance laparotomy. Pregnancy which is, for instance, 
characterized by enhanced levels of ceruloplasmin in the blood, also results 
in an improvement of rheumatoid arthritis. 
Ceruloplasmin, the copper transport protein, is a superoxide radical 
scavenger, is the major serum antioxidant and has anti-inflammatory proper-
ties against experimental inflammation. ~ith respect to the sca~enging of 
superoxide radicals, it is much less effective than superoxide dismutase 
(see Part I, Chapter 2.4). Even at very high dosage levels, we were unable 
to demostrate any beneficial effects of the local administration of bovine 
superoxide dismutase in a model of granulomatous inflammation in the rat 
(see Appendix, Chapter 7). This may be due to the size of the molecule, 
which prevents superoxide dismutase from reaching its site of action. How-
ever, catalase with a molecular weight of about seven times that of super-
oxide dismutase, was a potent inhibitor of granuloma formation and exudation 
under the same experimental conditions. This may mean that hydrogen peroxide 
is a more potent inflammatory mediator than superoxide, but it is also 
1 ikely that superoxide dismutase is rapidly inactivated by one of its own 
products, namely hydrogen peroxide. This may also partially explain why 
the low-molecular weight copper-amino acid chelates, which are relatively 
stable and also easily cross membranes because of their 1 ipophil icity, are 
effective anti-inflammatory agents (Sorenson, 1976). 
Although we were unable to demonstrate anti-inflammatory effects 
of hydroxyl radical scavengers in our experiments (see Appendix, Chapter 7), 
it is still likely that hydroxyl radicals are inflammatory mediators by 
virtue of their high reactivity to biological molecules, for instance 1 ipids 
and proteoglycans. This implies that scavengers need to be administered in 
concentrations high enough to compete with ubiquitous biological molecules 
as 1 substrates 1 for hydroxyl radicals. Inhibitors of hydroxyl radical 
formation, rather than scavengers of preformed hydroxyl radicals, would 
then be expected to display anti-inflammatory properties. In this context, 
we were able to demonstrate that specific combinations of superoxide 
dismutase and catalase as wel 1 as an iron chelator, were effective as 
inhibitors of granuloma formation, presumably by preventing the Fenton 
reaction of iron(ll) with hydrogen peroxide, yielding hydroxyl radicals 
(see Appendix, Chapter 7). A pharmacological implication of these findings 
is that iron chelators might be promising anti-rheumatic agents in view 
of their potential inhibiting properties on granuloma formation and synovial 
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fluid depolymerization. 
The observed anti-inflammatory effects of antioxidants (see 
Appendix, Chapter 7) have a number of pharmacological implications. Some 
antioxidants are markedly ineffective as inhibitors of prostaglandin bio-
synthesis and since PGE 2 is an inhibitor of experimentally-induced granuloma 
formation, this lack of inhibition may be advantageous. In addition, such 
antioxidants may also lack gastrotoxicity, as the latter seems to be 
coupled with inhibition of prostaglandin biosynthesis in the stomach. Other 
antioxidants potentiate the inhibitory actions of indomethacin on carra-
geenin-induced rat paw edema (Sobanski et al, 1976). This means that smaller 
amounts of indomethacin are required to achieve therapeutically active 
levels and thus, disadvantageous side effects of nonsteroidal anti-inflamma-
tory drugs may be reduced. Some antioxidants inhibit (albeit not selectively) 
soybean 1 ipoxygenase. Should mammalian lipoxygenases be sensitive to 
to inhibition by selected antioxidants, then antioxidants may prevent the 
formation of chemotactic principles and slow-reacting substances, which 
are formed via a 1 ipoxygenase mediated pathway. 
Finally, it would be interesting to evaluate drugs which act as 
inducers of the synthesLs of acute phase proteins or as inhibitors of 
repression at the DNA-RNA level. Oestrogens, amongst other agents, may 
provide a matrix for new drugs to be developed, since they induce enhanced 
levels of ceruloplasmin and have beneficial effects on inflammatory dis-
orders. They may be used to investigate interactions between 1 ipid peroxid-
ation,· drug metabolism and the hepatic acute phase response in animals as 
we] 1 as in man, and to study whether 1 ipid peroxidation products, migrating 
from the inflamed site, a~t as triggers of the hepatic adaptive syndrome 
during inflammation. 
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PART IV. APPENDIX 
1 . Cannulated Teflon Chamber Implant in the Rat: A New 
Model for Continuous Studies on Granulomatous 
Inflammation 
P. C. BRACT, I. l. BONTA, AND M. j. P. ADOLFS 
A granulomatous inflammation model is described. It is a modification of the 
cannulated sponge method and consists of a subdermally implanted teflon cyl-
inder in the rat. This 'chamber' is cannulated and provided with holes to ensure 
contact and exchange of materials between the inner chamber and the surround-
ing tissues. The cannulae are exteriorized at the back of the neck and allow 
materials to be injected and exudate to be collected at any given time during the 
development of granulomatous tissue around the chamber. Some parameters of 
this inflammation, such as exudation, granuloma growth, cellular infiltration in 
exudate, and the formation of prostaglandins' were studied, and a comparison 
was made with the sponge implant model. The value of the chamber method is 
illustrated by brief reference to a study on the metabolism of 14C-arachidonic 
add during granulomatous inflammation. 
Key Words: Arachidonic acid metabolism in vivo; Cannulated chamber im-
plant; Granulomatous inflammation; Exudative inflammation; Cells in granu-
lomatous inflammation; Prostaglandins in granulomatous inflammation. 
INTRODUCTION 
Recently, an inflammatory granuloma model was described (Bonta et al., 1979), 
consisting of cannulated polyether sponges implanted into the dorsal subdermal 
tissue of a rat. The merit of this method is that it allows the local injection of 
materials into the inflamed site at any give·n time during granuloma development. 
However, the method has the disadvantage that it does not allow the withdrawal 
of inflammatory exudate via the cannulae because of the high flow resistance of 
the sponge material. Another disa.dvantage, in common with other synthetic sponge 
implant models, is the fact that compounds (e.g. softeners, stabilizers) added to 
the sponge material during its manufacture may have an influence on the inflam-
matory process (Parnham et al., 1977). 
Therefore, we have developed a new model that allows materials to be injected 
and exudate to be withdrawn at any given stage of granuloma development. Our 
model combines the advantages of both the cannulated sponge implant of Bonta 
et al. (1979) and the wound chamber described by Lundgren and Undhe (1973); it 
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consists of a cannulated teflon cylinder with a perforated mantle that is implanted 
into the dorsal subdermal region of a rat. The main constituent, teflon, evokes a 
minimal tissue reaction by itself (Harrison et al., 1957; Calnan, 1963) and is inert 
towards almost all chemicals. We compared some parameters of granulomatous 
inflammation iriduced by teflon chamber implants with those following sponge 
implantation. In addition, as the newly developed chamber method enabled us to 
study the local metabolism of arachidonate in vivo during granulomatous 
inflammation (Bragt and Bonta, 1979), some data from this study on arachidonate 
metabolism are presented to illustrate the use of the method. Our results are 
compared with the results of Chang eta!. (1978), who reported arachidonate con~ 
version by granulomatous tissue in vitro. 
MATERIALS AND METHODS 
Materials 
Polytetrafluoroethylene (Teflon, Fluon, Fluorof!ex) tube, i.d. 8 mm and wall thick~ 
ness 1 mm (Eriks; Alkmaar, The Netherlands), was cut into pieces of 30 mm in 
length. Each piece of teflon was installed in a piercing gauge and 108 holes were 
made, 1.5 mm in diameter and distributed into 12 rows of 9 holes around the 
cylinder mantle. After piercing, residual curls of teflon were filed off. One end of 
the cylinder was closed with a plug of silicone (Silastic Medical Adhesive, Dow 
Corning; Midland, Texas) and after having inserted two small pieces of Tygon tube 
(0.7 x 2.3 mm, Rubber; Hi!versum, The Netherlands) "20 and 40 mm in length, 
respectively, through the open end; this end was also sealed with silicone. Two 
nylon cannulae, about 120 mm in length (0.65 X 1.02 mm, Rubber; Hilversum, The 
Netherlands), were inserted into the Tygon tubes, after the silicone had been left 
to harden overnight. This completed the assembling of the unit and the cannulated 
teflon chamber was ready for implantation into rats. 
The materials used permit sterilization of the chamber at 120°(, if this is required. 
The internal volume of the chamber is 1.5 ml, plus that of the cannulae (0.04 ml 
each). Thus, after the injection of a compound only 2.7% (by volume) will fail to 
enter the granuloma. Jf necessary, this can be overcome by the inclusion of a small 
volume of air in the injection syringe. The total area of the perforations represents 
25.3% of the mantle area. ' 
Sodium carrageenin (Viscarin, Marine Colloids Inc.; Springfield, Mass.) was preM 
pared as a 1% (w/v) gel in sterile pyrogenMfree saline, by- stirring for several hours 
at room temperature. 
[1- 14C] Arachidonic acid (55.5 Ci!mole, The Radiochemical Centre; Amersham, 
England) was removed from its solvent, benzene, by evaporation under a stream 
of nitrogen, and redissolved in absolute ethanol to a specific activity of 12.5 tJ.Cil 
mi. 
May~GnJnwald (number 1424) and Giemsa (number 9207) solutions were purM 
chased from Merck; Darmstadt, West Germany. 
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FIGURE 1. Schematic representation of the implanted teflon chamber in the rat, with the 
cannulae exteriorized at the back of the neck. Sizes of the chamber are given in the upper 
figure. The cylinder mantle is provided with holes of 1.5 mm in diameter and the total area 
of the holes is 25.3% of the mantle area. The inner chamber volUme is 1.5 mi. The top and 
bottom of the cylinder have been closed by means of silicone. 
Implantation Procedure 
Male Wistar rats (TNO; Zeist, The Netherlands), weighing 190-230 g, were main~ 
tained on standard laboratory food (Hope Farms; Woerden, The Netherlands) and 
drinking water, to which they had free access. 
The implantation was performed according to the method of Bonta et al. (1979), 
except for the fact that, instead of a midline incision in the back of the rat, an 
incision of about 10 mm was made in the flank. The cannulated chamber was then 
pushed through the incision into a thoraco-sacral position under the dorsal skin 
and the wound was closed. The situation and the size of the chamber are sche-
matically presented in Figure 1. To illustrate the position of the chamber in the 
intact animal, a lateral X-ray picture was made without using any.contrast fluid. The 
positive print of this picture is presented' as Figure 2. After implantation, 1 ml 
FIGURE 2. a rat chamber. 
In order to visualize the no contrast fluid was injected. The cannulae from the 
chamber, exteriorized at the back of the neck, are not visible in this photograph. 
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carrageenin was injected into the chamber via one of the exteriorized cannulae. 
The cannulae were closed by a plug of tube sealer (Seal-ease, Clay-Adams; Parsip~ 
pany, N. J.). In order to ensure good contact of the carrageenin (through the 
perforations) with the tissues surrounding the chamber, the rats were rotated 
around the thoraco~sacral axis immediately after the injection of the inflammagen. 
The development of granuloma around the chamber was studied for 7 days follow~ 
ing the administration of carrageenin. 
Characteristics of the Granulomatous Inflammation 
Five groups of 5 rats were used for the study of changes in exudation, cell 
accumulation in the inflammatory exudate, and postaglandin formation at different 
stages of granuloma development, i.e.: 6 hr, 1,3,5, and 7 days after the induction 
of inflammation by carrageenin. The inflammatory response as a result of the 
implantation of the teflon chamber alone without stimulation by carrageenin, was 
investigated in two groups of 10 rats on day 3 and day 7 after the implantation. At 
the appropriate times, rats were killed by chloroform inhalation, bled by an incision 
in the neck, and the chambers with the surrounding granulomata were removed. 
The isolated granulomata were cut open and the individual exudates collected in 
2 ml heparinized (Thromboliquine, Organon; Oss, The Netherlands) saline by 
centrifugation of the granulomata over a polypropylene tube (15 min at 800 x g). 
The supernatant was used for the determination of the exudate volumes and the 
bioassay of prostaglandin-like material (PGL) according to the method of Suit et al. 
(1977), after lipid extraction at pH 3. The pellet, consisting of cells present in the 
exudate, was resuspended in 2-5 ml heparinized saline depending on the amount 
of sediment. Twenty microliters suspension was mixed with 20 ml lsoton fluid 
and the sample was counted for total cells in a Coulter Counter type 3260 B 
(thresholds: lower 9, upper 100). The total cell number in each exudate was cal~ 
culated by correcting for the dilutions made. Cell differentiations were performed 
on smears of sediment by light microscopy, after staining with May-GnJnwald-
Giemsa. For this differentiation, 350 cells were counted in each smear. The criterion 
for the discrimination between monocytes and macrophages present in the inflam~ 
matory exudate was based on the presence of a vacuolized cytoplasm and a bean-
shaped nucleus in the··macrophages, while the monocytes did not show vacuoles 
and had nuclei with irregular shapes. Following the removal of the ·exudate and 
separation of the chamber from the granulomata, the lat_ter were weighed, dried at 
80"C for 24 hr, and finally reweighed for the determination of the dry granuloma 
weights. In experiments involving comparison of inflammation in the chamber 
model with that in the sponge implant model, the latter was used according to the 
method described earlier (Bonta et al., 1979), except that in the present study the 
size of the sponges was halved in comparison with the original method. 
Arachidonate Metabolism In Vivo by the Granuloma 
A group of 4 rats was used for the study of the metabolism of arachidonate by 
granulomatous tissue in vivo. On days 1,4,8, and 12 after the induction of inflam-
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mation (1~14 C], arachidonic acid (2.5 ,u.Ci/rat in 200 ,u.l ethanol) was injected via one 
of the cannulae while the rats were under ether anaesthesia, the isotope labeled 
arachidonic acid was left in the rat for a 1~hr incubation in vivo. 
Recovery of the Exudates Containing Metabolites of Arachidonate 
After the 1~hr incubation, the rats were again subjected to ether anaesthesia and 
the ends of the cannulae, dosed with tube sealer, were cut off. The exudate was 
withdrawn via one of the cannulae using a S~ml syringe equipped with a 0.6 x 25 
mm needle. To obtain maximal recovery of the exudates containing the radioactive 
metabolites, 1 ml saline was injected into the other cannula and the perfusate was 
collected into the first syringe. The perfusates were collected into calibrated, sili-
conized glass tubes, and identification and quantitation of the arachidonate metab-
olites were performed by a method combining thin-layer chromatograpy and liquid 
scintillation counting as described by Vincent and Zijlstra (1?78). 
Cleaning of the Chamber for Re-use 
After use, the cannulae were removed from the Tygon tubes attached to the 
chamber. The silicone plugs, together with the Tygon tubes, were pulled out, and 
all parts of the chambers submersed in decontamination fluid to remove residual 
tissue ·and radioactivity inside the cylinders and tubes. The decontamination fluid 
was discarded and frequently refilled until no tissue or radioactivity could be 
detected either on the inside or the outside of the materials. Finally, the chambers 
and cannulae were rinsed with water and absolute ethanol, dried under a stream 
of air, and reassembled ready for re-use. 
RESULTS 
Properties of the Implanted Chamber 
The implantation of chambers into rats is a procedure that can be very easily 
performed in large groups of animals. Becal!lse of the good mechanical and chem-
ical stability, the chambers can be used for ·long-term studies. Sometimes, the 
Tygon tubes tend to become less flexible over time, which makes it advisable to 
replace them after each experiment. As a result of the carrageenin~stimulated 
inflammatory process, the chambers may be rejected through the skin. This was 
only observed in rats that had been inflicted with chronic inflammation for more 
than 20 days. 
The cannulation of the chamber allows the injection of materials directly into the 
inflamed site. As can be seen in Figure 3A the injected fluid spreads over the 
subdermal layers when no granuloma is present around the chamber. This has the 
disadvantage that the local concentration at the inflamed site of an injected com-
pound is Jess than in the presence of a granuloma. Figure 38 shows that, a few 
minutes after the injection of a contrast fluid, the distribution is limited to the 
exudate within a 4-day-old granuloma. The main merit of the chamber method for 
the study of experimental inflammation is the ability to obtain exudate from the 
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FIGURE 3. Posterior-anterior X8 ray photograph of two rats taken within a few seconds after 
the injection of contrast fluid into the implanted chambers. A: A rat 4 hr after the injection 
of carrageenin, when no granuloma had yet developed. The contrast fluid is spread over the 
subdermal space. 8: When injected into the chamber of a rat 4 days after the administration 
of carrageenin, the distribution of the contrast fluid is limited to the intra-granulomatous 
fluid. Because the rat bent foreward, the major part of the contrast fluid is localized in the 
rostral part of the chamber. Note that in both pictures only one cannula is filled with contrast 
fluid. 
granuloma at any given moment, without killing the rat, for at least 12 days after 
the induction of inflammation. When perfusion with saline is carried out as de-
scribed in the "methods" section, the recovery of exudate is possible in spite of 
the presence of a spongy granuloma that has grown into the chamber. In this way, 
about 30% of the radioactivity injected as sodium 14C-arach,idonate, could be re-
covered from an 8-day-old granuloma, either unchanged or as metabolites. Liquid 
scintillation counting of the homogenates of the isolated granulomata showed that 
about 35% of the injected radioactivity had been incorporated into the granuloma. 
The chemical nature of the incorporated radioactivity and the fate of the remaining 
35% of the injected radioactivity, was not further investigated. This perfusion tech-
nique cannot be applied to the cannulated sponge model (Bonta et al., 1979), 
because the sponge acts as a filter with an enormous flow resistance. Within the 
chamber the resistance is relatively low because it is empty, and good mixing of 
the perfusion fluid with the exudate is ensured by the difference in the inserted~ 
length of the Tygon tubes, to which the nylon cannulae are connected. 
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Characteristics of the Inflammatory Process with the Chamber Model 
The implantation of the teflon material, without the addition of carrageenin, led 
to an inflammatory response that was macroscopically different from the carra~ 
geenin~stimulated response. Rats implanted with teflon alone did not show any 
retardation in weight gain, and an easily removable granuloma developed. It is 
remarkable that even on day 7 after implantation, the chamber remained free within 
the subcutaneous space, being easily movable with the finger. At this stage the 
inflammatory exudate contained a large number of erythrocytes, together with 
leucocytes. ln contrast, as early as 24 hr after the injection of carrageenin into the 
newly implanted chamber, a solid granuloma had developed and had grown into 
the dorsal muscle layer and skin. 
Several parameters of the inflammatory process induced by carrageenin are 
shown in Figure 4B. The development of a granuloma around the chamber was not 
detectable until day 1 after the administration of carrageenin, whereas a maximal 
dry granuloma weight of 310 mg was reached on day 5. On days 1-5 the total 
amount of exudate that could be removed from the granulomata was fairly constant 
at about 1.5 ml, whereas on day 7 the volume was 0.8 mi. The total number of cells 
present in the exudate showed a submaximum in the acute inflammatory phase 6 
hr after the administration of carrageenin, whereas an almost continuous increase 
was observed over days 3-7. Differential cell counting revealed that, during the 
entire period of investigation, the cell population consisted mainly of granulocytes. 
These granulocytes were almost all neutrophils and practically no eosinophils could 
be detected. The number of granulocytes was constant from 6 hr to day 3, at about 
10 x 106 , and then constantly increased to a mean number of40 x 106 granulocytes/ 
exudate on day 7. The second important population in the exudate was the lym-
phocytes. Apart from 6 hr, this cell type showed an increase from 1.1 x 106 on day 
1 to 3.5 x 106 cells/exudate on day 7. Monocytes and macrophages were present in 
relatively very small amounts during the whole period of investigation. PCL in the 
exudate was present in amounts within the picogram (PCE2 equivalents) range. 
Figure 5 shows the increase in PCL from the moment of the induction of inflam~ 
mation to a value of 33 pg equiv. PGE2 on day 7. 
Comparison with the Sponge Model 
The courses of the granuloma weights, exudate volumes, and total cells present 
in the exudate as a result of the implantation of carrageenin-soaked sponges, are 
depicted in Figure 4A. As in the chamber model, the sponge implantation resulted 
in the development of granuloma and a maximal dry granuloma weight of 440 mg 
was reached at the same stage of inflammation, namely on day 5. As can be judged 
from this granuloma weight, the inflammation is more severe around the sponge 
implants. The exudate volume (pooled from 2 sponges, implanted in 1 rat) increased 
from 1.8 ml on day 1 to 2.7 ml on day 7. The total number of cells present in the 
exudate was maximal on day 1 at 250 X 106 and decreased thereafter to.a constant 
level of 100 x 1011 cells/pooled exudate on days 5-7. During the entire period of 
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FIGURE 4. Time courses for changes in the exudate volume (open circles, broken line), the 
dry granuloma weight (closed circles, unbroken line) and the total number of cells present 
in the exudate (triangles, broken line) following the injection of carrageenin at zero time. A: 
the model of cannulated sponge implants of Bonta et aL (1979), with two sponges per rat. 
The dry weights of the separate granulomata were recorded and the exudate from both 
sponges was pooled for the determination of exudate volume and total cells per exudate. 
8: the model of cannulated teflon chambers implantation. Each point represents the mean 
± s.e.m. of five rats. 
investigation, as in the chamber model, the granulocytes form·ed the major popu-
lation of the cells in the exudate (>70%). However, lymphocytes were detectable 
in numbers less than 1% of those of total cells in the sponge exudates. Unlike the 
chamber model, the PGL in the sponge exudate showed a maximum of 62 ng equiv. 
PGE2 on day 1 and subsequent decrease to 8 ng equiv. PGE2 on day 7 (Fig. 5). 
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FIGURE 5. Changes in the levels of prostaglandinMiike material (PGL) during carrageenin-
induced granuloma development in the sponge model (open circles) of Bonta et al. (1979) 
and in the newly developed chamber model (dosed circles). Carrageenin was injected at 
:z:ero time and PGL was measured by bioassay on the rat stomach and expressed as PGE2 
equivalents. Points represent means ± s.e.m. of five rats. 
Prostaglandin Biosynthesis from [1-14C] Arachidonic Acid In Vivo 
A concise presentation of the results is shown in Table 1. The major products of 
the metabolism of arachidonate, injected into the chamber, appeared to be hydroxy 
fatty acids and PGE2 , whereas 6~ketoPGF 1,. and TXB2 were hardly formed. We were 
unable to resolve the fraction of hydroxy fatty acids into 12~LMhydroxy-5,8,10- hep-
tadecatrienoic acid (HHT) and the lipoxygenase product 12-LMhydroxy-5,8,10,14-eiM 
TABLE 1 Arachidonate Bioconversion by Granulomatous Tissue In Vivo in Percentages of 
Total Radioactivity 
INFLAMMATlON HYDROXY 6-KETO 
DA> fATIY ACIDS PGE: PGF2oo TXB, PGF1" 
1.2::!;: 0.2 0.5::; 0.1 0.2 = 0.04 0.3 = 0.1 0.1 :t O.Q2 
4 1.7;:!;: 0.4 1.1 ± 0.5 0.3 ± 0.1 0.1 ± 0.05 0.1::!:. 0.03 
8 2.1::!:. 0.4 1.0±0.1" 0.4::!:. 0.04·· 0.2 ::!:. 0.05 0.2 = 0.03• 
12 3.4::!:.1.1° 1.8::!:. 0.6 .. 0.6::!;: 0.02"" 0.2 ± 0.05 0.3 = 0.1 
Mean values of 4 experiments. 
•p < 0.05, ••p < 0.01 vs day 1 (Student's t-test). 
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cosatetraenoic acid (HETE). During the development of granulomatous tissue from 
days 1-12 of inflammation, the capacity for biosynthesis of all metabolites, except 
for TXB2, increased about threefold. A detailed report dealing with the in vivo 
metabolism of arachidonate during carrageenin~induced inflammation in the rat, 
using the teflon chamber method, has been published elsewhere (Bragt and Bonta, 
1979). 
DISCUSSION 
The newly developed cannulated teflon chamber for the study of experimental 
inflammation combines the property of the sponge model of Bonta et al. (1979), 
namely accurate local injection of materials into the inflamed site, with the advan-
tage of allowing for the withdrawal of inflammatory exudate from the inflamed site, 
for at least 12 days after the injection of the inflammagen. This means that bio-
chemical changes at the inflamed site can be studied over a desired period of time 
in one and the same animal. Moreover, this is clearly of economic benefit since 
smaller numbers of animals need to be used in studies on inflammation. When 
carrageenin was used for the induction of granuloma growth, the development of 
the granuloma proceeded in the same fashion in both the sponge and the chamber 
model. The maximum dry weight occurred at the same time (day 5). but in the 
sponge model the amount of tissue formed and the exudate volume were higher. 
Since the total number of cells present in the exudate of the implanted sponges is 
also high in comparison with the chamber method, this suggests that the inflam-
matory reaction in response to the injection of carrageenin into the sponges is 
more severe than when teflon chambers are used. It may well be that this is due 
to an inflammatory response induced by the sponge itself, whereas teflon evokes 
only a very moderate tissue reaction in comparison with other materials (see Cal-
nan, 1963). In both models, the granulocytes were the dominant cell type in the 
exudate. The fact that in the sponge model practically no lymphocytes could be 
detected, whereas in the chamber model this population was the second most 
important cell type, may be due to sponge constituents with an inhibitory effect on 
lymphocyte migration. The effects of a polyether sponge constituent on granuloma 
formation and on the biosynthesis of prostaglandins has been described recently 
(Parnham eta!., 1977). However, the possibility that one or the other constituent 
of the synthetic sponge may have an inhibitory effect on lymphocyte infiltration 
remains conjecture, because there are no data to further support this proposal. 
In the sponge model, the appearance of PGL at different stages of inflammation 
shows a maximum on day 1 with a close resemblance to the plot of the total amount 
of cells in the exudate. On the other hand, the curve of PGL in the chamber model 
parallels that of the variation in granuloma weight over time. Jn relation to the 
small number of cells present in the exudate, it would seem likely that the major 
site for the biosynthesis of prostaglandins is localized in the cells constituting the 
granuloma. 
Although teflon has been claimed to produce only a very moderate tissue reaction 
on implantation (see the Introduction), we observed that the implantation of the 
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teflon chamber alone evoked appreciable exudation and granuloma growth. How~ 
ever, the injection of carrageenin into the chamber produced a specific inflam~ 
matory response that was macroscopically different from and obliterate<;! the effects 
of mere implantation of teflon. In view of the different tissue responses to carra~ 
geenin in the chamber and sponge model, respectively, it may be concluded that 
the characteristics of the inflammatory response induced by carrageenin are liable 
to alteration, depending on the material into which the inflammagen has been 
injected. 
The fact that after 1 hr, approximately 65% of the injected radioactivity can be 
recovered, whether from the exudate or from the granuloma, suggests that the 
newly developed model may be suitable for general studies on both the local 
metabolism of drugs and on precursors of local hormones at the inflamed site. This 
has been demonstrated with the specific example of the injection of the prostag~ 
Iandin precursor arachidonic acid into the chamber at different stages of granu~ 
lomatous inflammation. Thus, the study of the in vivo metabolism of arachidonate 
at the site of inflammation shows that hydroxy fatty acids and PGE2 are the main 
products formed (Bragt and Bonta, 1979). These results are in marked contrast with 
the results of Chang et al. (1978), who reported TXB2 and 6-ketoPGF 1o: as the major 
metabolites formed by granulomata in vitro. The use of the chamber model for 
studies in vivo, may avoid the introduction of interfering factors during in vitro 
handling and thus speculative extrapolations from in vitro to in vivo conditions are 
unnecessary. 
Thanks are due to Mr.). F. Fassotte for skilled assistance in making the X-ray photographs and to 
Miss G. A. P. Schoester for the differentiation of cells. We are most indebted to Dr. M. j. Parnham for 
grammatical corrections of the text and for helpful suggestions. 
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Abstract-The meubolism of [l-' 4C]a.ro.chidonic o.cid wo.s studied in vlvo during the development of 
co.rrngeenin-induced gro.nuloma in the ro.t. For this purpose a double-cannulnted teflon cylinder wo.s 
imp!Mted into the dorsal subdermal tissue of rats, and the CMnulae were extcriorised through the skin nt the 
scruff of the neck. The "chamber" allowed the injection of subst.:mces and collection of exudate at different 
~'tllges of granuloma development. When I V"C ]lll'llchidonute wo.s injected into the chamber one hour before 
recovery of the exudate at periods up to 12 days after initillting the inflammation, hydroxy fatty acid.~ and 
prostaglandin E2 appeared to be the main products forined. Only very small amounts ofthromboxnne B2 and 
6-ketoprostaglandin F ,. were detectable. These in vivo results o.re in mo.rked contradiction to observations of 
other workers with granuloma tissue ln vitro. The present findings are discussed in relation to the postulnted 
negative-feedback function of E-typc prostaglandins and a possible role of hydroxy fatty acids in 
inflammation. 
The main precursor of endogenous prostaglandins 
(PG's) is arachidonic a.cid (AA). which occurs abun-
dantly in cell membrane lipids of virtually all mammal-
ian tissues [ 1]. PG's are released upon a variety of 
stimuli [2] and increased amounts of PG 's. particularly 
those of the E-type. are detectable at inflamed sites [ 3 ]. 
PG's exert pro-inflammatory actions. such as vasodila-
tion [ 4 ]. increased vessel permeability [ 5] and potentia· 
tion of similar actions of other inflammatory media-
tors [ 6]. It is now widely accepted that PGE's 
contribute significantly to the development of acute 
inflammatory conditions [ 7]. However, with respect to 
chronic inflammation the function of PG "s is not 
clear [ S]. Dietary depletion of AA in rats, resulting in a 
shortage of PG 's at the inflamed site. leads to an 
enhancement of the granulomatous component of 
chronic inflammation [ 9] and this enhancement is asso-
ciated with an increased synthesis of collagen [ 10]. 
While this indirectly suggested that PG's exert a sup-
pressive action on granulomatous inflammation. direct 
evidence was obtained more recently. Thus it was 
shown that local administration of PGE1 inhibits the 
formation of inflammatory granulomata in rats, pro-
vided that the administration is carried out a stage of 
granuloma development when tissue growth is already 
in progress [ 11]. A similar inhibitory action on granu-
loma formation wa.s also demonstrated with 
PGE,Il2]. 
Prostacyclin (PGI2). a recently discovered product 
of arachidonate bioconversion. has been found to be 
even more potent than PGEz in producing vasodila-
tion [ 13. 14]. However. PGI2 fails to inhibit granuloma 
formation, when i·njected locally in the chronic phase of 
inflammation at a dose which is equivalent to the 
inhibitory dose of PGE2 [ 12]. 
Studies involving ln vitro incubations of AA with a 
fraction of the homogenate of rat granuloma tissue. 
identified thromboxane B1 (TXB2) and 6-ketoPGF1 .. (a 
metabolite of PGI2) as the major products formed [ 15. 
16]. Furthermore. at different stages during the devel-
opment of granuloma tissue. the capacity of the particu-
lar tissue fraction used to convert AA into TXB. 
increased. whereas its capacity to form 6-ketoPGF,~ 
decreased [ I 7]. 
The present study was undertaken to investigate the 
metabolism of AA in vivo at different stages of granu· 
lorna development in the rat. using a modification of the 
model involving implantation of sponges with indwell-
ing cannulae [IS], This modification allowed with-
drawal of exudate from the intact rat at any desired 
moment during the development of inflammatory 
granuloma. 
MATERIALS AND METHODS 
Materials. [ 1- 14C]Arachidonic acid (specific radio-
,activity 56.2 Ci/mole) was purchased from the Radio-
chemical Centre. Amersham, England: Carrageenin 
(Viscarin) from Marine Colloids Inc. Springfield. 
U.S.A.: arachidonic acid, prostaglandin A2• E;: and F1 .. 
from Sigma. St. Louis, U.S.A.: 12L-hydroxy-5.S.-
10.14-eicosatetraenoic acid (HETE) and 12L-hydroxy-
5.S.l 0-heptadecatrienoic acid {HHT) were gifts from 
Unilever. Research. Vlaardingcn, The Netherlands. 6-
KetoPGEu, was a gift from Wellcome Research. Beck-
enham. England and PGD2 and TXB2 from Upjohn. 
Kalamazoo. U.S.A. Phosphomolybdic acid and 
60 F254-silicagel thin layer chromatography (tJ.c.) 
plates were purchased from E. Merck. Darmstadt. Ger-
many and dioxane scintillation fluid from Packard. 
Brussels. Belgium. Teflon tube: 8 >< 10 mm, was pur-
chased from Eriks. Alkmaar. TheN etherlands. silicone 
adhesive (Silastic) from Dow Coming Co .. Midland. 
U.S.A. and nylon tube: 0.62 '< 1.02 mm. from Rubber. 
Hilversum. The Netherlands. All other chemicals used 
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were of the highest degree of purity commercially 
available. 
Animal treatment. 4 Male Wistar rats (TNO. Zeist. 
The Netherlands). weighing 245-260 g. were each im-
planted with a Teflon cylinder (length 30 nun. inner 
diameter 8 mm) provided with 108 boles of 1.5 mm 
diameter and two longitudinally indwelling nylon can-
nulae of0.65 mm in diameter. The ends of the cylinder 
were sealed with silicone kit and the whole then im-
planted subcutaneously in the lumbar region. the can-
nulae being exteriorised at the back of the neck. 
Inflammation was induced by injection through a 
cannula of 1 ml of a 1% (w/v) gel of carrageenin in 
sterile pyrogen-free saline into the implanted cylinder. 
The cannulae were then closed by means of tube-sealer. 
The injected carrageenin had access to the surrounding 
tissue via the holes in the implanted chamber. thus 
inducing granulomatous inflammation. The granuloma 
developed initially on the outside of the cylinder. sub-
sequently growing in through the holes. Macroscopi-
cally, the whole granuloma had a similar appearance to 
that induced bY carrageenin-soaked sponges [ 18]. A 
detailed description of the methodology will be pub-
lished elsewhere. 
Rats had free access to water and standard labora-
tory food (Hope Farms. Woerden. The Netherlands). 
Injection and collection of radioactive material. 
Arachidonic acid (lO,uCi) was dissolved in 800)1.1 
ethanol after having evaporated the stock solvent, ben-
zene. under a stream of nitrogen. Of this solution 200 ,ttl 
were injected through the cannula into the teflon cylin-
der in each of the 4 rats on days I. 4. 8 and 12 of the 
inflammatory process. After 1 hour of in vivo incuba-
tion with the arachidonate, exudate was collected by 
infusing 1 ml saline into one cannula., while fluid was 
drawn out of the other one into a 5-ml syringe. During 
handling. rats were under slight ether anaesthesia Exu-
date was transferred into a calibrated glass tube and its 
volume recorded. 
Extraction and thin layer chromatography. Extrac-
tion of lipid material was carried out twice. by mixing 
the exudate with 4 ml ethylacetate after acidification to 
a pH of 3 with 2M HCI. Phase separation was facili-
tated by centrifugation at 1000 g for 5 min. The sepa-
rate extracts of each exudate were pooled. the volumes 
recorded and subsequently the solvent was evaporated 
in vacuo at room temperature. Samples of 10 and 
100 ,ul exudate and extract. respectively. were taken up 
into IO m1 scintillation fluid and recovery was esti-
mated by counting radioactivity in a Packard Tricarb 
Model 3375 liquid scintillation counter with external 
standardization for quench correction. T.l.c. plates 
were activated at ·100° for 10 min and after. cooling 
5 fi.S samples of arachidonic acid. PGA~. D2• E.z. F2• 
and 6-ketoPGF 1" were spotted at one point as internal 
standards. The extract residue was dissolved in 50 ,ttl 
chloroform and spotted on the t.l.c. plate at the same 
point as the reference compounds. 
T.l.c. plates were initially developed in a solvent 
system consisting of chloroform:methanol:acetic 
acid:water (90:8: 1 :0.8) [ I9] and subsequently in the 
organic phase ·of a mixture of ethylacetate: iso-oc-
tane:acetic acid: water (11: 5:2: 10) [201. This two-di-
mensional chromatography procedure produced excel-
lent separation of the metabolites under study. 
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Radioactive spots were visualized by scanning the 
t.l.c. plates in a Berthold LB 2723 thin layer scanner 
equipped with a dot scan unit for ,8-radiation. After 
scanning, plates were sprayed with a freshly prepared 
7.5% (w/v) solution of phosphomolybdic acid in abso· 
lute ethanol followed by heating for 10 min at 100°. 
Blue coloured spots, and finally the uncoloured remain-
der. were scratched off the plates into scintillation vials. 
mixed with 10 ml scintillation fluid and radioactivity 
was estimated by liquid scintillation counting. 
Calculation of the radioac,tivity of metabolites. Con-
version of c. p.m. into d. p.m. was performed by correc-
tion for quenching. via an external standard. Amounts of 
metabolites of arachidonic acid were expressed as per-
centages of total plate radioactivity. Activity represent-
ing PGE: was estimated by calculating the sum of 
radioactivities of the original spots ofPGE: and PGA2• 
because handling solutions containing PGE2 may lead 
to dehydration and hence PGA2 formation [ 21 ]. In 
addition, enzymatic conversion of PGE1 into PGA1 by 
a placental dehydrase has been reported [ 22]. In our 
experiments radioactivity representing PGA~ never ex-
ceeded that for PGE2• 
RESULTS 
The implantation of a porous Teflon chamber with 
two indwelling cannulae appeared to be a convenient 
model for studies of the metabolism of [ l-
14C]arachidonic acid in vivo in carrageenin-induced 
inflammation. It enables the biochemical changes oc-
curring within the inflamed locus to be investigated at 
any time during granuloma development in the same 
animal. Recovery of exudate is a simple atraumatic 
procedure. although on day I2 of inflammation accu-
mulation of cell debris occurred within the chamber. 
Injection of I ml saline into one cannula to reduce 
viscosity and removal of the perfusate through the other 
one overcame the problem of obstruction. The injected 
[ 1-1"C]arachidonate was more than 99.9 per cent pure 
as revealed by prior thin layer chromatography and 
subsequent scanning of radioactive dots. 
T .l.c. of the extract of the inflammatory exudate 
indicated that arachidonate was metabolised into hy-
droxy fatty acids. prostaglandins and thromboxane B2 (Fig. I). Maximally. 1.5 per cent of total radioactivity 
remained at the origin after development in both solvent 
systems. The amount of unconverted arachidonate. 
which represents the main spot in the chromatogram. 
showed a decrease during the development of inflam-
mation. In contrast. the total amounts of products of 
cyclo-oxygenase activity, i.e. prostaglandins. throm-
boxane B. and hydroxy fatty acids, increased three-fold 
from day. I to day 12 (Fig. 2). During this period 
radioactivity representing other lipids. running at the 
solvent front. increased from 8.2 per cent on day 1 to 
21.8 percent of total radioactivity on day 12 (Table 1). 
Elution of this fraction. followed byrechromatography. 
inO.icated that the fraction consisted. mainly oftriglycer-
ides (unpublished results), presumably originating 
from the membranes of accumulated cells. 
Our results further indicate that the major products 
formed by arachidonate cycle-oxygenase activity were 
hydroxy fatty acids and PGE2 (Fig. I). The major part 
of the hydroxy fatty acids. produced during metabolism 
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Fig. l. Distribution 'of radioactivity on a t.l.c. plate nfter two-dimensionnl chromatography of the lipid 
materinl from an inflammatory exudate. Radioactive spots, accentuated by circles, were visualised by dot-
scanning and the intensity of a dot is proportional to its radioactivity. Rv""' 0 indicates the origin. 
Table I. Frequency of radioactive matcriuls originating from locnlly injected arachidonate after 1 hour in 
vivo incubation 
Per cent of total radioactivity • 
Radioactive spot Day I Day 4 Day 8 Day 12 
PG~ 0.23 ± 0.04 0.88 ± 0.42 0.76± 0.14~ 1.40:!: 0.59~ 
PGF~ 0.18 ± 0.04 0.27 ± 0.10 0.38 ± 0.04! 6.58:!: 0.20~ 
PGD~ 0.11 ± 0.02 0.23:!: 0.07 0.24 ± 0.01 .. 0.35 = 0.12~ 
PGA~ 0.23 ± 0.05 0.24:!: 0.03 0.29 ± 0.03 0.40 = 0.06* 
Unidentified lipids 8.21 ± 4.14 9.19::;-2.67 19.73:!: 3.6.8* 21.80:!: 4.42* 
Origin 0.57 :±- 0.14 0.76 ± 0.15 1.11±0.20~ 1.35 ± 0.25** 
Ratio+ TXB~ 
PGE: + PGA, + PGF~ 
0.41 ± 0.13 0.11 ± 0.01* 0.17±0.04 0.09 ± 0.03* 
*Values represent means± S. E. M. of 4 rats at different stages of granuloma development. The total 
formation of POE: (not included in this table) was calculated from the sum of the individual values of 
PGE, and PGA: shown in the table. 
"·Ratios ofTX/PGs were calculated for individual rats and the ratios shown represent means± S. E. M. of 
4 rats. 
Metabolites of arachidonate included in the figures are not presented in this table. Significance was tested 
versus day I (one-tailed Student's t test. * = P < 0.05. :r. = P < 0.01. ~§ = P < 0.025 and 
••:=P<0.001). 
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Fig. 2. Decrea:>c in the amount of unconvcncd arachidonatc 
(closed circles, unbroken lines) and incre:.se in the total 
amount ofprosw.glandins, hydroxy fatty acids and thrombox-
ane (open circles, broken line). during the development of 
granuloma in the rat. Arrows indicate the respective axes for 
the two curves. Each point represents the mean:±: S.E.M. of 4 
experiments. 'Significance wns tested versus dny I va.lues'(one-
tniled Student's r test. •""' P < 0.05, • •"" P < 0.0 1), 
of arachidonate in vivo. may consist of 121.-hydroxy-
5.8.10-heptadecatrienoic acid (HHT) as deduced from 
the Rp value of the unlabelled standard. However. this 
cannot be concluded with certainty because the closely 
related substance, SL-hydroxy-6,8,12.14-eicosatetra-
enoic acid [23]. may occupy more or less the same 
position in the chromatogram. Moreover. the relatively 
small reSolution capacity of the dot-scanner did not 
allow specification of the exact chemical nature of the 
fraction of hydroxy fatty acids. As our interest was 
primarily the formation of PGEz. 6-ketoPGF1"' and 
TXB2• we did not make an attempt to separate the 
fraction into HETE and HHT. 
The capacity of the inflamed locus to convert arachi-
donate into both hydroxy fatty acids and PGE2 showed 
~ 
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2 
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• 
' " 
Stage of Inflammation, days 
Fig. 3. Increase irihydtoxy fatty acids (open circles.. broken 
line) and prostaglandin ~ (closed circles, unbroken lines) as 
a result of the in vh·o metabolism of arachidon:rte by a 
developing granuloma in the rat. Each point represents the 
mean :1:: S.E.M. of 4 experiments. Significance was tested 
versus vo.lues from day 1 of inflammation (one-tailed Stu-
dent's t test, * "" P < 0.05, '"• = P < 0.005). 
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Fig. 4. Bioconversion of the injected arachidonate to 6-keto-
prostaglandin F 1• (closed circles. unbroken line) and throm-
boxane 8~ (open circles. broken line) at different stages of 
granulomatous inflammation in the rat. Each point represents 
the mean ± S.E.M. of 4 experiments. Significance was tested 
versus vo.lues from day 1 of granuloma development (one-
tailed Student's t test. '""" P < 0.05). 
an approximately threefold increase during granuloma 
development, refl.e"cting an enhancement of cycle-oxy-
genase activity in the later stages of inflammation 
(Fig. 3). At all time periods investigated, hydroxy fatty 
acids were formed in greater amounts than PGE2• 
However. PGF1"' and PGD2 were minor metabolites. 
which also increased approximately threefold between 
days 1 and 12 of the inflammatory process (Table 1). 
Another interesting observation was the very small 
capacity of the tissue for the biosynthesis ofTXB2 and 
6·ketoPGF1" from arachidonate in vivo. From day 4 to 
day 12 both metabolites were synthesized in amounts 
even smaller than those of PGD1 and PGF:a· The 
capacity for synthesis of 6-ketoPGF 1" increased during 
granuloma development by two- to threefold (Fig. 4 ). 
TXB1 formation did not incre<l.Se in later stages when 
compared with day 1. but actually showed a tendency 
to decrease during the development of inflammation. 
From day 1 to day 8 TXB2 formation exceeded that of 
6-ketoPGF1"'. whereas on day 12 6~ketoPGF1" synthe-
sis dominated. 
The ratio TXB2/(PGE2 + PGF2~) showed a progres-
sive decrease from day 1 to day 12 (Table 1). As the 
ethanol vehicle might possibly have influenced conver-
sion of arachidonic acid or the ratios between the 
different metabolites, we carried out a separate experi-
ment. using two rats. in which we investigated the 
metabolism of arachidonate. injected in a saline vehicle. 
on day 1 of inflammation. However. when suspending 
the arachidonate in saline it was found that a large 
percentage of the fatty acid adhered to the test tube and 
did not enter suspension. Nevertheless, when the small 
amount ofarachidonate, which was suspended in saline. 
was injected into the cylinder, TXB2 and 6-ketoPGF1" 
were again minor metabolites as compared to hydroxy 
fatty acids and PG~ while hydroxy fatty acid levels 
were somewhat less than those obtained using arachi-
donate dissolved in ethanol (data not shown). When 
acetone was used as a vehicle the results were similar to 
those obtained with the ethanol vehicle (data not 
shown). 
DISCUSSION 
The presence of prostaglandin-like activi:y in the 
exudate of a carrageenin-induced granuloma tn the _rat 
was first demonstrated by Willis in 1969 [31. usmg 
bioassay. Ever since. the role of prostaglnndins as 
mediators of the early inflammatory response has been 
widely investigated [24-261. However. it was discov-
ered recently that PGE1 can display an anti-inflamma-
tory effect during the later stages of chronic ~amm~­
tion [9. 11]. Possible mechanisms underlymg th1s 
phenomenon have been reviewed [ 8]. . . 
a s.c. implanted Teflon cylinder containing carrageenin. 
the metabolism of injected AA is not restricted to the 
granulomatous tissue itself. The inflammatory exu~e 
may contribute to the metabolism of AA by supplymg 
enzymes originating from cell breakdown. Phagocytoz-
ing polymorphonuclear leukocytes [32, 33], macro-
phages [34. 35], fibroblasts [36. 37],and platelets [38] 
accumulating in the inflamed area [39]. have been 
shown to convert AA into prostaglandins. thrombox-
anes and hydroxy fatty acids. 
Our results reveal the small tendency for the biocon-
version of injected AA into TXB~. This is consist:nt 
with results from the clinical experiments of Trang and 
his colleagues [ 40 ], who measured TXB2 and PG level? 
in the synovial fluid of patients with rheumatoid arthri-
tis. PGE, amply exceeded TXB2 levels and the ratio 
TXBj{PGF:o: + PGE2) was an average ofO.I ~ 0.05 
in 5 patients- This ratio is in good agreement wtth 0e 
ratio in the chronic phnse of experimental inflammatton 
observed in our study (Table 1 ). Only at day 1 was this 
ratio relatively high. and this may indicate that throm-
boxanes play a major role in the early inflammatory 
It has also been suggested that labile intermechate$ m 
prostaglandin biosynthesis may also play an i?Iportant 
role in inflammation [ 27]. and granuloma ussue has 
been shown to convert arachidonate into TXB2 [ 15] 
and 6-ketoPGF1:: [ 16] in }'itro as major metabolites: 
The sodium salt and methylester of prostacyclm 
(PGIJ both increased local vascular pcr~eability when 
injected into an 8 day old granuloma m the rat. 6-
KetoPGF1" and TXB2 were inactive in this re-
spect [28]. PGE1 and PGE1 also increased vascular 
permeability, when administered locally on day 7. but 
failed to exhibit any effect when injected on day 1 [ 29 l. 
Depriving rats of the essential fatty acid pre7ursors 
for prostaglandin and thromboxane _biosynthe~lS leads 
to a reduction in exudate accumulatiOn but an mcrease 
in sranuloma formation. when examined on day 8 of 
granuloma development. suggesting an inhibitory effect 
of fatty acid derivatives on the granul~n:ato~s compo-
nent of inflammation [9]. Indeed. local mJecttOn of 1;1g 
PGE/day on days 4-7 of inflammation r;s.ulte_d in a 
decreased dry granuloma weight. whereas tn.JectJo? ~n 
day 1 enhanced granuloma formation [ 11]. AdmmlS· 
tration of PGE, showed similar effects on granuloma 
formation. but PGI2 failed to reduce the weight of an 8 
day old granuloma. when injected locally at 1;1g twice 
a day on days 4-7 of granuloma developm;nt [12]. 
The results reported in the present paper mdtcate u:nt 
PGE.. is a major metabolite formed from locally m-
jected arachidonate by granulomatous tissu: in vivo. 
During development of the granuloma an mcreased 
cycle-oxygenase activity. measured as the sum ofpr?s-
taglandins. thromboxane and hydroxy fatty ac1ds 
formed from a fixed amount of AA in 1 hr. seems to 
parallel tissue growth. Capacity for biosynthesis of 
PGE. is enhanced in the later sta,ge of granuloma 
deveiOpmcnt as compared to the initial phase, empha-
sising the possibility that PGE plays :m important rot: 
in the chronic phase of inflammatton. However. 1t 
should be noted that other authors have observed a 
decrease in the concentration of PGE in exudate during 
later phases of carrageenin-induced granuloma [30]. 
Our results further show the very small capacity of 
the granuloma tissue to convert arachidonate hlto 
TXB~ and 6-ketoPGF 1:: in vivo. This is in strong 
di$ag'reement with the observations ofCh~g eta!. [ 31] 
obtained from in vitro experiments, showmg that PGE2 
and PGF~" were hardly formed but rather two other 
products. later established as being TXB2 [ 15 l and 6-
ketoPGF to: [ 16]. were synthetised. However, these re-
sults were obtained by the use of the 600 g supernatant 
of the homogenized granuloma tissue as an enzyme 
source. while membrane fractions of the homogenate 
were not investigated. . . 
Moreover. in our inflammatory model, conststmg of 
stage. . 
The observation that hydroxy fatty actds are the 
major products formed from AA in vh·o. suggests a 
possible role for these compounds in inflammation. It 
has been shown that the hydroxy fatty acids HETE and 
HHT exert a selective chemotactic effect on human 
polymorphonuclear (PMN) leukocytes but not on 
monocytes. and these compounds enhance random cell 
migration [ 41. 42l. In addition, increased conc_entra-
tions of HETE have been reported to occur m the 
epidermis during psoriasis, an inflammatory skin disor-
der[43]. 
The hydroxy fatty acid HHT is formed from arachi-
donate by a cycle-oxygenase. whereas HETE is formed 
by lipoxygenase activity. which is insensitive to inhibi-
tion by nonsteroidal anti-inflammatory drugs [38]. 
Both HHT and HETE can be identified and quantified 
by chromatography in combination with mas$ spectro-
metry. using deuterated standards [38]. Despite ti:e 
availability of authentic standard compounds, we dtd 
not attempt to further specify whether HHT or HETE 
were present in the inflammatory exudate. because the 
resolution capacity of the dot-scanner was insufficient. 
Furthermore we had no access to mass spectrometry. 
Nevertheless. our o]:lservation that hydroxy fatty 
acids. irrespective of. their exact chemical nature, arc the 
main metabolites formed during arachidonatc biocon-
version in vivo, combined with the chemotactic proper-
ties of these molecules. tempts speculation that HHT 
and H~TE play an important role in inflammation. 
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3. Indomethacin inhibits the in vivo formation of the lipoxygenase product 
HETE (12-hydroxy-5,8,10,14-eicosatetraenoic acid) during granulomatous 
inflammation in the rat 
P. C. BRAG'f*, I. L BoNTA, Department of Pharmacology, Faculty of Medicine, Erasmus University Rotterdam, 
P.O. Box 1738, Rorrcrdam, The Net!terlands 
Owing both acute and chronic phases of carrageenan~ 
induced granulomatous inflammation in the rat, 
arachidonic acid is mainly converted in vivo into poly-
unsaturated hydroxy fatty acids and PGE, (Brast & 
Bonta 1979). The hydroxy fatty acids HETE and HHT 
(12-hydroxy-5.8.10-heptadecatrienoic acid) arc ehemo~ 
tactic to polymorphonuclear (PMJ'.:) leucocytcs (Turner 
et al1975; Goetz! & Gorman 1978). The formation of 
HHT can be blocked by non-steroidal anti-inflamma-
tory drugs (NSAIDs) and thromboxane synthetase 
inhibitors (Diczfalusy eta! 1977). whereas the lipoxy-
genase-depcndent formation of HETE is not blocked 
by the NSAIDs, but rather stimulated, at least in 
human platelets (Hamberg et al 1974). In addition, 
aspirin, phenylbutazone and indomethacin, when given 
orally 1 h before sponge implantation in the rat, 
significantly inhibit the migration of PMN leucocytes 
into the 5 h sponge exudate (Ford-Hutchinson et a! 
1975). More recently, it was demonstrated that low 
doses of indomethacin and aspirin stimulate the 
migration of PMN lcucocytes into the inflamed area 
24 h after the implantation of sponges, but high doses 
inhibit. Moreover, the migration was also inhibited by 
the compound BW755C (3-amino-l~[m~(trifluoro­
methyl)-phenyl]-2-pyrazoline), an inhibitor of both 
lipoxygenase and cyclo-oxygenase (Higgs et al 1979). 
Higgs (1979) subsequently suggested that high doses of 
aspirin and indomethacin might inhibit lipoxygenase 
activity. 
We have investigated the effects of indomethacin on 
the in vivo metabolism ofarachidonate, 24 hand 8 days 
after the implantation of cannulated Teflon chambers 
and the induction of granuloma growth around the 
chamber by the injection of carrageenan. 
Cannulated Teflon chambers were implanted, sub-
dermally, into the backs of male Wistar rats (19G-220 g), 
divided into two groups of 5 animals, as previously 
described (Bragt et all979). Inflammation was induced 
immediately afterwards by the injection through each 
cannula of 1 m1 I% {w/v) carrageenan in 0·9% NaCI 
(saline}. One group of rats received a daily dose of 
indomethacin (200 p.g) directly into the chamber. 
whereas the other group received the vehicle. Four 
hours after these injections, on days I and 8 of granu~ 
lorna development, sodium [1-1'qarachidonate was 
injected into the chambers. The in vivo incubation 
procedure, the recovery of the inflammatory exudate by 
perfusion and the identification and quantification of 
the arachidonate metabolites formed, were carried out as 
• Correspondence. 
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previously described {Brag! et al 1979). One sample of 
the labelled arachidonate was aerobically incubated for 
I h at 37 "C and stirred at 500 rev min-1, as a control for 
the autoxidative formation of prostaglandin~like 
products. 
Effects of indom(·rhacin on araehidonate metabolism. 
The results of the present set of experiments are sum-
marized in Table l. The local injection of indomethacin, 
immediately after the induction of inflammation, 
resulted, after 24 h. in a significant decrease in the 
formation of PGE,. PGF,,.. TXB:: and HHT. While the 
synthesis of 6-ketoPGF,", the metabolite of prostacy-
clin, was unaltered by indomethacin, the synthesis of the 
lipoxygcnase product HETE was markedly inhibited, to 
a level approaching the amount of HETE-like material 
formed during autoxidation. 
When the local administration was continued daily up 
until day 8 of granuloma development, only the forma-
tion of PGE~ ~s significantly inhibited by indome-
thacin, The formation of all other metabolites, including 
HETE, was not significantly reduced at this stage. 
Results not included in Table 1 show that, whereas on 
day I there was an increased conversion of the total 
injected arachidonate after indomethacin treatment 
(24·8 ± 2·2% in control and 16·0 ± 1·0% in drug 
treated r:.1.ts, P < 0·01. one~tailed Student's /-test), 
arachidonate conversion was unchanged by the drug on 
day 8. Furthermore, the amount of arachidonate in-
corporated into the phospholipid (Rr = 0) fraction on 
day I was significantly enhanced by treatment of the 
rats with indomethacin (14·1 :±: 1·4% in control animals 
against a mean ± s.e.m. of 1B·2 :±: 0·7% of total 
radioactivity in- indomethacin-treated rats (P < 0·025). 
No difference in this parameter was observable on day 
8 of inflammation. Similar changes were observed in 
the glyceride fraction (data not shown). 
Except for the hydroxy fatty acids, HHT and HETE, 
the capacity for biosynthesis of the arnchidonate 
metabolites was more pronounced on day 8 than on day 
l (Table 1). On day 8, the animals were killed and the 
granulomata were dissected out and weighed. There was 
almost no reduction in the mean wet granuloma weight 
following indomethacin treatment (2·3 :±: 0·3 g against 
2·4 ± 0·1 g in control rats, P > 0·4), although the 
formation of PG£.: was still significantly inhibited at 
this stage of inflammation (Table I). Thus, granuloma 
growth and the formation of PG&. can be influenced 
independently of cac~ other, as recently reported by 
Bonta et al (1979). 
Our data clearly show that the daily administration of 
indomethacin (200 fJ.&. locally), inhibits the biosynthesis 
Table 1. Effects of daily administration of indomethacin (200 1-'f!.· locally) on the in vivo metabolism of sodium 
[1~14C]arachidonate on days I and 8 of carragecnan~induced granulomatous inflammation in the rat. 
Product formed as a percentage of total plate radioactivity 
Day I Day 8 
Metabolite 
PGE, 
PGFz« 
&.kctoPGFl"' 
~1fT 
HETE 
Vehicle 
0·88 ± 0·04 
0·28 ± 0·04 
0·34 ± 0·07 
0·34...:... 0·03 
1-86 ± 0·25 
1·27 ± 0·04 
Drug 
0·50 ± 0·09U 
0·20 ± 0·02* 
0·29 ± 0·09 
0·25 ± 0·03* 
1'16 = 0·10* 
0·71 ± 0·06'·· 
Vehicle 
5·30 = 2·40 
0·73 ± 0·31 
0·83 ± 0·63 
0·85 ± 0·31 
0·68 ± O·ll 
0·63 ± 0·17 
Drug 
0·72 ± 0·10~ 
0·24 ± 0·02 
0·10 ;;i;: 0·03 
0·42 = 0·14 
0·72 ± 0·12 
0·50 ± 0·10 
Autoxidation 
0·14 
0 
0 
0 
0·35 
0·71 
Values represent means± s.e.m. of 5 rats. Significance of the differences between indomethacin and vehicle treated 
rats was tested by the onc~tailcd Student's t~tcst (• P < 0·05 and*" P < 0·01). The values ranked in the last column 
represent the formation of products during the autoxidation of arachidonate with identical R...-values as the 
metabolites formed in vivo. 
of most arachidonatc metabolites during the acute 
phase of inflammation, whereas in the chronic phase the 
inhibition is less pronounced. This finding is consistent 
with the results of other investigators that indomethacin 
is a more effective inhibitor of granuloma growth 
during the acute, rather than the chronic phase 
(Fukuhara & Tsurufuji 1969). Furthermore, our 
experiments confirm the observation that the pool of 
cycl<roxygenase involved in the ultimate synthesis of 
prostacyclin is relatively insensitive towards inhibition 
by low doses of NSAID in vivo (Basista et al 1978). 
Although the inhibition of HETE formation on day I 
might be the result of a direct inhibition of lipoxy~ 
genase(s) by indomethacin, two other explanations arc 
also possible, as indomethacin has not been reported to 
be a lipoxygenase inhibitor in vitro {Hamberg et a\ 
1974). Indomethacin inhibits the migration ofleucocytcs 
(Ford~ Hutchinson ct a! 1975) and this inhibition may 
lead to a reduced amount of arachidonate converting 
enzymes at the inflamed site and a reduced formation of 
metabolites. The insensitivity of the formation of 
arachidonate metabolites on day 8 towards inhibition by 
indomethacin, may be due to the relative dominance of 
other cell types in·this phase of inflammation. 
It is of particular interest that at least a part of the 
injected arachidonate is incorporatedin to phospholipids 
and indomethacin increases the amount of arachidonate 
incorporated into this fraction on day I. Kaplan et a\ 
(1978) have shown that indomethacin, in very low 
concentrations, inhibits the phospholipase ~ of rabbit 
PMN leucocytes. If the major part· of the arachidonate 
administered in our inflammation model is indeed 
incorporated into membranes and subsequently released 
by a phospholipase, it is not inconceivable that the 
inhibition by indomethacin of the formation of HETE 
and other products during the acute stage of inflamma· 
tion is due to the inhibition of phospholipase A2, 
resulting in a decreased avallability of arachidonic acid 
for cyclo~oxygenase and lipoxygenase. 
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Parnham for corrections of the text. 
September 20. 1979 
Note added in proof: 
It has recently been shown that aspirin~like drugs 
inhibit the formation of HETE by human platelet 
microsomcs, owing to the inhibition a HPETE per~ 
oxidase (Siegel, M. I., McConnell, R. T., Cuatrecasas, 
P. (1979) Proc. Natl. Acad. Sci. U.S.A. 76: 3774-3778). 
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4. DISSOCIATION BETWEEN PROSTAGLANDIN AND MALONDIALDEHYDE FORMATION IN 
EXUDATE AND INCREASED LEVELS OF MALONOIALOEHYOE IN PLASMA AND LIVER 
DURING GRANULOMATOUS INFLAMMATION IN THE RAT. 
P.C. Bragt, E.P.M. Schenkelaars, I.L. Bonta. 
Department of Pharmacology, Faculty of Medicine, Erasmus University, 
P.O.Box 1738, Rotterdam, The Netherlands. (reprint requests to PCB) 
ABSTRACT 
During kaolin-induced granuloma pouch inflammation in the rat the con-
centration of malondialdehyde (MDA) in the exudate, measured by the 2-
thiobarbiturate method, steadily increased and this increase was correl-
ated with the increase in granuloma weight. There was a complete lack 
of correlation between the concentrations of MDA ana prostaglandin (PG)-
like material in the inflammatory exudate. Whereas the concentration of 
PGs reached a maximum 1 day after the induction of inflammation and re-
turned to control levels on day 4, the MDA concentration continuously 
increased from the initiation of inflammation up to day 16. During gra-
nuloma development the concentration of MOA in the plasma reached a 
maximum on day 2 in parallel with the concentration in the liver, then 
both plasma and liver MOA decreased to levels observed in control rats. 
Between day 2 and 8 of the inflammatory process homogenates of livers 
from inflamed rats showed an increased formation of MDA on incubation, 
the amount formed being maximal on day 4. 
The results of the present study are discussed in view of a possible in-
volvement of lipid peroxidation in inflammation. 
IIITRODUCT I ON 
Mammalian tissues contain large amounts of polyunsaturated fatty acids 
(PUFAs) in their cell membranes. PUFAs are highly susceptible to oxid-
ation by oxygen, and the process in which fatty acids become rancid on 
exposure to atmospheric oxygen, is called 1autoxidation 1 • It has now 
been amply shown that lipid peroxidation can occur in living organisms, 
presumably having the same underlying free radical mechanism and kinetics 
as the autoxidation process. 
Malondialdehyde (MDA) is a product of both cycle-oxygenase-dependent (1) 
and independent (2) peroxidation of certain PUFAs. The enzymatic bio-
conversion of arachidonic acid (20:4, w6) into prostaglandins at the in-
flamed site and its relevance for the acute as well as the chronic phase 
of inflammation has already been the subject of numerous investigations 
(3,4). However, there is evidence that lipid peroxidation and the 
parallel formation of MDA is not limited to the site of inflammation. 
Thus, it has been shown that incubation of liver homogenates obtained 
from mice and rats with carrageenin-induced paw edema, results in en-
hanced 1 ipid peroxide formation, when compared with 1 ivers· from normal 
animals {5,6). However, with adjuvant arthritic rats, liver homogenates 
showed a decreased tendency to produce lipid peroxides on incubation (6). 
The liver is a source of the enzymes superoxide dismutase (S.O.O.), 
glutathione peroxidase, and of the acute phase protein ceruloplasmin. 
SOD scavenges the superoxide free radical (0:), which can, by itself, 
induce inflammation (7), and has been shown !o inhibit microsomal lipid 
peroxidation in vitro (8). In addition, SOD inhibits the depolymerizat-
ion of synovial fluid caused by superoxide (9) and is antiinflammatory 
(10). Glutathione peroxidase is very effective in reducing organic 
hydroperoxi"des (11) and the copper enzyme ceruloplasmin, which is present 
in increased concentrations in the serum of patients with rheumatoid ar-
thritis (12), has antioxidant properties (13). Other antioxidants such 
as N,N-diphenyl-p-phenylenediamine, propyl gallate, and d-a-tocopherol, 
also have antiinflammatory activity in inflammation models (14-16). 
Jn the present study 1 ipid peroxidation was studied at different stages 
of kaolin-induced granulomatous inflammation in the rat, by determining 
thiobarbituric acid reactive substances (MDA) and prostaglandins in the 
exudate, furthermore MDA levels in plasma and in homogenates of the liver 
before and after i.1cubation. 
MATERIALS AND METHODS 
Animals and induction of inflammation 
Male Wistar rats (TNO Zeist, The Netherlands), weighing about 250 g 
were divided at random into groups of 5 animals and kept on standard 
laboratory food (Hope Farms, Woerden, The Netherlands) and water, to 
which they had free access. Under light ether anaesthesia, the backs 
of the rats were shaved and 6 ml air was injected s.c. With the needle 
remaining in situ, inflammatory granuloma was initiated by the injection 
into the preformed airsac of 4 ml of a 10% (w/v) kaolin suspension in 
sterile, pyrogen-free saline. 
Tissue removal and processing 
At different stages of granulomatous inflammation rats were lightly 
anaesthesized under ether, and blood was obtained from each rat by card-
iac puncture,·using a heparinized needle, and collected in a polystyrene 
tube. Immediately afterwards, the liver was removed, rinsed with ice-
cold saline, and homogenized in liquid nitrogen, using a mortar and 
pestle. The frozen liver powser from each rat was stored under nitrogen 
at -25oc, until required. 
The blood samples were centrifuged for20 min at 1,500 x g and the clear 
plasma fraction was used for the determination of MDA levels. 
Finally, the granuloma pouch was removed and the exudate collected by 
cutting the pouch on one side and rinsing, with 2 ml saline into sili-
conized glass tubes containing 100 ~g indomethacin added in 10 ~1 ethan~ 
to prevent prostaglandin biosynthesis and hence artefactual MDA formation 
during handling. 
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The exudate volumes and the dry (20h, 100°C) granuloma weights were re-
corded. 11 Exudate 11 was collected from control rats by injecting kaolin, 
followed by immediate sucking up of the fluid. Further treatment was 
carried out as for the inflamed rats. 
Fractions of the frozen 1 iver powder (O.Sg weighed at 0°C) were suspend-
ed in 4.5 ml of an ice-cold 150 mM KCl solution (S), and aliquots of 
1 ml were removed for measurement of intrinsic liver MDA levels. 
The remainder was incubated for 3h at 37°C in 25 ml vials in a Lab-Line 
Model 3569 metabolic shaker (oscillations: 120 min- 1 , stroke length: 5 
em). Reactions were terminated by adding an equal volume of 15% (w/v) 
trichloroacetic acid and after centrifugation (800xg, 15 min) the super-
natants were used for the determination of MDA. 
Assay methods 
Protein was determined according to lowry et al. (17), using 10 ~1 dil~­
ed exudate with bovine serum albumin as a standard. Protein levels were 
calculated for the undiluted 3xudate. 
After addition of 10 J.ll [5,6- H] PGE 1 (approx 25,000 dpm) ethanol, 1 ml diluted exudate was acidified with 1M HCl to pH 3, and lipids were ex-
tracted by mixing with 2 volumes chloroform. Phase separation was faci-
litated by brief centrifugation. The organic phase was then collected 
and the solvent evaporated in vacuo at room temperature. The residue 
was dissolved in 100 J.il saline and from this solution 10 ].11 was used for 
the determination of recovery by liquid scintillation counting in a 
Packard Tricarb Model 3375. The remaining 90 ul was used for bioassay 
of prostaglandins. Prostaglandin-] ike material (PGL) was bioassayed 
against authentic PGE 2 on a rat stomach strip superfused with aerated Krebs buffer, contain1ng a mixture of antagonists (18), at a rate of 
1.3 ml/min at 37°C. PGL in exudates was expressed as nanogram equiva-
lents PGE2 per ml exudate, after correction for recovery. MDA was determined according to the thiobarbituric acid (TBA) method of 
Smith (19), using 1 ml aliquots of plasma, diluted exudates, and liver 
homogenates from inflamed and control rats. The TBA reagent was prepar-
ed according the method of Stuart (20). Hydrolysed samples of tetrame-
thoxypropane served as a standard·for the MDA determination, the molar 
extinction coefficient being (1.33 + 0.02) x 105 1/mole/cm (mean+ sem 
of 14 experiments). The amounts of-MDA present in plasma and in !he in-
flammatory exudates were expressed as nmoles MDA/ml, whereas MDA levels 
in the liver homogenates, were expressed as nmoles/g wet liver. Net MDA 
production during incubation was calculated by subtraction of the MDA 
values, found in the unincubated samples, from those formed in the cor-
responding incubated samples. 
As bilirubin or biliverdin might have interfered with our assay for MDA 
(21), a qualitative test was performed with representative samples from 
plasma and liver to investigate this possibility. Extraction of the 
chromophor from the acid aqueous phase into butanol, followed by re-
extraction into an alkaline aqueous phase (21), revealed that no inter-
ference had occurred, as no shift in colour from pink to blue could be 
observed. 
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Materials 
The following agents were purchased: narcose ether from Hoechst, Frank-
furt, Germany; kaolin from Baker Chemicals, Deventer, The Netherlands; 
tetramethoxypropane from Merck-Schuchardt, Hohenbrunn, Germany, 2-thio-
barbituric acid from Merck, Darmstadt, Germany; heparin (Thromboliquine) 
from O~anon, Oss, The Netherlands; PGEz from Sigma, St. Louis, U.S.A.; 
~,6-3~ PGE1 from The Radiochemical Centre, Amersham, England, and 
dioxane scintillation fluid from Packard, Brussels, Belgium. Indometha-
cin, and other antagonists used for bioassay of prostaglandins, were ob-
tained from the pharmacist, Dijkzigt Academic Hospital, Rotterdam, The 
Netherlands. 
RESULTS 
The acute inflammatory response was characterized by marked exudation 
and accumulation of exudate protein within the granuloma pouch, the 
total amount of protein reaching its maximum on day 1 of inflammation 
(Fig.1). 
The granuloma weight, a component of the more chronic phase of inflamma-
tion, steadily increased from the time of kaolin injection reaching a 
maximum on day 8 (Fig.l}. The granuloma removed 6 hours after i~jection 
of kaolin, were soft and had a jelly-like appearance, whereas on day 16 
the granulomata were relatively hard and had a more or less spherical 
shape. 
The concentration of PGL in the exudate increased rapidly from the time 
of kaolin administration, reaching a maximum on day 1 of inflammation 
(Fig.2). In contrast, the levels of MDA in the exudate began to in-
crease 6 hours after kaolin and did not reach a maximum within the per-
iod of investigation (Fig.2). Thus, alterations in MDA concentration 
in the exudate did not show a correlation ~ith alterations in the conce~ 
tration of PGL (Spearman rank test p > 0.05)_. However, the MDA concen-
tration in the exudate showed a significant correlation (Spearman rank 
test, p< 0.01) with the granuloma weight in 2 separate experiments 
(Fig.3). When plasma fractions from infl.amed and control rats were 
examined for their content of MDA, increased levels were observed in 
animals with a developing granuloma pouch. The MDA concentration in 
the plasma obtained from rats with 1, 2.and 4 days inflammation was 
significantly increased in comparison with control animals (p < 0.01, 
Student•s t-test), achieving maximal levels on day 2 of inflammation 
(Fig.4, lower part). From 4 to 16 days the plasma MDA level decreased 
to the value observed at tbe moment of the induction of inflammation. 
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Figure 1. Development of the granuloma, expressed as the increase in 
dry granuloma weight (closed circles), and the accumulation of protein 
(open circles) in the inflammatory exudate during the development of 
the kaolin granuloma pouch. Inflammation was induced at zero time by 
the injection of 4 ml kaolin (10% w/v in saline) into a preformed sub-
dermal airsac. Arrows indicate the respective axes. Each point repre-
sents the mean~ s.e.m. of 5 animals. 
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Figure 2. Time dependency of the concentrations of prostaglandin-like 
material {PGL, open circles) and malondialdehyde (MDA, closed circles) 
in the inflammatory exudate. PGL, measured by bio-assay on a rat fundus 
strip, is expressed as nanogram equivalents PGEz per ml. Arrows indica-
te the respective axes. Each point represents the mean + s.e.m. of 5 
animals. Significance was tested versus values at zero "time. (one-
tailed Student 1 s t-test, • = p<0.01, ** = p<0.001). 
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Figure 3. Correlation of the malondialdehyde (MDA) concentration in the 
pouch exudate with the dry granuloma weight in two separate experiments. 
Correlation coefficients and degrees of significance were calculated 
with the Spearman rank test. 
Increased intrinsic MDA levels were observed in the liver homogenates 
from rats with 1 and 2 days old granuloma pouches {Fig.4, upper part). 
The maximal intrinsic MDA concentration in the liver coincided with the 
maximum concentration in the plasma, but, although the plasma concen-
tration was still significantly elevated on day 4, the MDA concentration 
in the liver had already decreased to values detectable in uninflamed 
rats (Fig.l+, upper part). 
When aerobic incubation of liver homogenates from inflamed and control 
rats was carried out at 370 C for 3h, formation of MDA was significantly 
increased in the livers from inflamed rats, when compared with controls, 
2, 4 and 8 days after the initiation of inflammation (Fig.4, upper part). 
DISCUSSION 
The results in this paper indicate that remote local inflammation in the 
rat leads to elevated lipid peroxide levels in the plasma and in the 
liver. Interestingly, the extent of lipid peroxidation at the inflamed 
site is correlated with the severity of the inflammatory process (i.e. 
granuloma weight). . 
Our data also clearly indicate that the observed formation of MDA in the 
pouch exudate cannot have solely been the result of the action of PG 
synthetase. Jn granulomatous inflammation in the rat, induced by carra-
geenin, locally formed metabolites of arachidonate consist mainly of PGE2 
~22). As the carrageenin-induced granulomatous inflammation is akin to 
the granuloma pouch model, used in the preSent study, it appears justifi-
ed to compare the levels of PGEz and MDA in two models. Thus, on a molar 
base, local levels of MDA exceed PG levels by more than a hundred-fold, 
assuming that the bioconversion of endogenous arachidonate is identical 
in both models. In addition, the time courses of PGL and MDA formation 
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Figure 4. Changes in the malondialdehyde concentrations in plasma 
(squares) and in incubated (closed circles) and unincubated (open circle~ 
homogenates of 1 ivers from rats at different stages of kaol in-i·nduced 
granuloma pouch development. Homogenates were made 10% w/v in 150 mM 
KCl. Incubations were performed for 3h at 37°C in a metabolic shaker. 
Unincubated samples were withdrawn at zero time. Net MDA production on 
incubation was calculated by subtracting the MDA values in the corres-
ponding unincubated samples. Unless otherwise indicated (in brackets) 
each point represents the mean + s.e.m. of 5 animals. Significance was 
tested versus the moment of the-induction of inflammation (one-tailed 
Student 1s t-test, * p<O.Ol, ** p<O.OOl). 
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are totally dissimilar (Fig.2). In fact, at any time when PG levels 
have already decreased to values observed in control rats, the concen-
tration of MDA in the exudate is still increasing. 
During the phagocytosis of particles by polymorphonuclear leucocytes 
and macrophages, the respiration of these cells is dramatically increas-
ed, and large quantitie~ of the superoxide anion (o;) are produced by 
the membrane-bound NAD(P)H oxidase system {23). The inner part of the 
phagocytosing cell is protected against this radical by the enzyme supe~ 
oxide dismutase (SOD), which converts superoxide into oxygen and hydro-
genperoxide. However, part of the superoxide is released into the extr~ 
cellular space, thereby inducing peroxidation of tissue cell membranes 
with concomitant MDA formation, either by itself (24), or via conversion 
into reactive species like the hydroxyl radical {25) and singlet oxygen 
{26). As this generation of oxygen metabolites during phagocytosis is 
completely independent of PG biosynthesis, it may very well explain the 
absolute dissimilarity between the local formation of MDA and PGs. 
Besides an increase in local MDA levels, we observe increased MDA levels 
in the plasma and liver from rats with a granuloma pouch. There may be 
two major explanations for this phenomenon. 
One possible reason for the increase in the concentration of plasma and 
hepatic MDA is a decreased elimination of lipid peroxides by protecting 
enzymes, of which glutathione peroxidase is the most important one (11). 
The activity of this enzyme depends on the availability of reduced glu-
tathione. As it has been reported that, during inflammation in rats, 
levels of hepatic glutathione and plasma thiols are reduced (27,28), it 
is not inconceivable that the peroxide metabolizing system is also af-
fected. The increased hepatic synthesis of the acute phase reactant 
ceruloplasmin, a protein with strong antioxidant properties {13), can 
then be explained as a physiologically operating feedback mechanism to 
restore the peroxide metabolizing capacity. 
Another valid explanation may be that, during inflammation, increased 
synthesis of lipid peroxides occurs rn the liver. It has been shown 
that 1 uncoupling 1 of the cytochrome P-450 system leads to the production 
of superoxide radicals on the one hand and a decreased metabolism of 
drugs on the other one (29). Interestingly, a reduction of the in-vivo 
capacity of drug metabolism has been reported to occur during inflamma-
tion in the rat (30), whereas lipid peroxidation interferes with hepatic 
drug metabolism in vitro (31). · 
This tempts to speculate that a relation exists between the increased 
hepatic synthesis of the antioxidant acute phase protein ceruloplasmin, 
the increased lipoperoxide concentration in the plasma and liver, and 
the decreased hepatic drug metabolism during the inflammatory process. 
However, experimental evidence for such a correlatron.has still to be 
delivered. 
Finally, it is worth mentioning, that the phenomenon of increased plasma 
MDA levels is apparently not restricted to the presently investigated 
animal model of inflammation, but occurs also under clinical inflammatory 
conditions, i.e. in patients with rheumatoid arthritis {32). 
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5. Increased lipid peroxidation and decreased 
hepatic aminopyrine metabolism during 
carrageenin-induced granulomatous 
inflammation in the rat 
M.J.P. ADOLFS. I.L. BONTA & P.C. BRAGT• 
Departnwnt of Pharmucolofiy, M.:di<'ul Faculty. Erusmu~ 
Unhwsity, P.O. 8os 1738. 3000 DR Rotradam. The ,'1/<•t!r-
<'tlands 
Hepatic drug metabolism is decreased during adju-
V'J.nt arthritis in the rat (Beck & Whitehouse, 1973). 
We observed increased levels of the stable lipid per-
oxidation product malondialdehydc (MDA) in plasma 
and liver of rats with kaolin granuloma pouch inflam-
mation (Bragt, Schcnkelaars & Bonta. 1979). We have 
now investigated. both hepatic aminopyrine demethy-
lation and lipid peroxidation during carrageenin-
induced granuloma in the rat. Wistar rats weighing 
200-250 g were used. Lipid peroxidation was esti-
mated by determining MDA in plasma and livers 
from rats with carrageenin-induced (10 mg) grrlnulo-
mata growing around subcutaneously implanted teflon 
chambers (Bragt. Bonta & Adolfs, 1979). Drug meta-
bolism was measured in vivo by the expiration of 
14C02 after the i.p. injection (120 mg/kg. OA 1-1Cijkg) 
of [ 14C]-aminopyrine (Radiochemical Centre. Amer-
sham). as described by Lauterburg & Bircher (1976~ 
in rats which had either polyether sponge implants., 
carrageenin-soaked (10 mgjsponge) sponge implants 
(Bonta. Adolfs & Parnham. 1979). or which wei-e 
sham-operated. 
The injection of carrageenin resulted in a significant 
rise in the MDA concentrations in plasma and liver 
after 6 h (340% and 64%. respectively, P < 0.01 vs 
day 0. Mann-Whitney U test) a change which was 
still present after 7 days (700% and 54% respectively. 
P < 0.01). The increase in liver MDA was associated 
with a decrease in hepatic reduced glutathione (GSH) 
content ( -40%) throughout the entire period of in-
vestigation (data not shown). The plasma MDA con-
centration showed a correlation with the severity of 
inflammation expressed as wet granuloma weight 
(r, = 0.53. n = 25. P < 0.01 Spearman rank test). Five 
days after operation {i.e. peak of granuloma forma-
tion). the half-life (Tj) of aminopyrine was longer in 
rats with a stronger inflammatory response (Table 1 ): 
the T, correlated significantly with the amount of 
granuloma formed (r, = 0.76, n =IS. P < 0.01). The 
extended r, during inflammation might be due to the 
reduced hepatic levels of GSH. since the binding of 
dcmethylated aminopyrine metabolites would also be 
reduced. Consequently. these metabolites would com-
pete with the aminopyrine for the active site of cyto-
chrome P-450. We, thus.. injected GSH (400 mg/kg 
i.v.) into rats implanted with carrageenin-soaked 
sponges. 45 min prior to the administration of .lmino-
pyrine. The T1 was not altered (fable I). Therefore. 
GSH depletion per se may not be responsible for the 
decreased drug metabolism during inflammation. 
As the two sets or experiments indicate that in-
creased lipid peroxidation .1nd a reduction in drug 
metabolism occur in parallel during carrageenin-
induced granuloma. it is not inconceivable that the 
two phenomena are interrelated. 
References 
BECK. F.J. & WHITEHOUSl. M.W. (1973). Effect of adjuvant 
disease in rats on cyclophosphamide and isophospha-
mide metabolism. Biochem. Pharmac .. 22, 2453· 246X. 
BONTA, J.L., AOOt.FS. M.J.P. & PARNHAM, M.J. (19791. Can· 
nulated sponge implants in rats for the study of time-
dependent pharmacological influences on inflammatory 
granulomata. J. Phurmuc. M<'th~ .. 2. I -11. 
BllAGT. P.C. BoNTA, I.L. & Aoot.FS. M.J.P. (1979). Cannu-
lated teflon chamber implant in the rat: a new model 
for continuous studies on granulomatoUs inflamm:;tion. 
J. Phurmac. Meths .• (in press). 
Table 1 Extension of the in ri~-o half-life (T112 ) of C ... CJ-aminopyrine in rats 5 days after subdermal sponge 
implantation 
Sham-operation 
Sponge implant without carrageenin 
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6. Depletion of Hepatic Antioxidants During 
Granulomatous Inflammation in the Rat and Local 
Anti-Inflammatory Effects of Free Radical Scavengers 
by P .C. BRAGT, J .1. BANSBERG and l.L. BONTA 
Department of Pharmllcology, Erasmus University Rottcrdum. P.O. Box 1738, Rotterdam. The Netherlands 
Abstract 
Cbangt::J in hepatic o;tidative events have been 
studied durins extmbcpalie ifWlUlomatous in the rat, 
toaetber with the local antl-lnJlammutory dfecra of 
scavenaen of reactive oxysen species. During remote 
localized ln!iwnmation iD the r~.~;t, we observed increased 
hepatic lipid pc:rox.idatioo and reduced hepatic levcls of 
protcetlna substance. such as ascorbic acid, CJ&taluse and 
reduced &].utatblonc, the speclflc :Jubstrate for the 
perox.ide-metabolhlns ea;~,;yme, iJutatbione peroxidase. 
Tbe levels of supcrox.lde d.i5mu~ did not ulter 
sl&nifii!antly duriaa the period of Investigation (7 days). 
The half-life of IUDinopyrine w.a1 lonaer In rara witb a 
stronaer iufl.ammatory ruponae. In addltioo. cutllluse 
and the aotl-oxldanls, a-tocopherol lllld propyl pilate, 
inhibited itanu.loma development on local i.Qjection 
durini tbc acute phase of inflammation. Superoxidc 
d.lsmutaa;e Won~: wu devoid of anti-inflammatory effecU. 
but markedly enhanced tb~: effect of calai.D.se. Scavengers 
of hydroxyl radlcnla and of slniJet oxygen fa1Ied to 
display anti-i.nftammatory activity. Tbe ruults indicate 
that p~:roxides may act as mediators of inftammation and 
that increued lipid peroxidation Is not limited to tbe lite 
of inflammation. 
Introduction 
Apart from local changes which occw· at 
a site of inflammation, systemic changes are 
also seen. These include increased body 
temperature, increased pituitary-adrenal 
function and increased hepatic synthesis of the 
acute phase reactants (APR), reflected bY 
elevated levels of these substances in the blood 
[ IJ. The function of the APR is generally 
thought to be a protective one. For example, 
the copper storage protein. ceruloplasmin, 
which is a superoxidc: raa.ical t ·02) scavc:nger, 
has anti-inflammatory properties in a rat 
model of inflammation l19]. In this respect, it 
resembles the copper and zinc containing 
enzyme, superoxide dismutase (SOD), which 
is present in the [21 cytoplasma and catalyses 
the reaction:·Oz + ·02 + 2H+ - H20 2 + 0 2 
[3]. The protective function of the superoxide 
scavengers during inflammation is probably 
due to their capacity to eliminate a potentially 
damaging radical, which is released during 
the phagocytosis by polymorphonuclear 
leukocytes. It has been shown that, during the 
synthesis of the APR, the liver •neglects' the 
synthesis of other substances, as a result of the 
adaptive syndrome [4], and it is possible that 
the synthesis of protective substances (e.g. 
scavengers of reactive intermediates) may also 
be reduced. We, therefore, .investigated the 
changes in hepatic SOD, catalase, reduced 
glutathione (GSH) and ascorbic acid during 
granulomatous inflammation in the rat and the 
effects of administration of some of these 
protective agc:ntS into tne inliamed S1u:. 
Materials and methods 
Male Wistar rats (about 200 g) were implanted 
with polyether sponges or with te!l.on chambers, in the 
dorsal subdermal region [5, 6]. Both the sponges and the 
chambers were provided with indwelling cannulae, which 
were exteriorized o.t the back of the neek. Carrageenin 
(10 mg) was used to induce the formation of granu" 
!ornata around the implanted materials. At different 
stllges of granulomatous inflammation. the livers were 
removed from the chamber-implanted rats., homo-
genized and assayed for lipid peroxidntion us previously 
described [71. SOD and catalll:le activities and tbe 
hepatic concentrations of GSH and ascorbic acid were 
determined by established assay methods [8-11]. 
Scavengers of superox.ide, hydrogen peroxide, 
hydroxyl radicals and singlet oxygen (I02)and anti-
oxidants were administered into the cannul111: of sponge-
implanted rats, either in a single dose immediately after 
implantation or daily, on days 3-6 of granulomatous 
inflammation. The vehicles were eitber saline or arachis 
oil (200 p].), depending on the lipophilicity of the drugs 
used. Control rots received vehicle only. The effects of 
the administration of the drugs on the i.o.fiammation were 
11 0 
estimated from the exudate' volumes and the dry weights 
of the granulomata on day 7 after the implantation of the 
sponges. 
The in vivo demethylation of 1•C-labelled amino-
pyrine {120 mg/kg, 0.4 ,uCi/kg, i.p.) was investigated 
after the induction of inftammation with differing 
severP.ty. namely in sham"{)perated rats and in rats either 
implanted with sponges alone, or with carrageenin-
soaked sponges. The metabolism studies were performed 
on day 5 after the operation (the time of maximal 
granuloma weight) and the aminopyrine half-life Wit$ 
estimated from the expiration of 1"C02• essentially as 
described by LAUTilRBURO and BIRCHeR Ll2]. 
mg GSH/g wet liver A 
"' 
• "' • • • 
200 
stage of inf\anvnatlon (d.lys) 
units catalase/mg wet 1 iver 
30 
20 
-.t.1ge of infl.lmm.ltion (days) 
Flgu.rel 
ResuLts 
Some of these results have been com-
municated to the British Pharmacological 
Society, [ 13 J. As a result of a remote localized 
inflammation, the hepatic concentration of 
GSH was significantly reduced (p < O.Q25, 
one-sided Mann-Whitney U test versus 
control) from 6 hours after the induction of 
inflammation up until day 7 (Fig. lA). On day 
3, the hepatic concentration of ascorbate was 
also significantly reduced (p < 0.025, Fig. lD) 
un l ts SOO/mg wet 1 i ver B 
2 
stage of inf1arrrnatlon (days) 
ng ascorbic acld/mg wet 1 iver 
5 7 
S'tage of infl.lnvnation (days) 
Time-dependent chansi:s in the hepatic levels of A: reduced glutathione (GSH), B: superoxide dismutase (SOD), C: 
ca.tala:Je and D: llllCOrbic acid.. during a remote locnlized inflammation in the rat. Inflll.llUllation was induced at t""' 0 
and the corresponding control values are indicated with dotted lines. Each point represents the mean ± S.E.M. of at 
least 5 rats. With GSH. the S.E.M. vnlues arc smaller than the size of the dots. Asterisks indicate that the values differ 
significantly from the corresponding controls (p < 0.025, one-tailed Mann-Whitney U test). 
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nmoles malonaldehyde/g wet 1 iver 
40 
30 
~~~·-~-~~~~~--------------------
20 
3 5 7 
stage of inflanmation (days) 
Figure2 
Time-dependent changes in hepu.tic lipid peroxidation 
foUowing the induction of inflammation at zero time. 
Lipid perox.idation was estimated by the determination of 
malooaldeb.yde by the 2-tb.iobarbituric acid method. 
. Values indicate means ± S.E.M. The dotted line 
represents the control values. Points. other than t = 0, 
differ signilicantly from conttol tP < 0.01, one-tailed 
Ml!.llll-Whitney U test). 
and was still low on day 7 of inflammation. 
After a small initial rise, there was a decreased 
hepatic catalase activity, which was signifi-
cantly lower than control on days 3-5 of 
inflammation (p < 0.025). From day 5 to day 
7, the catalase activity tended to increase 
slightly towards control levels (Fig. lC). 
Wherea:> there was no significant change (p > 
0.05) in the activity of hepatic SOD (Fig. 1B), 
there was a dramatic increase in the concen-
tration of the lipid peroxidation product 
rnalonaldehyde (Fig. 2). From.6 hours after 
the induction of granulomatOUs inflammation 
up until day 7, hepatic lipid peroxidation was 
signill.candy increased (p < 0.01) in inflamed 
rats in comparison with healthy animals. 
Simultaneously, there was also a drastic 
change in the hepatic capacity for meta-
bolizing drugs. Thus, the aminopyrine half-life 
(T ~ was longer in rats with a more :)evere 
inflammation, the T l- showing a significant 
positive correlation (r8 = 0.76, n = 18 rats 
with a p < 0.0 1, Spearman rank test) with the 
wet granuloma weight. Figure 3 shows the 
linearity of the mean half-lives plotted against 
the mean granuloma weights in tlu:ee groups of 
rats. 
130 ** Amino~YrineT~ 
m1n. 
90 
granuloma weight 
50 
0 1.45 s. 06 9 
FiJ:,'l.l.re3 
Aminopyrine half-life plotted against the granuloma 
weight in sham-operated rats. rats implanted with 
sponges alon.: and rats implanted with carrageenin-
soaked sponges. Each point represents the mean amincr 
pyrine half-life with the corresponding mean granuloma 
weight (± S.E.M.) i.n a group of 6 rats. • and •• indicate 
significant differences in the aminopyrine half-lives 
against sham-operated rats at the S and the 1% level, 
respectively (one-tailed Mann-Whitney U test). 
SOD (363-12,088 U/sponge) neither 
inhibited granuloma growth nor exudation 
following local administration at the time of 
sponge implantation. In contrast, catalase 
showed a dose-dependent anti-inftainmatory 
effect. A dose of 46,667 U per sponge 
inhibited both granuloma growth and 
exudation (Table 1). The addition of 363 U 
SOD, which was inactive in itself, markedly 
potentiated the inhibitory effect of catalase on 
the granuloma weight (Table 1). This effect 
was due to an enzymic activity, since 
denaturation prior to injection abolished the 
inhibition. The hydroxyl radical scavengers, 
mannitol, benzoate and thiourea, failed to 
inhibit the parameters of inflammation to any 
significant extent. In fact, thiourea enhanced 
the granuloma growth (Table 1). In addition, 
the singlet oxygen scavengers DABCO and 
P-carotene were inactive in inhibiting granu~ 
loma growth and exudation following admini-
stration immediately after the induction of 
inflammation. However, on administration 
into a preformed granuloma (i.e. daily on days 
3-6), both compounds tended to enhance 
exudation and granuloma weights (Table 1). 
GSH (30 mg/sponge) was inactive under both 
dose regimes (data not ·shown). The anti-
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Table 1 
Effects of scavengers of reactive oxygen species on granulomatous infl.ammation in the rat. 
Scavenger and dose• Intermediate Time of Inhibition granuloma Inhibition exudation 
scavenged admini:>trru.ion° (% cb.a.nge vs. control)" (%change vs. control)" 
SOD (363-12.088 U) .o, day 0 -12-6 io--5 
CAT (313--46,667 U) H102 dayO -l4-3Si" 2-27 t 
CAT(6260U)+SOD ·OH? day 0 42i' 17 
(363 U) 
Denatuted CAT + SOD dayO -ll -25 
Mannitol (40 mg) ·OH day 0 -33 0 
Sodium benzoate (26 mg) ·OH dayO 14 9 
Thiourea (20 mg) ·OH day 0 -1ot -13 
DABCO (3.5 mg) '0, day 0 36 
days 3-6 -12 -8 
,8-Carotene (125 p.g) 'O, dayO 12 10 
days 3-6 -41t -1 
a-Tocopherol (19 mg) '02/LOO· dayO 20 ,t 
days 3-6 -27t 12 
Propyl gallate (1 mg) LOO· dayO 32'i" -18 
days 3-6 2!t 34 
• The doses were administered into each sponge (2 sponges per rat) in rats of about 200 g. 
b The drugs were given either in a single dose on day 0, or daily on days 3-6. 
• The inhibition of granuloma weight and exudation is expressed as percent change ven>us controls. Significance was 
tested by the one-tailed Mann-Whitney U test versus controls ( t p < 0.05). Negative signs indicate stimulation of 
granuloma or exudation. 
SOD: superoxide clismutase, CAT: cataluse, DABCO: 1.4-diazabicyclo\2.2.2)octane, ·02: superoxide anion, 
·OH: hydrOxyl radical, 10 2: singlet oxygen, LOO·: lipid~peroxy radical. 
oxidant and singlet oxygen scavenger, a~ 
tocopherol, inhibited granuloma growth and 
exudation following administration on day 
0, whereas it significantly enhanced the 
granuloma weight following injection on days 
3-6 (Table 1). The anti~oxidant propyl gallate 
inhibited granuloma weight independently of 
.the time of administration (Table 1). 
Discussion 
The involvement of the liver in a remote 
localized inflammation is not only obvious 
from the production of the acute phase 
proteins, but also from an increased lipid 
peroxidation and a reduced hepatic availability 
of reducing substances (GSH, ascorbate) and 
protecting enzymes (catalase), as shown in the 
present study. Since in vitro studies revealed 
that lipid peroxidation and microsomal drug 
metabolism are competitors for reducing 
equivalents, it is not surprising that, during 
inflammation, there is also a reduced hepatic 
drug metabolism. The reduced hepatic drug 
metabolism was clearly demonstrated by tile 
elongation of the aminopyrine half~life in rats 
with different degrees of granulomatous 
inflammation. These results are in close 
agreement with the observations of BECK and 
WHITEHOUSE [14], who showed an increased 
sleeping~time following the administration of 
hexobarbital and trichloroethanol and a 
decreased hepatic metabolism of aniinopyrine 
and cyclophosphamide in vitro, in rats with 
acute inflammation. As far as present know~ 
ledge is concerned, it is not clear what actually 
causes the hepatic changes. It has, for 
example, been postulated that some kind of 
humoral factor from the inflamed site induces 
an adaptive syndrome in the liver, after its 
transport via the blood [15]. 
As it seemed conceivable that the liver, 
via catalase, SOD and ceruloplasmin, may 
protect the organism against oxidative damage 
by reactive intermediates ( ·Oz, 10 2, H202> 
lipid peroxides) generated at the inflamed site, 
we locally injected some scavengers of these 
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intermediates into the inflamed site to investi~ 
gate their possible anti~intlammatory e!Tects .. 
Using this route of administration, •false~ 
positive' anti-inflammatory drugs are 
excluded, by avoiding cOWlter-IIntation 
effects. From the fact that catalase exerted a 
dose-dependent inhibition of the granuloma 
formation it may be concluded that hydrogen 
peroxide plays a role as an inflammatory 
mediator. It is not likely that superoxide also 
plays such a role, since SOD was not 
inhibitory even at extremely high dosage 
levels. The addition of specific amounts of 
SOD to catalase prior to injection, resulted in 
a potentiated inhibition of the granuloma 
weight. As combinations of SOD and catalase 
may prevent the formation of hydroxyl 
radicals in vitro [16], we tested some 
established HO· scavengers. None of Lhc: 
compounds tested could signjiicandy reduce 
the amount of granuloma formed, thus, it is 
unlikely that the hydroxyl radical is an 
important pro~inflammatory species in the 
acute phase of granulomatous inflammation. 
The same can be said of singlet oxygen in view 
of the results with the 10 2 scavengers. How-
ever, lQ 2 may be invo!ver.i in llle breakdown of 
collagen or in the inhibition of macrophage 
proliferation in the chronic phase of inflam~ 
mation, since the WJection of specific 
scavengers at this stage, tended to enhance the 
granuloma weight. This observation is in 
agreement with the results of other investi-
gators [17], who showed that singlet oxygen 
causes the cleavage of non~helical regions of 
the collagen molecule in vitro, by an oxidative 
attack on susceptible amino acids. When 
applied to a pre-existing granuloma, a-
tocopherol behaves like the other 10: 
scavengers tested. However, on admini~ 
stration immediately after the induction of 
inflammation, it inhibits both granuloma 
formation and exudation. In addition, the 
anti-oxidant propyl gallate inhibits the granu-
loma growth irrespective of the time of 
administration. In view of this and of the fact 
that a-tocopherol is a very poor inhibitor of 
the enzyme fatty acid cycio-oxygenase, 
which produces prostaglandins and throm~ 
boxanes from specific polyunsaturated fatty 
acids [18J, it is likely that lipid peroxides 
(LOOH) or lipid-peroxy radicals (LOO·) are 
potential mediators of inflammation. -
Therefore, efforts should be made to 
develop and to test drugs, which inhibit the 
formation of lipid peroxides, via the lipoxy-
genase pathway or via the free radical 
mediated pathway. 
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7- ANTIINFLAMMATORY EFFECTS OF FREE 
RADICAL SCAVENGERS AND 
ANTIOXIDANTS 
Further Support for Proinflammatory Roles 
of Endogenous Hydrogen Peroxide and 
Lipid Peroxides' 
P. C. BRAGT, J. L BANSBERG. and L L. BONTA 
Department of Pharmacology, Faculty of Medicine, 
Erasmus University Rotterdam, Box 1738,3000 DR Rotterdam, The Netherlands 
Abstract-Scavengers of reactive oxygen species were tested by local adminis--
tration during granulomatous inflammation in the rat, induced by the subder-
mal implantation of carrageenin-soaked sponges. Drugs were administered 
either in a single dose immediately after sponge implantation, or in daily doses 
on days ~ of inflammation. The effects of the injected drugs were assessed 
using the day 7 granuloma. When given at the moment of sponge implAntation, 
catalase showed antiinflammatory effects, whereas superoxide dismutase did 
not. However, the addition of superoxide dismutase to catalase, prior to injec-
tion, markedly potentiated the inhibition of granuloma formation by catalase 
alone. Negntive results obtained with scavengers of hydroxyl radicals and singlet 
molecular oxygen suggest that protection of superoxide dismutase by catalase 
from inactivation by hydrogen peroxide, is a likely explanation for the observed 
potentiation. When administered at the moment of the induction of inflamma-
tion, a-tocopherol and propyl gnl!Ate, both antioxidants, also inhibited granu-
loma formation. All drugs tested were either ineffective or even enhanced 
granuloma weight following administration into a preformed granuloma. An 
inhibitor of both pathways of araehidonate metabolism, phenidone, inhibited 
granuloma formation irrespective of the moment of administration. The results 
presented in this paper suggest proinflammatory roles for hydrogen peroxide 
and lipid peroxides and a. possible involvement of hydroxyl radicals and sin-
glet oxygen in the breakdown of collagen. 
INTRODUCTION 
During inflammation, a massive invasion of granulocytes and/ or macro-
phages occurs at the inflammatory site. Both cell types are capable of 
1Some of the data presented in this paper were communicated at the International Meeting on 
Inflammation, Verona.., Italy, September 1979. 
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producing the cytotoxic superoxide anion (·0;) during the phagocytosis 
of bacteria or particles (1. 2). That the intracellularly generated superox-
ide can escape into the extracellular space, thereby stimulating the pro-
inflammatory response, is demonstrated by the observation that superoxide 
dismutase (SOD). a copper- and zinc-containing enzyme which converts 
superoxide into hydrogen peroxide and oxygen, has antiinflammatory 
properties (3, 4). In vitro experiments have shown that superoxide can 
react with other molecules to produce the extremely reactive hydroxyl 
radical (·OH). which is considered to be the main initiator of lipid peroxi-
dation with deleterious consequences for the organism (5). Recently. 
evidence has been provided that hydroxyl radicals are produced as a result 
of the zymosan-stimulated oxygen burst in monocytes and granulocytes 
(6, 7). The exact mechanism of the generation of hydroxyl radicals in bio-
logical systems is still speculative. but likely sources are the iron(II)-cat-
alyzed decomposition of hydrogen peroxide (8) and lipid hydroperoxides 
(9). This is confirmed by the observation that the iron chelator, diethylene-
triamine pentaacetic acid, inhibits the formation of hydroxyl radicals in a 
system containing iron. hydrogen peroxide and superoxide anions as es-
sential components (10). 
A possible role of hydroxyl radicals in the amplification of an inflam-
matory process might be anticipated from their ability to cause depoly-
merization of hyaluronic acid and bovine synovial fluid (II), labilization of 
lysosomal membranes (5), lipid peroxidation with subsequent generation 
of chemotactic principles from lipids (12). and enhancement of the release 
of anaphylactic mediators from challenged sensitized guinea pig lungs (13). 
In the present study, we investigated the possible antiinflammatory 
effects of catalase, superoxide dismutase, and combinations of both. scav-
engers of hydroxyl radicals and singlet oxygen and of the iron chelator 
bathophenanthroline sulfonate. Furthermore, we tested the antioxidants 
propyl gallate and a-tocopherol and an inhibitor of both the lipoxygenase 
and cyclooxygenase--dependent oxidative metabolism of arachidonic acid, 
phenidone (14). The effects of the administered drugs on the intensity of 
inflammation were determined from their effe,cts on granuloma weight, 
exudation and, for some drugs, on the amounts of prostaglandin-like 
material (PGL) in the exudate. 
MATERIALS AND METHODS 
Animals and Treatment. Inflammation was induced in male Wistar rats (TNO, Zeist, 
The Netherlands) by the implantation of two carra~nin-soaked and cannulated polyether 
sponges (20 X 10 X 5 mm·'). according to the method of Bonta eta!. (15). The rats weighed 175-
200 g and were maintained on standard laboratory food (Hope Farms: Wocrden, The Nether-
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lands) and tap water, to which they had free access. For the study of drug effects. the rats were 
mndomly divided into groups of 5, and the drug:; to be tested or the corresponding vehicles 
were injected through the cannulae into both sponges. either as a single dose directly after 
implantation. or daily on days 3-6 of inflammation. On day 7 of inflammation, the rats were 
reweighed, sacrificed by carbon dioxide inhalation. and bled by carotid incision. The effects 
of the test drugs on the intensity of inflammation were assessed from the volume of accumu-
lated exudate. the dry weights of the granulomata. formed. and corrected for the differences 
in body weights. Furthcnnore. for some drugs. the amounts of prostaglandin-like material 
in the exudates were estimated by bioassay on a rat stomach fundus ~trip in the presence of a 
mixture of antagonists in the superfusion fluid (16). 
Preparation of Sponges. In order to prevent interference from an antioxidant material 
(17) present in the polyether during testing of the drugs. the sponges were boiled in absolute 
ethanol for 30 min, dried. impregnated with 0.5 ml of a 2% (w/v) carrageenin solution. and 
finally dried again before implantation. 
Drugs. Superoxide dismutase (Palosein®, 2900 unitsjmg) was a gift from Diagnostic 
Data Inc .• Mountain View. California and another batch was purchased (bovine superoxide 
dismutase. 2700--2900 units/mg) from Sigma. St. Louis. Missouri. Also from Sigma were: 
thymol-free bovine liver catalase (10.000 units(mg). the iron chelator. bathophenanthrolinc 
sulfonate. and the !ipoxygenase and cyclooxygenase inhibitor. 1-phenyl-3-pyrazolidone (phen-
idone). The hydroxyl radical scavenger. o-mannitol. and the antioxidants. a-tocopherol and 
propyl gallate. were purchased from ICN. Cleveland. Ohio. The hydroxyl radical scavengers, 
sodium benzoate and thiourea. were obtained from E. Merck, Darmstadt. West Germany. 
The singlet oxygen quenchers, DABCO [I.4-diazabicyclo(2.2.2)oetane] and trans-,8-caro-
tene. were from Fluka. Buchs. Switzerland. and Aldrich, Milwaukee. Wisconsin. respectively. 
Reduced glutathione (GSH) was purchased from Boehringer. Mannheim. West Germany. 
The lipophilic substances were dissolved in arachis oil and the water soluble drugs in 
saline in such concentrations that the volume of the solutions administered to the animals was 
always 200,ul. 
Statistics, Statistical analysis was performed using the one-tailed Mann-Whitney U~test. 
Differences between drug~ and vehicle-treated groups of animals were considered to be signifi~ 
cant at the 5% level. Linear regression and correlation analysis were performed with the method 
of the least squares and the Spearman rank test, respectively. 
RESULTS 
Table 1 shows that the administration of catalase during the acute phase 
of inflammation results in a dose-dependent inhibition of both granuloma 
formation and exudation. The inhibition of exudation, however, was only 
statistically significant at the highest dose tested, i.e., 46.667 units/sponge 
(4.7 mg protein). The lowest dose of catalase significantly inhibited the 
accumulation of prostaglandins in the exudate, without displaying and 
effect on granuloma formation and exudation. An opposite phenome-
non was observed with the combined administration of 6260 units/sponge 
catalase and 2417 units/sponge SOD namely, a significant increase in pros-
taglandins in association with a lack of effect on granuloma fonnation and 
exudation. 
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Table 1. Effects of Local Injection of Catalase, with and without Different Additions of Superoxide Dismutase (SOD), on Some 
Parameters of Granulomatous InOammation in the Rat, when Gi\·en Immediately after Induction of Inflammation by Implantation of 
Carrageenin-Soaked Sponges• 
Drug combination tested Dry granuloma weight {g) Exudate volume (ml) PGL (ng equiv PGEli 
SOD (unit/sponge) Catalase Drug Vehicle Drug Vehicle Drug 
0 313' 0.37 ± 0.05' 0.34 ± 0.02 1.34 ± 0.25 1.36 ± 0.05 29.4 ± 11.6' 
0 ~260 0.33 ± 0.03* 0.40 ± 0.03 1.50±0.14 1.74 ± 0.15 
0 23)34 0.33 ± 0.04** 0.45 ± 0.04 1.66 ± 0.14 1.94 ± 0.21 
0 46,667 0.31 ± 0.02** 0.47 ± 0.05 1.22 ± 0.07** 1.68 ± 0.21 
363 313' 0.32 ± 0.03* 0.40 ± 0.03 1.23 ± 0.21 1.74±0.15 
363 6,26if 0.30 ± 0.02** 0.47 ± 0.05 1.40 ± 0.17 1.68 ± 0.21 
363 23,334 0.]5 ± 0.03* 0.47 ± 0.05 1.66 ± 0.07 1.68 ± 0.21 
2,417 6,260 0.31 ± 0.03 0.35 ± 0.04 1.54 ± 0.05 1.76 ± 0.10 48.5 ± 6.0* 
2,417 23,334 0.41 ± 0.01 0.47 ± 0.05 1.30 ± 0.15 1.68 ± 0.21 
12,088 23,334 0.37 ± 0.05' 0.47 ± 0.05 1.52 ± 0.23 1.68 ± 0.21 
~The parameters were determined on day 7 of granulomatous inflammation. 
bpGL =prostaglandin-like material in the inflammatory exudate, detected by bioassay on a rat stomach strip. 
'Follov.-ing daily administration on days 3-6 of inflammation, this drug combination was ineffecth·e . 
.tnmaturation, prior to injection, abolished the inhibitory properties on the granuloma fonbation. 
~•p < 0.05, '' P < 0.01, one-tailed Mann-Whitney U test \'ersus control. 
Values represent means± SEAl of 5 rats, unless indicated otherwise-. 
Vehicle 
40.5 ± 14.7 
30.5 ± 5.J 
For the drug treatment on the day of implantation, correlation analy-
sis was performed with the parameters of inflammation determined on 
day 7. The Spearman rank correlation coefficients were determined for 
granuloma weight and exudate volume against prostaglandin-like activ-
ity in the exudate, respectively. There was no correlation between granu-
loma weight and PGL (rs = 0.38, P > 0.05) or between exudate volume 
and PGL (rs = 0.14, P > 0.05) for eight different drug treatments. The 
granuloma weight and the exudate volume were significantly correlated 
(r, = 0.67, p < 0.05). 
Following administration on day 0. SOD alone was devoid of any 
effect on the parameters of inflammation. even at the highest dose tested, 
i.e .• 12.088 units/ sponge (4.2 mg protein). In contrast, the addition of low 
doses of SOD to catalase. prior to injection, resulted in a marked potenti-
ation of the inhibition of granuloma formation, but this combination was 
ineffective in inhibiting exudation. Figures I and 2 show the dose-effect 
CHANGE GRANUlOMA WE I GHT 
~0 p; of control] 
c 
0 
CAT + 36=-U .s.gp 
-
.-
ENZYME ACTIVITY (U/sponge) 
Fig. 1. Percent changes in the dry granuloma weight in response to the local injection of dif· 
ferent doses of catalase (CAT, --0--), superoxide dismutase (SOD,---). and combinations 
of catalase with 363 units superoxide dismutase (CAT+ 363 units SOD,-·-·A·-·-) into 
sponges, at the moment of sponge implantation. Denaturation prior to injection abolished the 
inhibitory effect on the granuloma weight of the most effective combination of catalase and 
superoxide dismutase (0). Each point represents the mean percent change for a group of 5 
rats versus its corresponding. Vehicle-treated, control group of 5 rats. 
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Fig. 2. Percent changes in the exudate volume in response to the local injection of different 
doses of caulase (CAT,--o--). superoxide dismutasc (SOD, -e-). and combinations of 
cata.lase and superoxide dismutase (CAT+ 363 units SOD,- ·-·A·-·-). In order to test the 
requirement for enzymatic activity, the combination of 363 units SOD with 6260 units CAT 
was denatured. Denaturation Jed to a reversal of the effect of the combination (r::l). See the 
legend of Figure I for funhcr details. 
relationships for the percent changes in granuloma dry weight and exudate 
volume, respectively, as a function of different doses of catalase, SOD, and 
combinations of both. The combined administration of 363 units SOD and 
6260 units catalase per sponge was the most effective treatment for the in-
hibition of granuloma formation (Figure I). However. this inhibition was 
completely abolished when the enzymes were heat-denaturated before in-
jection, showing that the inhibition of granuloma formation was due to an 
enzymic action. When given daily to a preexisting granuloma (days 3-6), 
catalase (313 units) and SOD (363 units), alone or in combination, were 
ineffective in inhibiting granuloma formation and exudation (data not 
shown), but the combination significantly enhanced the granuloma weight. 
As the results with some of the combinations of SOD and catalase 
suggested the involvement of hydroxyl radicals in the acute phase of in-
flammation, we tested some established hydroxyl radical scavengers, with 
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Table l. Effects of local Administration of Free Radical Sca\·engers and Antioxidants on Some Parameters of 
Granulomatous Inflammation in the Rat, when GiYen at Different Stages of Granuloma Development in Response 
to Implantation of Carrageenin-Soaked Sponges 
Dry granuloma \\tight (g) Exudate Yolurne (ml) POL (ng equi\' PGE1) 
Do1e 
ScaHng~r te~ted' (mg/5pong~) Drug Vthide Drug Vehicle Drug Vehicle 
Mannitol 04 0.32 ± O.D3 0.34 ± 0.02 1.68 ± ().21 1.36 ± 0.05 21.0 ± 6.0 40.5 ± 14.7 
4 0.38 ± 0.0-t 0-45±0.0-t 1.38 ± 0.09° 1.94 ± 0.21 
40 0.20 ± 0-03 0-14 ± 0.01 0.84 ± 0.07 0.77 ± 0.10 5.5 ± 1,5 6.1 ± 16 
Sodium benzoate 25.5 0.38 ± O.o3 0.45 ± 0.04 1.76 ± 0.20 1.94 ± 0.21 
Thioureab 20 0.35 ± om• 0.21 ± 0.02 0.85 ± 0.29 0.73 ± 0.10 
BPS' 10 0.15 ± 0.02° 0.21 ± 0.02 0.55 ± 0.06 0.73 ± 0.10 
DABCO 
Day 0 ,, 0.36 ± 0.02 0.39 ± 0.04 1.14 ± 0.19" 1.78 ± 0.10 62.7 ± 13.7 104.8 ± 35.4 
Da}'S 3--6 3.5 0.29 ± 0.03 0.26 ± 0.02 1.62 ± (l_J4 1.50 ± 0.09 
Carotene 
DayO 0.125 0.33 ± 0.03 0.39 ± 0.0-t 1.60 ± 0.21 1.78 ± 0.10 52.5 ± 10.1 104.8 ± 35.4 
Da}'S 3--6 0.!25 0.36 ± 0.04' 0.26 ± 0.02 1.52 ± 0.21 1.50 ± 0.09 
Tocopherol N 
Day 0 18.75 0.30 ± 0.03' 0.39 ± 0.0-t 1.30 ± 0.13' 1.78 ± 0.10 49.8 ±IS.! 104.8 ± 35_4 N 
Days J-6 15 0.33 ± 0.02" 0.26 ± 0.02 1.32 ± 0.16 1.50 ± 0.09 
Pr. gallate 
DayO I 0.35 ± 0.03 00 0.48 ± 0.03 1.16 ± 0.08 0.98 ± 0.02 110.5 ± 22.0 
Da}'S 3-6 I 0.37 ± 0.04 0.45 ± 0.03 1.24 ± 0.20 1.87 ± 0.37 
Phrnidone 
DayO 0.835 CU7 ± 0.04" 0.48 ± 0.03 0.92 ± 0.10 0.98 ± 0.02 56.3 ± 12.1• 110.5 ± 22.0 
Da}'S 3-6 0.835 0.30 ± 0.02' 0.45 ± 0.03 1.82 ± 0.26 1.87 ± 0.26 
GSH 
DayO 30 0.33 ± 0.03 0.35 ± 0.0-t 1.84 ± 0.09 1.76 ± 0.10 56.9 ± 9.7° 30.5 ± 5.3 
Da}'S 3--6 30 0.31 ± 0.02 0.30 ± 0.03 2.06 ± 0.19 2.34 ± 0.25 128.1 ± 48.8 80.0 ± 7.5 
'ScaHD8CfS were administered either ln a lingle dole, immediately after the indudion of inflammation, or daily, on da}"S 3--6ofinfl=matlon. 
AbbreYiation~: BPS= bathophenanthroline !iU!!onalt, DABCO = 1,4-diazabk)"ro(2,2,2)octane, pr. gallate= prop)·! ga!lat~. phenidone"" 
1-phenyJ.J-pyra>olidone, GSH = reduted glutathione. 
•p < 0,05, "P< 0.01, one.tailed Mann-Whitney U test \ersu~ 'ontrol 
Sec also leg~nd of Table I. 
~4 Rat-> in the drug·lreated group, of "hlch 2 died within 24 h. 
'4 Rat-> in the drug·lr~ated group. 
completely different chemical structures, as possible inhibitors of the de-
velopment of granuloma. Neither mannitol, benzoate, nor thiourea showed 
an inhibition of the dry granuloma weight (Table 2). The media-n dose of 
mannitol significantly reduced exudation. Moreover. thiourea, besides 
being extremely toxic, appeared to be an irritant since it significantly stim-
ulated the granuloma weight. Interestingly, the administration of an iron 
chelator. with the intention of preventing the formation of hydroxyl rad-
icals via a Fenton-like reaction, resulted in a significantly decreased gran-
uloma weight (Table 2). The singlet oxygen scavengers, DABCO and 
,8-carotene, did not inhibit granuloma weight, following administration 
during the acute phase of inflammation, but rather tended to enhance 
the amount of granuloma formed, when given on days 3-6. Whereas only 
DABCO strongly inhibited exudation, both DABCO and carotene re-
duced the accumulation of prostaglandins in the exudate, albeit not sig-
nificantly (Table 2). 
The antioxidant, propyl gallate, reduced the amount of granuloma 
formed. following injection shortly after sponge implantation. The anti-
oxidant and singlet oxygen scavenger, a-tocopherol, behaved like propyl 
gallate when given at the moment of induction of inflammation, and also 
inhibited exudation, whereas following administration to a preexisting 
granuloma it behaved like the other singlet oxygen scavengers as it en-
hanced the amount of granuloma formed. GSH, a nonspecific scavenger 
and the essential electron donor in the glutathione peroxidase-catalyzed 
reduction of peroxides, was ineffective with respect to granuloma forma-
tion and exudation, but significantly enhanced the amount of prostaglan-
dins in the exudate on administration during the acute phase of inflamma-
tion. Finally, the inhibitor of enzyme-catalyzed oxidative metabolism of 
arachidonic acid, phenidone, was the only drug which inhibited the gran-
uloma formation, irrespective of the stage of administration. It also 
significantly inhibited prostaglandin formation, when injected on sponge 
implantation (Table 2). 
DISCUSSION 
The present study demonstrates that SOD, even at high doses (i.e., 
12,088· units/sponge), does not display antiinflan:~:matory properties in 
the inflammation model used. Thus, we failed to confirm the results of 
Huber and coworkers (18), who showed that SOD (orgotein) is an effec-
tive antiinflammatory agent in several species, including the rat, mouse, 
guinea pig, dog, horse, and man. However, McCord and coworkers (19) 
showed that native bovine superoxide dismutase was ineffective, after 
intravenous injection, against carrageenin-induced paw edema and the 
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passive Arthus reaction in the rat. As the plasma half-life of native SOD 
was about 6 min and as the coupling of SOD to Ficoll resulted in a half-
life of about 24 h which was associated with antiinflammatory effects in 
both models, it was concluded that renal clearance limits the antiinflam-
matory effects of native SOD (19). The local injection of SOD directly 
into the inflamed site, which was perl'ormed in our studies and which is not 
prone to interference by renal clearance because its high molecular weight 
prevents SOD from crossing membranes, appears to be ineffective. How-
ever, on administration in the same way, catalase showed a dose-depen-
dent antiinflammatory effect in our model, although McCord claimed that 
the plasma half~life of catalase is even shorter than that of SOD. 
From these data and from the fact that combined administration of 
catalase and SOD was more effective than the administration of catalase 
alone, it is likely that other mechanisms than merely the interference of 
renal clearance should be considered. The fact that catalase inhibits gran-
uloma development and exudation on administration at the moment of 
induction of inflammation suggests that hydrogen peroxide is a proinflam-
matory species in the acute phase of inflammation. In fact, hydrogen 
peroxide is produced during the SOD-catalyzed dismutation Of super-
oxide radicals. In view of the marked potentiation by SOD of the inhibi-
tion of granuloma formation by catalase, it is likely that catalase protects 
SOD from inactivation by hydrogen peroxide (20). 
An alternative explanation for the potentiation is that specific com-
binations of SOD and catalase prevent the generation of hydroxyl radicals, 
which, at least in vitro, have been shown to be produced in solutions con-
taining iron, hydrogen peroxide, and superoxide anions (10). Scavengers 
of hydroxyl radicals, however, failed to mimic the effects of combinations 
of SOD and catalase in our experiments, thus making an involvement of 
hydroxyl radicals unlikely. Surprisingly, the iron chelator, BPS, which is 
effective in the prevention of the hydroxyl radical-induced degradation of 
hyaluronic acid (21), was also effective in the inhibition of granuloma 
formation in our model. Probably, inhibiting hydroxyl radical formation is 
much more efficient than scavenging the radical before it reacts with bio-
logically important molecules. 
An involvement of singlet oxygen in the acute phase of inflammation 
is unlikely in light of the ineffectiveness of the quenchers DABCO and 
,8-carotene as inhibitors of granuloma formation. Only DABCO inhib-
ited exudation. The fact that the administration of the scavengers into a 
preexisting granuloma (daily administration on days 3-6) fend to enhance 
the granuloma weight, raises the possibility that the scavengers directly 
stimulated fibroblast functions or that singlet molecular oxygen is involved 
in the breakdown of collagen. The latter is likely, since it has recently been 
shown that reactive oxygen species may evoke the degradation of col-
lagen in vitro (22, 23). 
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The antioxidants a~tocopherol and propyl gallate inhibited granu~ 
lama formation on administration during the acute phase of inflammation. 
Moreover, a-tocopherol also inhibited the exudation. On administra~ 
tion during the chronic phase of inflammation, propyl gallate was inef-
fective whereas a-tocopherol enhanced the granuloma weight, thus 
behaving in a manner related to its properties as a singlet oxygen scaven-
ger, rather than to its antioxidant properties. The lipoxygenase and cyclo-
oxygenase inhibitor phenidone was effective in inhibiting granuloma 
formation, irrespective of the time of administration. Therefore, it is likely 
that lipid peroxides, besides prostaglandins, are involved in inflammation 
as mediators, because a~tocopherol, as an inhibitor of granuloma in the 
acute phase, is a very weak inhibitor of cyclooxygenase (24) and pheni~ 
done is equally potent in inhibiting lipoxygenase and cyclooxygenase 
(14). The involvement of lipid peroxides is also emphasized when one 
considers the fact that the levels of prostaglandin-like material did not 
correlate with the granuloma weight under any conditions of drug ad~ 
ministration. In addition, we have recently shown that the exudate lev-
eis of malonaldehyde, a compound which is formed both during the bio-
synthesis of prostaglandins and during radical-induced lipid peroxidation, 
were significantly correlated with the granuloma weight but not with 
prostaglandin-like material (25). 
In conclusion, while bearing in mind the limitation that we are com-
pletely ignorant as to the pharmacokinetics of the majority of the scav-
engers used, it is evident that hydrogen peroxide plays an important role 
in the acute phase of inflammation, and it is likely that lipid peroxides are 
also involved. Knowledge of the interaction of these substances with the 
humoral and cellular events occurring during the inflammatory response 
may provide new perspectives for antiinflammatory drug design. 
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SUMMARY 
The investigations which have led to this thesis, are concerned with 
the role of free radicals and 1 ipid peroxidation in inflammation. Free radi-
cals are relatively reactive toward other molecules because they have an 
unpaired electron in the outer orbital. This reactivity is advantageous in 
the chemical processes involved in polymer production. Free radical reactions 
also occur within the body, for instance, during enzymatic processes. 
Generally, the free radicals generated by enzymes remain closely associated 
with the protein and are not often released, but there are exceptions. 
Xanthine oxidase, an enzyme converting xanthine to uric acid, 1 iberates 
superoxide radicals during its enzymatic actions. These radicals are 
very reactive and they are not very specific in choosing molecules to react 
with. This implies that the body should be equipped with 1 ines of defence 
against free radicals and harmful products generated during free radical 
reactions. These 1 ines of defence exist of enzymes and compounds which 
react with preformed radicals to render them less harmful to biologically 
important molecules. 
Free radical formation may lead to undesired effects, when too may 
radicals are formed within a relative short period and in states of 
inefficiency of the 1 ines of defence. An example of undesired reactions is 
the reaction of free radicals with lipids, leading to a 1 chain 1 of reactions 
which may be self-supporting for several minutes and this sequence of 
reactions is called 1 1 ipid peroxidation 1 • As a consequence, membranes may 
loose their structure and fluidity and harmful products may also be formed. 
Antioxidants, for instance vitamin E, inhibit. lipid peroxidation and protect 
the ce11 against damage due to this process. 
Virtually all cells of the body have 1 ipoxygenases and cycle-oxygen-
ase, enzymes catalyzing the formation of peroxides from specific poly-
unsaturated fatty acids. The endoperoxides formed as a result of cyclo-
oxygenase action, are precursors of prostaglandins which are local hormones 
involved in a number of physiological processes (e.g. platelet aggregation, 
protection of vascular endothelium). During inflammation, pr·ostaglandit1s 
promote the acute phase of this process due to the stimulatory effects on 
oedema formation. Aspirin-1 ike drugs inhibit the biosynthesis of prosta-
glandins and, as a consequence, the acute phase of inflammation. This is 
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one reason for the therapeutical applications of these drugs as anti-
inflammatory agents. However, aspirin-) ike drugs are markedly ineffective 
against rheumatoid arthritis, characterized by chronic inflammation of the 
synovia which leads to the formation of enormous amounts of collagen. In 
view of this lack of effects, many investigators made efforts to develop 
alternative drugs. One of the results has been the successful therapeutical 
application of immune modulators against rheumatoid arthritis. 
Another approach in the development of new drugs is the study of 
free radical formation during phagocytosis and its implication for the 
inf.lamed area. Free radical generation by phagocytosing granulocytes and 
macrophages may lead to tissue damage and depolymerization of synovial 
fluid. Furthermore, free radicals may induce 1 ipid peroxidation by 
affecting polyunsaturated fatty acids embedded in cell membranes or in the 
free form. The products formed have a certain degree of toxicity for 
1 iving cells and tissues. The investigations which have been described in 
this thesis have been performed from the point of view that 1 ipid peroxida-
tion is involved in inflammation. 
The introduction of this thesis is concerned with the mechanisms of induction 
of 1 ipid peroxidation by free radicals, the products formed, the measurement 
of lipid peroxidation and the ways via which the process may be prevented 
or inhibited. Furthermore, some interactions have been described between 
free radical-induced 1 ipid peroxidation and the formation of prostaglandins. 
The second part of the introduction describes the interactions of free radi-
cals and 1 ipid peroxidation with inflammation, while much attention has been 
paid to the role of the acute phase proteins. Ceruloplasmin is especially 
important in this context as it is a- scavenger of superoxide radicals and 
as it is the major serum antioxidant. Furthermore, ceruloplasmin has been 
shown to be effective as an anti-inflammatory agent in animal models of 
inflammation. In this respect it is obvious that the 1 iver is involved in 
the systemic response on a remote localized injury, because it synthesizes 
the acute phase reactants and undergoes 1 ipid peroxidation in an enhanced 
rate. Malonaldehyde is a stable end product of 1 ipid peroxidation and it 
has been used for many decades as a monitor of 1 ipid peroxidation in food 
technology as well as in the study of biological systems. Malonaldehyde 
has also been used as a monitor of J ipid peroxidation in the experiments 
included in this thesis. 
As malonaldehyde is also formed during the biosynthesis of prosta-
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glandins which play an important role in inflammation, attention has been 
initially focussed on the conversion of radioactively labelled arachidonate 
to prostaglandins and related substances. 
Appendix 1 is concerned with the development of an inflammation 
model in the rat, which enables accurate injections of arachidonate into 
the inflamed area (granuloma) and the perfusion of metabolites, without the 
necessity of surgically traumatizing the animal or sacrificing it. The 
newly developed model, a teflon chamber provided with two cannulae, has 
many appaerances in common with the model of cannulated sponge implants 
with respect to inflammatory parameters. 
The metab0l ism of arachidonate in vivo by granulomatous tissue has 
been described in Appendix 2. The metabolism studies with the newly 
developed chamber model reveal that prostaglandin (PG) E2 and hydroxy-
fatty acids are main metabolites at any stage of granuloma formation. These 
results are in marked contrast with the findings of other authors working 
with in vitro systems. The metabolism of arachidonate in the chamber model 
is very similar to arachidonate metabolism in the affected joints of patients 
with rheumatoid arthritis, for which the model is thought to be relevant. 
Appendix 3 is concerned with the pharmacological aspects of inflam-
mation because indomethacin was the drug of choice to investigate the 
effects of nonsteroidal anti-inflammatory drugs on arachidonate metabolism 
and granuloma formation. PGE 2 biosynthesis and granuloma formation may be 
independently influenced by indomethacin in view of the inhibition of PGE2 
formation in combination with unaffected granuloma growth. Furthermore, in 
the acute phase of inflammation indomethacin inhibited the formation of the 
1 ipoxygenase product, HETE, which had not been previously described at that 
moment. Indomethacin could never fully suppress metabolite formation from 
arachidonic acid, suggesting nonenzymatic formation of products. 
The formatiOn of malonaldehyde at the site of inflammation, inde-
pendently of the biosynthesis of prostaglandins is given in Appendix 4. Thus, 
it is very 1 ikely that nonenzymatic 1 ipoperoxidation occurs during inflamma-
tion. Enhanced levels of malonaldehyde were observed in the blood of rats 
during inflammation and this was probably due to enhanced hepatic formation 
in view of elevated levels of malonaldehyde in 1 ivers from these rats. 
As 1 ipid peroxidation in vitro in 1 iver homogenates has been 
described to interfere with oxidative drug metabolism by the cytochrome 
P-450 system, the in vivo metabolism of the model drug, aminopyrine, has been 
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studied and the results have been presented in Appendix 5. During inflamma-
tion, aminopyrine metabolism is more inhibited in rats with a stronger 
inflammatory response. 
Appendix 6 is concerned with decresed levels of antioxidants in the 
1 iver. Thus, catalase activity and the levels of reduced glutathione and 
ascorbic acid were decreased, but superoxide dismutase activity was not 
significantly affected. Although the mechanisms behind these observations 
have not yet been elucidated, it is obvious that there is some kind of 
oxidant stress in the 1 iver during remote localized inflammation. 
Finally, Appendix 7 describes the possibility of pharmacologically 
influencing granulomatous inflammation by free radical scavengers and 
antioxidants. Catalase was a potent anti-inflammatory drug as it was effect~ 
ive against exudation and granuloma formation. Superoxide dismutase, however, 
was inactive, which might have been anticipated in view of the low chemical 
reactivity of the superoxide radical. Combinations of catalase and superoxide 
dismutase were more potent than catalase alone as inhibitors of granuloma 
formation. As a consequence, scavengers of hydroxyl radicals were investig-
ated, but without effect. That this does not simply justify the conclusion 
that hydroxyl radicals are not important in inflammation is emphasized by 
our observation that an iron chelator was an effective inhibitor of granuloma 
formation. In in vitro experiments, iron chelators inhibit hydroxyl radical 
formation and subsequent depolymerization of synovial fluid. 
The results have been evaluated in the discussion, whereas 
pharmacological consequences of the use of antioxidants as anti-inflammatory 
agents have been given. The possible advantages of these compounds, either 
alone or in combination with frequently used nonsteroidal anti-inflammatory 
drugs, have been considered and suggestions for future research have not 
been omitted. 
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SAMENVATTING 
Het onderzoek dat in dit proefschrift staat beschreven betreft de 
rol van vrije radical en en 1 ipoperoxidatie bij ontsteking. Vrije radicalen 
zijn atomen of moleculen met een ongepaard elektron in de buitenste schil, 
waardoor deze een grate reaktiviteit bezitten. Deze reaktiviteit kan nuttig 
zijn wanneer via vrije-radicaal mechanismen wordt getracht een kunststof te 
synthetiseren, of welke chemische stof dan oak. Oak in het 1 ichaam komen 
vrije-radicaal reakties voor, bijvoorbeeld tijdens enzymatische processen. 
!n het algemeen laat het enzym de ontstane radicalen niet los, maar er zijn 
enzymen bekend d.ie dit echter wEd doen. Een voorbeeld i'.s xanthine oxidase, 
een enzym dat xanthine omzet in urinezuur. Tijdens deze omzetting ontstaan 
superoxide radicalen. Omdat deze radicalen zo reaktief zijn en bovendien 
niet erg specifiek in het kiezen van stoffen waar ze mee reageren, heeft 
het 1 ichaam een aantal 1 verdedigingsmechanismen 1 tegen vrije radicalen en 
schadel ijke produkten die ontstaan tijdens vrije-radicaal reakties. Deze 
mechanismen bestaan uit enzymen en stoffen, die met grote snelheid met 
gevormde radicalen reageren, nog v66r deze met biologisch belangrijke mole-
culen kunnen reageren en de radicalen worden hierbij omgezet in minder 
schadel ijke produkten. 
Worden er op een bepaald moment teveel radicalen gevormd of schieten 
de beschermende mechanismen in hun doel tekort, dan kunnen de gevormde radi-
calen aanleiding geven tot ongewenste reakties. Een voorbeeld hiervan is 
de reaktie van radicalen met 1 ipiden, waarbij een soort kettingreaktie 
ontstaat die zichzelf enige tijd in sta~d kan houden en deze serie reakties 
wordt aangeduidt als 1 lipoperoxidatie 1 • Als ge~olg van 1 ipoperoxidatie ver-
1 iezen membranen hun struktuur en flu"lditeit en worden voor de eel schade-
1 ijke stoffen gevormd. Antioxidantia, zeals bijvoorbeeld vitamine E, remmen 
lipoperoxidatie en. beschermen dus de eel tegen de sC:hadelijke gevolgen ervan. 
Het 1 ichaam is in staat om in vrijwel al le cell en specifieke peroxi-
den te maken, via lipoxygenases en cycle-oxygenase. Dit Jaatste enzym is 
erg belangrijk, omdat de endoperoxiden die het maakt uit speciale meervoudig 
onverzadigde vetzuren worden omgezet in prostaglandines. Deze prostaglandines 
zijn betrokken bij tal van fysiologische processen (o.a. aggregatie van 
bloedplaatjes, bescherming van de vaatwand). Ook bij ontstekingen spelen ze 
een rol, zij het dat ze het ontStekingsproces verergeren, doordat ze oedeem-
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vorming in de beginfase van een ontsteking stimuleren. Aspirine-achtige 
farmaca remmen de vorming van prostaglandines en voorkomen daardoor een 
verergering van de ontsteking. Dit is een van de redenen dat deze kategorie 
van verbindingen toepassing vindt als ontstekingremmers. Tegen rheumatoide 
arthritis, gekenmerkt door een chronische ontsteking van de synovia die ge-
paard gaat met de vorming van grate hoeveelheden bindweefsel, zijn deze 
farmaca echter weinig aktief. Dit heeft ertoe geleid dat vele onderzoekers 
hun aandacht zijn gaan richten op het ontwikkelen van farmaca met andere 
werkingsmechanismen. Dit heeft onder andere tot gevolg gehad dat tegenwoordig 
modu.Jatoren van het immuunsysteem worden gebruikt in de therapie van rheuma-
toide arthritis. 
Een andere benadering in de ontwikkel ing van nieuwe farmaca is de 
bestudering van de vorming van vrije radicalen tijdens de fagocytose door 
granulocyten en macrofagen en de gevolgen hiervan voor ontstoken weefsels. 
Vrije radicalen kunnen weefselbeschadiging veroorzaken en leiden tot depoly-
merisatie van synoviaalvloeistof. Ook kunnen ze aanleiding geven tot peroxi-
datie van meervoudig onverzadigde vetzuren in celmembranen of in vrije vorm 
aanwezig, waarbij tal loze produkten ontstaan die een zekere mate van toxici-
teit bezitten. De onderzoekingen die in dit proefschrift zijn beschreven 
gaan uit van de veronderstell ing dat 1 ipoperoxidatie een rol speelt bij het 
ontstekingsproces. 
In de inleiding is beschreven hoe vrije radicalen lipoperoxidatie 
kunnen induceren, welke produkten er worden gevormd, hoe 1 ipoperoxidatie kan 
worden gemeten en hoe dit proces kan worden voorkomen of geremd. Bovendien 
is ingegaan op de interakties tussen 1 ipoperoxidatie en de biosynthese van 
prostaglandines. In het tweede deel v~n de inleiding is omschreven op welke 
wijze 1 ipoperoxidatie en vrije radical en invloed kunnen hebben op het ont-
stekingsproces en is ingegaan op de rol van de akute fase eiwitten. waarvan 
ceruloplasmine belangrijk is met het oog op het wegvangen van vrije radica-
len. In ontstekingsmodel len heeft ceruloplasmine een ontStekingremmende 
werking. Het is duidel ijk gebleken dat de lever een rol speelt bij een 
ontsteking die zich ver buiten de lever afspeelt, immers de lever maakt de 
akute fase eiwitten en het is beschreven dat de lever in verhoogde mate 
malonaldehyde vormt tijdens zo 1 n ontsteking. Malonaldehyde is een stof die 
een stabiel eindprodukt is van lipoperoxidatie en de vorming ervan wordt al 
tiental len jaren gebruikt als maat voor de peroxidatieve omzetting van 1 ipi-
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den, zowel in de voedingsmiddelen technologie als in het onderzoek van biolo-
gische systemen. Zo oak in de in dit proefschrift beschreven experimenten. 
Omdat malonaldehyde 66k gevormd wordt tijdens de biosynthese van 
prostaglandines, die zoals juist gezegd, belangrijk zijn bij ontsteking, 
is in eerste instantie gekeken naar de omzetting van radioaktief gemerkt 
arachidonzuur naar prostaglandines en analoga. 
Appendix 1 beschrijft de ontwikkel ing van een ontstekingsmodel bij 
de rat dat het mogel ijk maakt om op eenvoudige wijze arachidonzuur nauw-
keurig in het ontstoken gebied (granuloma weefsel) te injecteren en de 
metabol ieten te verkrijgen, zonder dat daarbij het dier opgeofferd hoeft te 
worden. Het ontwikkelde model, een ge'lmplanteerde teflon kamer voorzien van 
canules, is vergeleken met een reeds bestaand ontstekingsmodel en het bl ijkt 
hiermee in grate 1 ijnen overeen te komen. 
In Appendix 2 wordt beschreven dat het metabol isme van arachidonzuur 
door granulomaweefsel in vivo, met behulp van het nieuw ontwikkelde ontste-
kingsmodel, voornamel ijk leidt tot de vorming van hydroxy-vetzuren en 
prostaglandine (PG) E2 , in elk stadium van granulomavorming. De beschreven 
resultaten zijn volkomen verschillend van de resultaten die andere onderzoe-
kers verkregen uit in vitro experimenten. Bovendien bl ijkt het metabol isme 
van arachidonzuur door het experimentele granuloma sterk overeen te komen 
met dat in de gewrichten van patienten met rheumatoide arthritis, waarvoor 
het model overigens wordt geacht representatief te zijn. 
De farmacologische beinvloeding van de granulomateuze ontsteking en 
het metabol isme van arachidonzuur wordt beschreven in Appendix 3. De vorming 
van prostaglandine E2 bl ijkt te kunnen worden geremd zonder dat daardoor het 
ontstekingsproces wordt geremd. Bovendien bleek dat indomethacine de vorming 
van 1 ipoxygenase-afhankel ijke produkten te kunnen r.emmen, wat tot dat moment 
nog niet eerder beschreven was. lndomethacine was niet in staat om de vorming 
van metabol ieten voor honderd procent te remmen, zQdat een niet-enzymatische 
omzetting waarschijnl ijk was. 
Appendix 4 beschrijft de vorming van malonaldehyde op de plaats van 
ontsteking en deze bl ijkt onafhankel ijk te zijn van de vorming van prosta-
glandines. Dit maakt het zeer aannemelijk dat nonenzymatische 1 ipoperoxidatie 
optreedt. Verhoogde spiegels van malonaldehyde werden gemeten in het bleed 
van ratten met een ontsteking. Dit is mogelijk afkomstig van de lever, omdat 
ook hierin verhoogde 1 ipoperoxidatie optreedt tijdens een ontsteking ver 
buiten de lever. 
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Omdat 1 ipoperoxidatie in in vitro experimenten vaak gepaard gaat met een 
remming van het farmaconmetabol isme in de lever, werd het metabol isme van 
het modelfarmacon aminopyrine bestudeerd. Dit staat beschreven in Appendix 
5. Het metabol isme van aminopyrine in vivo blijkt sterker geremd naarmate 
de ontsteking heviger.is. 
Appendix 6 beschrijft de veranderingen in de antioxidant status 
van de lever tijdens een buiten de lever gelokaliseerde ontsteking. Het 
bl ijkt dat de hoeveelheid gereduceerd glutathion zeer sterk afneemt, terwijl 
oak de hoeveelheid ascorbinezuur en de katalase aktiviteit zijn afgenomen. 
Dit benadrukt de veranderingen die zich in de lever voltrekken, hoewel het 
mechanisme ervan niet duidel ijk is. 
Appendix 7, tenslotte, beschrijft de farmacologische beinvloeding 
van een granulomateuze ontsteking met behulp van vrije-radicaal scavengers 
en antioxidantia. Katalase had in het gebruikte ontstekingsmodel sterk 
anti-inflammatoire eigenschappen, terwijl superoxide dismutase niet effektief 
bleek te zijn. Op grand van de geringe reaktiviteit van het superoxide anion 
kan dit overigens wel worden verwacht. Combinaties van katalase en superoxide 
dismutase waren sterker anti-inflammatoir dan katalase alleen en dit gaf 
aanleiding tot het testen van scavengers van hydroxyl radicalen. Daar deze 
geen effekt hadden op het ontstekingsproces, mag niet zonder meer worden 
aangenomen dat hydroxyl radicalen geen rol spelen bij een ontsteking. Dit 
wordt nag eens benadrukt door het feit dat een ijzerchelator, een stof die 
in vitro de vorming van hydroxyl radicalen voorkomt, het ontstekingsproces 
kon remmen. 
In de discussie worden de resultaten gewogen en wordt ingegaan op 
de farmacologische betekenis van het gebruik van antioxidantia als 
ontstekingremmers, hetzij alleen, hetzij in combinatie 'met reeds veelvuldig 
toegepaste aspirine-achtige farmaca en worden suggesties gegeven voor 
nader onderzoek. 
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